Molecule ChEMBL ID;Molecule Name;Molecule Max Phase;Molecular Weight;#RO5 Violations;AlogP;Compound Key;Smiles;Standard Type;Standard Relation;Standard Value;Standard Units;pChEMBL Value;Data Validity Comment;Comment;Uo Units;Ligand Efficiency BEI;Ligand Efficiency LE;Ligand Efficiency LLE;Ligand Efficiency SEI;Potential Duplicate;Assay ChEMBL ID;Assay Description;Assay Type;BAO Format ID;BAO Label;Assay Organism;Assay Tissue ChEMBL ID;Assay Tissue Name;Assay Cell Type;Assay Subcellular Fraction;Assay Parameters;Assay Variant Accession;Assay Variant Mutation;Target ChEMBL ID;Target Name;Target Organism;Target Type;Document ChEMBL ID;Source ID;Source Description;Document Journal;Document Year;Cell ChEMBL ID;Properties
CHEMBL151527;;0;320.39;0;2.03;Z-Leu-Ala-H;CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](C)C=O;IC50;'=''';120;nM;6.92;;;UO_0000065;21.6;0.41;4.89;8.19;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL127322;;0;530.6;2;5.03;1g;CCOP(=O)(C(=O)[C@@H](CC(C)C)NC(=O)C(CC(C)C)NC(=O)OCc1ccccc1)c1ccccc1;IC50;'=''';370;nM;6.43;;;UO_0000065;12.12;0.24;1.4;5.8;0;CHEMBL658527;inhibitory activity measured against recombinant human Calpain-I receptor;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1131587;1;Scientific Literature;J. Med. Chem.;1998;None;
CHEMBL150208;;0;491.59;0;2.41;Z-Leu-Glu-Leu-H;CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@@H](C=O)CC(C)C;IC50;'=''';1200;nM;5.92;;;UO_0000065;12.04;0.23;3.51;3.92;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL357503;;0;383.53;0;1.8;Ac-Leu-Leu-D-Leu-H;CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](C=O)CC(C)C;IC50;'=''';62;nM;7.21;;;UO_0000065;18.79;0.36;5.41;6.91;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL23226;;0;382.39;0;1.44;4;CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)NC(CC(=O)O)C(=O)CF;IC50;'>''';10000;nM;;;;UO_0000065;;;;;0;CHEMBL657769;Compound was evaluated for its inhibitory activity against the Calpain 1 enzyme;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1147604;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL150366;;0;456.59;0;2.48;Ac-Leu-Leu-Trp-H;CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C=O)Cc1c[nH]c2ccccc12;IC50;'=''';150;nM;6.82;;;UO_0000065;14.95;0.28;4.34;5.68;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL1771024;;0;544.65;1;4.34;4g;CCCC/C(=C\c1ccc(O)c(O)c1)C(=O)N[C@@H](Cc1ccccc1)C(=O)C(=O)NCCc1ccc(OC)cc1;IC50;'=''';500;nM;6.3;;;UO_0000065;11.57;0.22;1.96;5.04;0;CHEMBL1771900;Inhibition of human erythrocytes mu-calpain using Suc-Leu-Tyr-AMC fluorogenic substrate after 30 mins by spectrofluorimetry;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1770073;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2011;None;
CHEMBL208986;;0;351.47;0;1.61;10;CC[C@H](C)[C@H](NC(=S)Nc1ccccc1)C(=O)N[C@H]1CCOC1O;IC50;'=''';600;nM;6.22;;;UO_0000065;17.7;0.35;4.61;7.53;0;CHEMBL863671;Inhibition of human erythrocyte mu calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138043;1;Scientific Literature;J. Med. Chem.;2006;None;
CHEMBL3706732;;0;441.55;0;3.26;6b;CC(C)C[C@H](NC(=O)c1ccc2c(c1)Nc1ccccc1S2)C(=O)N[C@H]1CCOC1O;IC50;'=''';22.5;nM;7.65;;;UO_0000065;17.32;0.34;4.39;7.67;0;CHEMBL654082;Inhibitory activity against on human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146815;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL332638;;0;508.6;1;2.75;15e;COc1cc2c(cc1OC)S(=O)(=O)N(Cc1ccccc1)C(C(=O)N[C@H](C=O)Cc1ccccc1)C2;IC50;'=''';1000;nM;6;;;UO_0000065;11.8;0.23;3.25;5.88;0;CHEMBL656196;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL118688;;0;441.34;0;2.47;15h;CN1C(C(=O)N[C@H](C=O)Cc2ccccc2)Cc2cc(Cl)c(Cl)cc2S1(=O)=O;IC50;'=''';7;nM;8.15;;;UO_0000065;18.48;0.4;5.68;9.76;0;CHEMBL877099;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL115963;;0;415.43;0;0.9;32b;O=C[C@H](Cc1ccccc1)NC(=O)C1=NS(=O)(=O)c2cc3c(cc2N1)OCCO3;IC50;'=''';28;nM;7.55;;;UO_0000065;18.18;0.36;6.65;6.13;0;CHEMBL877099;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL172051;;0;386.49;0;2.2;20;CC(C)C[C@H](C=O)NC(=O)[C@H](C(C)C)N(C)S(=O)(=O)c1ccc(F)cc1;IC50;'=''';21000;nM;4.68;;;UO_0000065;12.1;0.25;2.48;5.6;0;CHEMBL744609;In vitro inhibition of porcine mu-calpain.;B;BAO_0000357;single protein format;Sus scrofa;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1145779;1;Scientific Literature;J. Med. Chem.;2003;None;
CHEMBL8621;;0;578.65;1;1.4;8p;CCN1C(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCc2ccccn2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';170;nM;6.77;;;UO_0000065;11.7;0.23;5.37;4.7;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL267888;;0;684.79;1;1.17;11d;CCN1C(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCCCNS(=O)(=O)c2ccccc2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';35;nM;7.46;;;UO_0000065;10.89;0.22;6.29;4.21;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL267888;;0;684.79;1;1.17;11d;CCN1C(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCCCNS(=O)(=O)c2ccccc2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';2700;nM;5.57;;;UO_0000065;8.13;0.16;4.4;3.14;0;CHEMBL656844;In vitro inhibitory activity against human calpain 1 in Molt-4 cells (intact human T-cell leukemia cell line);B;BAO_0000219;cell-based format;None;None;None;MOLT-4;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;CHEMBL3307557;
CHEMBL197420;;0;491.54;0;1.46;2e;Cc1c(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCCN2CCOCC2)oc2ccccc2c1=O;IC50;'=''';8170;nM;5.09;;;UO_0000065;10.35;0.19;3.63;4.31;0;CHEMBL827857;Inhibitory concentration against human plasma mu-calpain;B;BAO_0000366;cell-free format;Homo sapiens;CHEMBL3559721;Plasma;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1139593;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2005;None;
CHEMBL8686;;0;642.71;1;0.05;11b;O=C(NCCNS(=O)(=O)c1ccccc1)C(=O)[C@H](Cc1ccccc1)NC(=O)C1Cc2cc3c(cc2S(=O)(=O)N1)OCCO3;IC50;;;nM;;;Not Determined;UO_0000065;;;;;0;CHEMBL656845;In vitro inhibitory activity against human calpain I in Molt-4 cells (intact human T-cell leukemia cell line); Not determined;B;BAO_0000219;cell-based format;None;None;None;MOLT-4;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;CHEMBL3307557
CHEMBL491898;;0;450.29;1;5.79;16;CC(=O)c1c(Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)[nH]c2c(F)ccc(F)c2c1=O;IC50;'>''';30000;nM;;;;UO_0000065;;;;;0;CHEMBL1021956;Inhibition of human erythrocytes mu-calpain after 30 mins by fluorometric assay using pep1 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL345543;;0;376.5;0;3.45;Z-t-BuAla-Leu-H;CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)(C)C)NC(=O)OCc1ccccc1;IC50;'=''';140;nM;6.85;;;UO_0000065;18.2;0.35;3.4;8.11;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL117006;;0;457.55;0;0.99;15k;CN1C(C(=O)N[C@H](C=O)Cc2ccccc2)Cc2cc(N3CCOCC3)ccc2S1(=O)=O;IC50;'=''';500;nM;6.3;;;UO_0000065;13.77;0.27;5.31;6.56;0;CHEMBL656196;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL8703;;0;436.53;0;2.5;2;O=C[C@H](Cc1ccccc1)NC(=O)C(Cc1ccccc1)NS(=O)(=O)c1ccccc1;IC50;'=''';20;nM;7.7;;;UO_0000065;17.64;0.34;5.2;8.34;1;CHEMBL654081;Inhibitory activity against calpain-I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL523822;;0;484.58;1;5.96;17;CC(=O)c1c(Nc2ccc(Br)cc2Br)[nH]c2c(Cl)ccc(C)c2c1=O;IC50;'=''';3060;nM;5.51;;;UO_0000065;11.38;0.3;-0.45;8.9;0;CHEMBL1021957;Inhibition of human erythrocytes mu-calpain by fluorometric assay using pep2 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL491918;;0;431.49;0;1.95;2j;Cc1ccc(=O)[nH]c1C(=O)N[C@@H](Cc1ccccc1)C(=O)C(=O)NCCc1ccccc1;IC50;'=''';7410;nM;5.13;;;UO_0000065;11.89;0.22;3.18;4.74;0;CHEMBL973384;Inhibition of human erythrocytes mu-calpain by spectrofluorimeter;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138543;1;Scientific Literature;Eur. J. Med. Chem.;2009;None;
CHEMBL524152;;0;418.45;0;1.3;2i;Cc1ccc(=O)[nH]c1C(=O)N[C@@H](Cc1ccccc1)C(=O)C(=O)NCc1ccccn1;IC50;'=''';84750;nM;4.07;;;UO_0000065;9.73;0.18;2.77;3.36;0;CHEMBL973384;Inhibition of human erythrocytes mu-calpain by spectrofluorimeter;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138543;1;Scientific Literature;Eur. J. Med. Chem.;2009;None;
CHEMBL149792;;0;396.49;0;3.25;Z-Phe-Leu-H;CC(C)C[C@@H](C=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1;IC50;'=''';230;nM;6.64;;;UO_0000065;16.74;0.31;3.39;7.86;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL356838;;0;491.59;0;2.41;Z-Glu-Leu-Leu-H;CC(C)C[C@H](C=O)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)OCc1ccccc1;IC50;'=''';40;nM;7.4;;;UO_0000065;15.05;0.29;4.99;4.9;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL99195;;0;380.51;0;2.76;Z-Leu-Met;CSCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1;IC50;'=''';33;nM;7.48;;;UO_0000065;19.66;0.39;4.72;8.85;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL465173;;0;398.46;0;1.81;4i-9;COc1ccc(OC)c(CCCC(=O)N[C@@H](Cc2ccccc2)C(=O)C(N)=O)c1;IC50;'=''';1860;nM;5.73;;;UO_0000065;14.38;0.27;3.92;5.32;0;CHEMBL1013486;Inhibition of human erythrocytes mu-calpain;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1154513;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2009;None;
CHEMBL150933;;0;327.43;0;0.38;Ac-Leu-Leu-Gly-H;CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)NCC=O;IC50;'~''';1000;nM;;;;UO_0000065;;;;;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL521771;;0;406.23;0;5;5;CC(=O)c1c(Nc2ccc(C)cc2Cl)[nH]c2c([N+](=O)[O-])cc(Cl)cc2c1=O;IC50;'=''';3730;nM;5.43;;;UO_0000065;13.36;0.27;0.43;5.16;0;CHEMBL1021956;Inhibition of human erythrocytes mu-calpain after 30 mins by fluorometric assay using pep1 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL491513;;0;372.4;1;5.28;8;CC(=O)c1c(Nc2cccc(F)c2)[nH]c2c(-c3ccccc3)cccc2c1=O;IC50;'>''';30000;nM;;;;UO_0000065;;;;;0;CHEMBL1021956;Inhibition of human erythrocytes mu-calpain after 30 mins by fluorometric assay using pep1 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL424142;;0;386.45;0;1.98;Z-Leu-His-H;CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@H](C=O)Cc1c[nH]cn1;IC50;'=''';15;nM;7.82;;;UO_0000065;20.25;0.38;5.84;6.91;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL253315;;0;511.58;1;3.11;3k;COc1ccc(CCNC(=O)C(=O)[C@H](Cc2ccccc2)NC(=O)c2[nH]c3ccccc3c(=O)c2C)cc1;IC50;'=''';730;nM;6.14;;;UO_0000065;12;0.22;3.03;5.23;0;CHEMBL928702;Inhibition of human mu-calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1140783;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2008;None;
CHEMBL401985;;0;497.55;0;3.07;3f;COc1ccc(CNC(=O)C(=O)[C@H](Cc2ccccc2)NC(=O)c2[nH]c3ccccc3c(=O)c2C)cc1;IC50;'=''';3810;nM;5.42;;;UO_0000065;10.89;0.2;2.35;4.62;0;CHEMBL928702;Inhibition of human mu-calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1140783;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2008;None;
CHEMBL126718;;0;409.8;0;3.65;21;NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccnc(F)c3)ccc2c1=O;IC50;'=''';30000;nM;4.52;;;UO_0000065;11.04;0.21;0.87;4.61;0;CHEMBL656843;In vitro inhibitory activity against human erythrocyte Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1153663;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1995;None;
CHEMBL340384;;0;391.81;0;3.51;8;NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O;IC50;'=''';500;nM;6.3;;;UO_0000065;16.08;0.31;2.79;6.42;0;CHEMBL656843;In vitro inhibitory activity against human erythrocyte Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1153663;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1995;None;
CHEMBL266784;;0;492;0;1.71;(text) (pg no 1038);CCNC(=O)C(=O)[C@H](Cc1ccccc1)NC(=O)C1Cc2cc(Cl)ccc2S(=O)(=O)N1CC;IC50;'=''';1000;nM;6;;;UO_0000065;12.2;0.25;4.29;5.33;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL274356;;0;595.68;1;1.09;8m;CCN1C(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCCCn2ccnc2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';5000;nM;5.3;;;UO_0000065;8.9;0.17;4.21;3.56;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL149406;;0;412.49;0;2.96;Z-Tyr-Leu-H;CC(C)C[C@@H](C=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)OCc1ccccc1;IC50;'>''';1000;nM;;;;UO_0000065;;;;;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL8641;;0;739.66;1;2.09;11g;CCN1C(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCCNS(=O)(=O)c2ccc(Cl)c(Cl)c2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';56;nM;7.25;;;UO_0000065;9.8;0.21;5.16;4.09;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL8391;;0;753.68;1;2.48;11h;CCN1C(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCCCNS(=O)(=O)c2ccc(Cl)c(Cl)c2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';56;nM;7.25;;;UO_0000065;9.62;0.2;4.77;4.09;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL461669;;0;502.57;1;3.25;4c-1;COCOc1ccccc1C(=O)CCC(=O)N[C@@H](Cc1ccccc1)C(=O)C(=O)NCc1ccccc1;IC50;'=''';4290;nM;5.37;;;UO_0000065;10.68;0.2;2.12;4.84;0;CHEMBL1013486;Inhibition of human erythrocytes mu-calpain;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1154513;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2009;None;
CHEMBL514112;;0;502.57;1;3.28;4.00E-001;COc1ccc(C(=O)CCC(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCc2ccccc2)c(OC)c1;IC50;'=''';6160;nM;5.21;;;UO_0000065;10.37;0.19;1.93;4.7;0;CHEMBL1013486;Inhibition of human erythrocytes mu-calpain;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1154513;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2009;None;
CHEMBL457768;;0;412.44;0;1.45;4.00E-002;COc1ccc(C(=O)CCC(=O)N[C@@H](Cc2ccccc2)C(=O)C(N)=O)c(OC)c1;IC50;'=''';1180;nM;5.93;;;UO_0000065;14.37;0.27;4.48;4.75;0;CHEMBL1013486;Inhibition of human erythrocytes mu-calpain;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1154513;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2009;None;
CHEMBL465169;;0;562.62;1;3.3;4i-4;COc1ccc(OC)c(C(=O)CCC(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCc2ccc(OC)c(OC)c2)c1;IC50;'=''';1640;nM;5.79;;;UO_0000065;10.28;0.19;2.49;4.48;0;CHEMBL1013486;Inhibition of human erythrocytes mu-calpain;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1154513;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2009;None;
CHEMBL8688;;0;612.71;1;0.82;8n;CCN1C(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCCCN2CCCC2=O)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';500;nM;6.3;;;UO_0000065;10.28;0.2;5.48;4.16;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL423222;;0;502.61;1;4.83;Z-Leu-Tyr(O-Benzyl)-H;CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@H](C=O)Cc1ccc(OCc2ccccc2)cc1;IC50;'=''';7;nM;8.15;;;UO_0000065;16.23;0.3;3.32;8.7;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL302897;;0;376.88;0;1.23;1b;CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)OCCCl;IC50;'=''';300;nM;6.52;;;UO_0000065;17.31;0.36;5.29;6.72;0;CHEMBL657758;The calpain inhibitory activity(I 50) was measured as ability to enter the platelet to inhibit calpain after cell lysis(assay 2);B;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None;
CHEMBL89100;;0;525.65;1;0.95;10;CS(=O)(=O)N[C@H](COCc1ccccc1)C(=O)N[C@H](C=O)CCCCNS(=O)(=O)c1ccccc1;IC50;'=''';400;nM;6.4;;;UO_0000065;12.17;0.25;5.45;4.33;0;CHEMBL658526;Inhibition of intracellular Calpain-I receptor using intact cell assay system;B;BAO_0000219;cell-based format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1131026;1;Scientific Literature;J. Med. Chem.;1998;None;
CHEMBL268950;;0;753.88;2;1.91;11k;CCN1C(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCCNS(=O)(=O)c2ccc(-c3ccccn3)s2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';20;nM;7.7;;;UO_0000065;10.21;0.21;5.79;4.05;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL123621;;0;448.56;0;2.16;6a;Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CCOC1O)O2;IC50;'=''';147;nM;6.83;;;UO_0000065;15.23;0.29;4.67;5.83;0;CHEMBL654082;Inhibitory activity against on human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146815;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL2408905;;0;487.45;1;-0.17;42;O=C(NCc1cn(-c2ccc([N+](=O)[O-])cc2)nn1)[C@H](Cc1cscn1)NC(=O)[C@H]1O[C@@H]1C(=O)O;IC50;'=''';300;nM;6.52;;;UO_0000065;13.38;0.26;6.69;3.35;1;CHEMBL2411626;Inhibition of human erythrocyte full length Cal1 using (DABCYL)TPLK-SPPSPR-(EDANS) as substrate after 20 min by FRET assay;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL2407090;1;Scientific Literature;J. Med. Chem.;2013;None;
CHEMBL2408897;;0;459.46;0;1.5;34;Cc1nc[nH]c1C[C@H](NC(=O)[C@H]1O[C@@H]1C(=O)O)C(=O)Nc1nc(-c2ccc(F)cc2)cs1;IC50;'=''';225;nM;6.65;;;UO_0000065;14.47;0.28;5.15;4.44;0;CHEMBL2411626;Inhibition of human erythrocyte full length Cal1 using (DABCYL)TPLK-SPPSPR-(EDANS) as substrate after 20 min by FRET assay;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL2407090;1;Scientific Literature;J. Med. Chem.;2013;None;
CHEMBL8391;;0;753.68;1;2.48;11h;CCN1C(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCCCNS(=O)(=O)c2ccc(Cl)c(Cl)c2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;;;nM;;;Not Determined;UO_0000065;;;;;0;CHEMBL656845;In vitro inhibitory activity against human calpain I in Molt-4 cells (intact human T-cell leukemia cell line); Not determined;B;BAO_0000219;cell-based format;None;None;None;MOLT-4;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;CHEMBL3307557
CHEMBL8104;;0;715.76;2;0.69;11e;CCN1C(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCCNS(=O)(=O)c2ccc([N+](=O)[O-])cc2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';47;nM;7.33;;;UO_0000065;10.24;0.2;6.64;3.32;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL436925;;0;545.61;1;0.45;8f;CCN1C(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCCOC)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';200;nM;6.7;;;UO_0000065;12.28;0.24;6.25;4.77;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL150257;;0;320.39;0;2.03;[(S)-3-Methyl-1-(3-oxo-propylcarbamoyl)-butyl]-carbamic acid benzyl ester;CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)NCCC=O;IC50;'>>''';10000;nM;;;;UO_0000065;;;;;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL357787;;0;433.55;0;2.56;Z-Leu-Ala-Leu-H;CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@H](C)C(=O)N[C@@H](C=O)CC(C)C;IC50;'=''';90;nM;7.05;;;UO_0000065;16.25;0.31;4.49;6.2;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL206737;;0;369.46;0;2.18;5;CC(C)C[C@@H](C#N)NC(=O)[C@@H](NS(=O)(=O)c1ccc(F)cc1)C(C)C;IC50;'>''';100000;nM;;;;UO_0000065;;;;;0;CHEMBL863671;Inhibition of human erythrocyte mu calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138043;1;Scientific Literature;J. Med. Chem.;2006;None;
CHEMBL42716;;0;435.56;1;5.28;1;CC(C)C[C@@H](C=O)NC(=O)[C@@H](CC(=O)C1c2ccccc2Oc2ccccc21)CC(C)C;IC50;'=''';25;nM;7.6;;;UO_0000065;17.45;0.32;2.32;10.49;0;CHEMBL656194;Inhibitory activity using recombinant human Calpain 1 with Suc-Leu-Tyr-MNA as substrate.;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1129824;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL490503;;0;448.75;1;6.17;4;CC(=O)c1c(Nc2ccc(C(F)(F)F)cc2)[nH]c2c(C(F)(F)F)cc(Cl)cc2c1=O;IC50;'>''';30000;nM;;;;UO_0000065;;;;;0;CHEMBL1021956;Inhibition of human erythrocytes mu-calpain after 30 mins by fluorometric assay using pep1 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL415736;;0;417.55;0;1.99;Ac-Leu-Leu-Phe-H;CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C=O)Cc1ccccc1;IC50;'=''';32;nM;7.5;;;UO_0000065;17.95;0.34;5.5;7.18;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL8733;;0;527.6;1;0.99;8l;C=CCNC(=O)C(=O)[C@H](Cc1ccccc1)NC(=O)C1Cc2cc3c(cc2S(=O)(=O)N1CC)OCCO3;IC50;'=''';200;nM;6.7;;;UO_0000065;12.7;0.25;5.71;5.11;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL356003;;0;498.67;0;2.45;Ac-Leu-Leu-Lys(t-Boc)-H;CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C=O)CCCCNC(=O)OC(C)(C)C;IC50;'=''';33;nM;7.48;;;UO_0000065;15;0.29;5.03;5.24;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL492089;;0;380.75;0;4.85;20;CC(=O)c1c(Nc2ccc(F)c(F)c2F)[nH]c2c(Cl)ccc(C)c2c1=O;IC50;;;;;;Not Determined;;;;;;0;CHEMBL1021957;Inhibition of human erythrocytes mu-calpain by fluorometric assay using pep2 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL126729;;0;391.81;0;3.51;9;NC(=O)c1cn(-c2ccc(O)c(Cl)c2)c2cc(-c3ccncc3)ccc2c1=O;IC50;'=''';2000;nM;5.7;;;UO_0000065;14.55;0.28;2.19;5.8;0;CHEMBL656843;In vitro inhibitory activity against human erythrocyte Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1153663;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1995;None;
CHEMBL8651;;0;543.64;1;1.61;8d (Single diastereomer);CCCCNC(=O)C(=O)[C@H](Cc1ccccc1)NC(=O)C1Cc2cc3c(cc2S(=O)(=O)N1CC)OCCO3;IC50;'=''';50;nM;7.3;;;UO_0000065;13.43;0.26;5.69;5.57;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL489530;;0;348.74;0;4.41;15;CC(=O)c1c(Nc2ccc(Cl)cc2)[nH]c2c(F)ccc(F)c2c1=O;IC50;'>''';30000;nM;;;;UO_0000065;;;;;0;CHEMBL1021956;Inhibition of human erythrocytes mu-calpain after 30 mins by fluorometric assay using pep1 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL423112;;0;382.46;0;2.86;MDL-28170;CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)NC(C=O)Cc1ccccc1;IC50;'=''';200;nM;6.7;;;UO_0000065;17.52;0.33;3.84;7.93;0;CHEMBL1021956;Inhibition of human erythrocytes mu-calpain after 30 mins by fluorometric assay using pep1 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL149969;;0;336.39;0;1;Z-Ser-Leu-H;CC(C)C[C@@H](C=O)NC(=O)[C@H](CO)NC(=O)OCc1ccccc1;IC50;'=''';530;nM;6.28;;;UO_0000065;18.66;0.36;5.28;5.99;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL150330;;0;377.44;0;1.28;Z-Gln-Leu-H;CC(C)C[C@@H](C=O)NC(=O)[C@H](CCC(N)=O)NC(=O)OCc1ccccc1;IC50;'=''';370;nM;6.43;;;UO_0000065;17.04;0.33;5.15;5.04;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL63440;ALOXISTATIN;0;342.44;0;1.01;E64d;CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C;IC50;'=''';4000;nM;5.4;;;UO_0000065;15.76;0.31;4.39;5.56;0;CHEMBL657758;The calpain inhibitory activity(I 50) was measured as ability to enter the platelet to inhibit calpain after cell lysis(assay 2);B;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None;
CHEMBL64647;;0;468.33;0;1.43;1d;CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)OCCI;IC50;;;nM;;;substantial inhibition by 5-44 uM;UO_0000065;;;;;0;CHEMBL659384;The calpain inhibitory activity(I 50) was measured as ability to enter the platelet and inhibit calpain in the intact cells(assay 3); (+)indicates substantial inhibition by 5-44 uM;B;BAO_0000219;cell-based format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None
CHEMBL41336;;0;387.56;0;4.75;7a;CC(C)C[C@@H](C=O)NC(=O)[C@@H](CC(=O)CCCCc1ccccc1)CC(C)C;IC50;'=''';138;nM;6.86;;;UO_0000065;17.7;0.33;2.11;10.85;0;CHEMBL654084;Inhibitory activity of compound against recombinant human Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1151519;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1996;None;
CHEMBL117553;;0;406.89;0;1.81;15j;CN1C(C(=O)N[C@H](C=O)Cc2ccccc2)Cc2cc(Cl)ccc2S1(=O)=O;IC50;'=''';15;nM;7.82;;;UO_0000065;19.23;0.4;6.01;9.36;0;CHEMBL656196;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL8294;;0;688.76;1;0.92;11i;CCN1C(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCCNS(=O)(=O)c2ccc(F)cc2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';2000;nM;5.7;;;UO_0000065;8.27;0.17;4.78;3.21;0;CHEMBL656844;In vitro inhibitory activity against human calpain 1 in Molt-4 cells (intact human T-cell leukemia cell line);B;BAO_0000219;cell-based format;None;None;None;MOLT-4;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;CHEMBL3307557;
CHEMBL3706732;;0;441.55;0;3.26;6b;CC(C)C[C@H](NC(=O)c1ccc2c(c1)Nc1ccccc1S2)C(=O)N[C@H]1CCOC1O;IC50;'=''';23490;nM;4.63;;;UO_0000065;;;;;0;CHEMBL659380;Inhibitory activity against on calpain in C6 glial cells;F;BAO_0000219;cell-based format;Rattus norvegicus;None;None;C6;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146815;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;CHEMBL3308345;
CHEMBL196113;;0;510.55;1;3.26;2b;Cc1c(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCc2ccccc2)oc2cc3c(cc2c1=O)CCO3;IC50;'=''';2480;nM;5.61;;;UO_0000065;10.98;0.2;2.35;4.89;0;CHEMBL827857;Inhibitory concentration against human plasma mu-calpain;B;BAO_0000366;cell-free format;Homo sapiens;CHEMBL3559721;Plasma;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1139593;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2005;None;
CHEMBL347742;;0;407.47;0;2.97;4-Nitro-Z-Leu-Leu-H;CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccc([N+](=O)[O-])cc1;IC50;'=''';8;nM;8.1;;;UO_0000065;19.87;0.38;5.13;6.34;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL150299;;0;350.42;0;1.39;Z-Thr-Leu-H;CC(C)C[C@@H](C=O)NC(=O)[C@@H](NC(=O)OCc1ccccc1)[C@H](C)O;IC50;'=''';190;nM;6.72;;;UO_0000065;19.18;0.37;5.33;6.42;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL151521;;0;362.47;0;3.06;Z-t-BuGly-Leu-H;CC(C)C[C@@H](C=O)NC(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)(C)C;IC50;'=''';4;nM;8.4;;;UO_0000065;23.17;0.44;5.34;9.94;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL150380;;0;382.53;0;2.42;MS-Leu_leu-H;Cc1ccc(S(=O)(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CC(C)C)cc1;IC50;'=''';35;nM;7.46;;;UO_0000065;19.49;0.39;5.04;8.07;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL269384;;0;444.51;0;1.32;(text) (pg no 1038);CCN1C(C(=O)N[C@H](C=O)Cc2ccccc2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';7;nM;8.15;;;UO_0000065;18.35;0.36;6.83;7.99;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL2376296;;0;393.87;0;4.37;24;CC1(Cc2ccccc2)OC(=O)c2c1ccn(CCc1ccc(Cl)cc1)c2=O;IC50;'=''';29600;nM;4.53;;;UO_0000065;11.5;0.22;0.16;9.38;0;CHEMBL2378746;Inhibition of calpain 1 in human erythrocytes using Suc-LLVY-AMC as substrate by fluorescence assay;B;BAO_0000219;cell-based format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL2375248;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2013;None;
CHEMBL196990;;0;540.57;1;3.14;2d;Cc1c(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCCc2ccccc2)oc2cc3c(cc2c1=O)OCCO3;IC50;'=''';4530;nM;5.34;;;UO_0000065;9.89;0.18;2.2;4.31;0;CHEMBL827857;Inhibitory concentration against human plasma mu-calpain;B;BAO_0000366;cell-free format;Homo sapiens;CHEMBL3559721;Plasma;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1139593;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2005;None;
CHEMBL302897;;0;376.88;0;1.23;1b;CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)OCCCl;IC50;;;nM;;;substantial inhibition by 5-44 uM;UO_0000065;;;;;0;CHEMBL659384;The calpain inhibitory activity(I 50) was measured as ability to enter the platelet and inhibit calpain in the intact cells(assay 3); (+)indicates substantial inhibition by 5-44 uM;B;BAO_0000219;cell-based format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None
CHEMBL420698;;0;372.45;0;1.16;15f;CN1C(C(=O)N[C@H](C=O)Cc2ccccc2)Cc2ccccc2S1(=O)=O;IC50;'=''';1700;nM;5.77;;;UO_0000065;;;;;0;CHEMBL714770;Inhibitory concentration against MOLT-4 cells (human T-cell leukemia cell line);F;BAO_0000219;cell-based format;None;None;None;MOLT-4;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;CHEMBL3307557;
CHEMBL254142;;0;377.4;0;1.23;3;Cc1c(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(N)=O)[nH]c2ccccc2c1=O;IC50;'=''';710;nM;6.15;;;UO_0000065;16.29;0.3;4.92;5.03;0;CHEMBL1013486;Inhibition of human erythrocytes mu-calpain;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1154513;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2009;None;
CHEMBL462912;;0;546.62;1;3.33;4i-6;COc1ccc(CCNC(=O)C(=O)[C@H](Cc2ccccc2)NC(=O)CCC(=O)c2cc(OC)ccc2OC)cc1;IC50;'=''';950;nM;6.02;;;UO_0000065;11.02;0.21;2.69;5.02;0;CHEMBL1013486;Inhibition of human erythrocytes mu-calpain;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1154513;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2009;None;
CHEMBL338878;;0;574.66;2;6.02;1e;CCCCOP(=O)(OCCCC)C(=O)[C@@H](Cc1ccccc1)NC(=O)C(NC(=O)OCc1ccccc1)C(C)C;IC50;'>''';10000;nM;;;;UO_0000065;;;;;0;CHEMBL658527;inhibitory activity measured against recombinant human Calpain-I receptor;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1131587;1;Scientific Literature;J. Med. Chem.;1998;None;
CHEMBL457767;;0;458.51;0;2.97;4d-1;O=C(CCC(=O)c1ccccc1O)N[C@@H](Cc1ccccc1)C(=O)C(=O)NCc1ccccc1;IC50;'=''';13840;nM;4.86;;;UO_0000065;10.6;0.2;1.89;4.32;0;CHEMBL1013486;Inhibition of human erythrocytes mu-calpain;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1154513;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2009;None;
CHEMBL503173;;0;488.54;0;2.98;4g-1;COc1ccc(C(=O)CCC(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCc2ccccc2)c(O)c1;IC50;'=''';12990;nM;4.89;;;UO_0000065;10;0.19;1.91;4.01;0;CHEMBL1013486;Inhibition of human erythrocytes mu-calpain;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1154513;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2009;None;
CHEMBL521771;;0;406.23;0;5;5;CC(=O)c1c(Nc2ccc(C)cc2Cl)[nH]c2c([N+](=O)[O-])cc(Cl)cc2c1=O;IC50;'=''';2390;nM;5.62;;;UO_0000065;13.84;0.28;0.62;5.35;0;CHEMBL1021957;Inhibition of human erythrocytes mu-calpain by fluorometric assay using pep2 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL513042;;0;426.1;1;5.54;10;CC(=O)c1c(Nc2ccc(Cl)cc2)[nH]c2c(Br)ccc(Cl)c2c1=O;IC50;'=''';3530;nM;5.45;;;UO_0000065;12.8;0.31;-0.09;8.8;0;CHEMBL1021956;Inhibition of human erythrocytes mu-calpain after 30 mins by fluorometric assay using pep1 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL471916;;0;330.75;0;4.27;13;CC(=O)c1c(Nc2ccccc2)[nH]c2c(Cl)ccc(F)c2c1=O;IC50;'>''';30000;nM;;;;UO_0000065;;;;;0;CHEMBL1021956;Inhibition of human erythrocytes mu-calpain after 30 mins by fluorometric assay using pep1 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL195728;;0;378.38;0;1.5;2;Cc1c(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(N)=O)oc2ccccc2c1=O;IC50;'=''';40;nM;7.4;;;UO_0000065;19.55;0.36;5.9;6.19;1;CHEMBL928702;Inhibition of human mu-calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1140783;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2008;None;
CHEMBL8728;;0;614.72;1;0.53;8o;CCN1C(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCCCN2CCOCC2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';195;nM;6.71;;;UO_0000065;10.92;0.21;6.18;4.67;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL62988;;0;660.85;1;4.01;1i;CCCCC(COC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1;IC50;'=''';100000;nM;4;;;UO_0000065;6.05;0.12;-0.01;2.43;0;CHEMBL659382;The ability of compound to inhibit calpain in a preparation of lysed platelets was measured with a caseinolytic assay(assay 1);B;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None;
CHEMBL294046;;0;360.43;0;0.96;1a;CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)OCCF;IC50;'=''';3000;nM;5.52;;;UO_0000065;15.32;0.3;4.56;5.69;0;CHEMBL657758;The calpain inhibitory activity(I 50) was measured as ability to enter the platelet to inhibit calpain after cell lysis(assay 2);B;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None;
CHEMBL471915;;0;416.09;1;6.09;11;CC(=O)c1c(Nc2ccc(Cl)cc2Cl)[nH]c2c(Cl)ccc(Cl)c2c1=O;IC50;'=''';3990;nM;5.4;;;UO_0000065;12.98;0.29;-0.69;8.71;0;CHEMBL1021956;Inhibition of human erythrocytes mu-calpain after 30 mins by fluorometric assay using pep1 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL2408903;;0;578.45;1;1.96;40;O=C(NCc1cn(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)nn1)[C@H](Cc1cscn1)NC(=O)[C@H]1O[C@@H]1C(=O)O;IC50;'>''';1000;nM;;;;UO_0000065;;;;;1;CHEMBL2411626;Inhibition of human erythrocyte full length Cal1 using (DABCYL)TPLK-SPPSPR-(EDANS) as substrate after 20 min by FRET assay;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL2407090;1;Scientific Literature;J. Med. Chem.;2013;None;
CHEMBL2408917;;0;462.48;0;1.92;31;O=C(Nc1nc(-c2ccc(F)cc2)cs1)[C@H](Cc1cscn1)NC(=O)[C@H]1O[C@@H]1C(=O)O;IC50;'=''';100;nM;7;;;UO_0000065;15.14;0.31;5.08;5.23;0;CHEMBL2411626;Inhibition of human erythrocyte full length Cal1 using (DABCYL)TPLK-SPPSPR-(EDANS) as substrate after 20 min by FRET assay;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL2407090;1;Scientific Literature;J. Med. Chem.;2013;None;
CHEMBL2408916;;0;361.38;0;0.66;30;O=C(Nc1ccccc1)[C@H](Cc1cscn1)NC(=O)[C@H]1O[C@@H]1C(=O)O;IC50;'=''';2500;nM;5.6;;;UO_0000065;15.5;0.31;4.94;4.63;1;CHEMBL2411626;Inhibition of human erythrocyte full length Cal1 using (DABCYL)TPLK-SPPSPR-(EDANS) as substrate after 20 min by FRET assay;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL2407090;1;Scientific Literature;J. Med. Chem.;2013;None;
CHEMBL2408915;;0;419.39;0;0.68;29b;O=C(Nc1nc2ccc(F)cc2s1)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1O[C@H]1C(=O)O;IC50;'>''';1000;nM;;;;UO_0000065;;;;;0;CHEMBL2411626;Inhibition of human erythrocyte full length Cal1 using (DABCYL)TPLK-SPPSPR-(EDANS) as substrate after 20 min by FRET assay;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL2407090;1;Scientific Literature;J. Med. Chem.;2013;None;
CHEMBL2408914;;0;419.39;0;0.68;29a;O=C(Nc1nc2ccc(F)cc2s1)[C@H](Cc1c[nH]cn1)NC(=O)[C@H]1O[C@@H]1C(=O)O;IC50;'=''';530;nM;6.28;;;UO_0000065;14.96;0.3;5.6;4.2;0;CHEMBL2411626;Inhibition of human erythrocyte full length Cal1 using (DABCYL)TPLK-SPPSPR-(EDANS) as substrate after 20 min by FRET assay;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL2407090;1;Scientific Literature;J. Med. Chem.;2013;None;
CHEMBL2408911;;0;386.41;0;0.85;27;Cc1cc(C)c(NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H]2O[C@@H]2C(=O)O)c(C)c1;IC50;'=''';5000;nM;5.3;;;UO_0000065;13.72;0.26;4.45;3.88;1;CHEMBL2411626;Inhibition of human erythrocyte full length Cal1 using (DABCYL)TPLK-SPPSPR-(EDANS) as substrate after 20 min by FRET assay;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL2407090;1;Scientific Literature;J. Med. Chem.;2013;None;
CHEMBL2367774;;0;425.51;0;1.82;10;Cc1ccc(S(=O)(=O)N2C[C@H](C#N)C[C@H]2C(=O)N[C@H](C=O)Cc2ccccc2)cc1;IC50;'=''';28;nM;7.55;;;UO_0000065;17.75;0.34;5.73;7.04;0;CHEMBL656842;Compound was tested for inhibitory activity against recombinant human Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130591;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1998;None;
CHEMBL91991;;0;510.61;1;2.63;11;CS(=O)(=O)N[C@H](COCc1ccccc1)C(=O)N[C@H](C=O)Cc1ccc(OCc2ccccc2)cc1;IC50;'=''';700;nM;6.16;;;UO_0000065;12.05;0.23;3.52;5.55;0;CHEMBL658526;Inhibition of intracellular Calpain-I receptor using intact cell assay system;B;BAO_0000219;cell-based format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1131026;1;Scientific Literature;J. Med. Chem.;1998;None;
CHEMBL4073900;;0;958.16;3;0.4;72;CCCCCC/C=C\CC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CO)[C@@H](O)CC(=O)N[C@H](C(=O)N[C@@H]1/C=C/C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](Cc2ccc(O)cc2)C(=O)OC1)C(C)C)C(C)C;IC50;'=''';3;nM;8.52;;;UO_0000065;8.9;0.17;8.12;2.82;0;CHEMBL4024817;Inhibition of human calpain 1 protease using Ac-LLY-AFC as substrate after 1 hr by fluorescence assay;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL4024702;1;Scientific Literature;J Med Chem;2017;None;
CHEMBL129068;;0;391.81;0;3.51;19;NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3cccnc3)ccc2c1=O;IC50;'=''';10000;nM;5;;;UO_0000065;12.76;0.24;1.49;5.09;0;CHEMBL656843;In vitro inhibitory activity against human erythrocyte Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1153663;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1995;None;
CHEMBL89668;;0;469.54;0;2.3;3a;CONC(=O)C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1;IC50;'=''';10;nM;8;;;UO_0000065;17.04;0.32;5.7;6.51;0;CHEMBL657770;Inhibition of human recombinant Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1133978;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2001;None;
CHEMBL316135;;0;582.7;1;2.83;3l;CONC(=O)C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1;IC50;'=''';20;nM;7.7;;;UO_0000065;13.21;0.25;4.87;5.07;0;CHEMBL657770;Inhibition of human recombinant Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1133978;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2001;None;
CHEMBL89771;;0;635.59;1;4.57;3d;CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)C(=O)NOCc1c(F)c(F)c(F)c(F)c1F;IC50;'=''';17;nM;7.77;;;UO_0000065;12.22;0.24;3.2;6.33;0;CHEMBL657770;Inhibition of human recombinant Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1133978;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2001;None;
CHEMBL89693;;0;447.56;0;0.98;Page 2616;CCNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](COCc1ccccc1)NS(C)(=O)=O;IC50;'=''';56;nM;7.25;;;UO_0000065;16.2;0.32;6.27;6.38;0;CHEMBL657770;Inhibition of human recombinant Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1133978;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2001;None;
CHEMBL491513;;0;372.4;1;5.28;8;CC(=O)c1c(Nc2cccc(F)c2)[nH]c2c(-c3ccccc3)cccc2c1=O;IC50;;;;;;Not Determined;;;;;;0;CHEMBL1021957;Inhibition of human erythrocytes mu-calpain by fluorometric assay using pep2 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL491964;;0;370.4;1;5.05;14;CC(=O)c1c(Nc2ccc(C(C)(C)C)cc2)[nH]c2c(F)ccc(F)c2c1=O;IC50;'>''';30000;nM;;;;UO_0000065;;;;;0;CHEMBL1021956;Inhibition of human erythrocytes mu-calpain after 30 mins by fluorometric assay using pep1 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL567893;GRASSYSTATIN A;0;1174.44;None;None;1;COC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](OC(=O)[C@@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(C)C)[C@@H](C)O;IC50;'=''';10000;nM;5;;;UO_0000065;4.26;None;None;None;0;CHEMBL1039229;Inhibition of calpain 1 after 10 to 15 mins by fluorescence assay;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1156023;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL80933;;0;428.54;0;3.14;5c;CN(C)Cc1ccc(/C=C/c2ncccc2C(=O)NC(Cc2ccccc2)C(N)=O)cc1;IC50;'=''';1000;nM;6;;;UO_0000065;;;;;0;CHEMBL654080;Inhibition of degradation of tyrosine kinase pp60src by Calpain 1 in human platelets;F;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1145789;1;Scientific Literature;J. Med. Chem.;2003;None;
CHEMBL446137;;0;400.49;0;4.02;13 (Cbz-Leu-Phe-CH2F);CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@H](CF)Cc1ccccc1;IC50;;;nM;;;Not Determined;UO_0000065;;;;;0;CHEMBL654085;Inhibitory activity of compound against recombinant human Calpain 1; No data;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1151519;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1996;None
CHEMBL126585;;0;554.67;2;6.21;1c;CCCCOP(=O)(OCCCC)C(=O)[C@@H](CC(C)C)NC(=O)C(CC(C)C)NC(=O)OCc1ccccc1;IC50;'>''';10000;nM;;;;UO_0000065;;;;;0;CHEMBL658527;inhibitory activity measured against recombinant human Calpain-I receptor;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1131587;1;Scientific Literature;J. Med. Chem.;1998;None;
CHEMBL63494;;0;421.33;0;1.39;1c;CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)OCCBr;IC50;'=''';2000;nM;5.7;;;UO_0000065;13.53;0.31;4.31;5.87;0;CHEMBL657758;The calpain inhibitory activity(I 50) was measured as ability to enter the platelet to inhibit calpain after cell lysis(assay 2);B;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None;
CHEMBL8641;;0;739.66;1;2.09;11g;CCN1C(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCCNS(=O)(=O)c2ccc(Cl)c(Cl)c2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;;;nM;;;Not Determined;UO_0000065;;;;;0;CHEMBL656845;In vitro inhibitory activity against human calpain I in Molt-4 cells (intact human T-cell leukemia cell line); Not determined;B;BAO_0000219;cell-based format;None;None;None;MOLT-4;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;CHEMBL3307557
CHEMBL316721;;0;431.6;0;4.4;2;CC(C)C[C@@H](C=O)NC(=O)[C@H](CCS(=O)(=O)c1ccc2ccccc2c1)CC(C)C;IC50;'=''';500;nM;6.3;;;UO_0000065;14.6;0.29;1.9;7.85;0;CHEMBL656194;Inhibitory activity using recombinant human Calpain 1 with Suc-Leu-Tyr-MNA as substrate.;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1129824;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL339558;;0;425.37;0;3.88;13;NC(=O)c1cn(-c2ccc(O)cc2C(F)(F)F)c2cc(-c3ccncc3)ccc2c1=O;IC50;'=''';20000;nM;4.7;;;UO_0000065;11.05;0.21;0.82;4.78;0;CHEMBL656843;In vitro inhibitory activity against human erythrocyte Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1153663;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1995;None;
CHEMBL471915;;0;416.09;1;6.09;11;CC(=O)c1c(Nc2ccc(Cl)cc2Cl)[nH]c2c(Cl)ccc(Cl)c2c1=O;IC50;'=''';3170;nM;5.5;;;UO_0000065;13.22;0.3;-0.59;8.87;0;CHEMBL1021957;Inhibition of human erythrocytes mu-calpain by fluorometric assay using pep2 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL491964;;0;370.4;1;5.05;14;CC(=O)c1c(Nc2ccc(C(C)(C)C)cc2)[nH]c2c(F)ccc(F)c2c1=O;IC50;;;;;;Not Determined;;;;;;0;CHEMBL1021957;Inhibition of human erythrocytes mu-calpain by fluorometric assay using pep2 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL1771027;;0;572.7;1;4.94;4j;CCCC/C(=C\c1ccc(OC)c(OC)c1)C(=O)N[C@@H](Cc1ccccc1)C(=O)C(=O)NCCc1ccc(OC)cc1;IC50;'=''';1380;nM;5.86;;;UO_0000065;10.23;0.19;0.92;5.69;0;CHEMBL1771900;Inhibition of human erythrocytes mu-calpain using Suc-Leu-Tyr-AMC fluorogenic substrate after 30 mins by spectrofluorimetry;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1770073;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2011;None;
CHEMBL418130;;0;438.95;0;2.84;1h;CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)OCc1ccccc1Cl;IC50;;;nM;;;substantial inhibition by 5-44 uM;UO_0000065;;;;;0;CHEMBL659384;The calpain inhibitory activity(I 50) was measured as ability to enter the platelet and inhibit calpain in the intact cells(assay 3); (+)indicates substantial inhibition by 5-44 uM;B;BAO_0000219;cell-based format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None
CHEMBL489727;;0;412.77;1;5.59;21;CC(=O)c1c(Nc2cc(C)ccc2F)[nH]c2c(Cl)ccc(C(F)(F)F)c2c1=O;IC50;'>''';30000;nM;;;;UO_0000065;;;;;0;CHEMBL1021956;Inhibition of human erythrocytes mu-calpain after 30 mins by fluorometric assay using pep1 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL2408913;;0;445.43;0;1.19;28b;O=C(Nc1nc(-c2ccc(F)cc2)cs1)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1O[C@H]1C(=O)O;IC50;'>''';1000;nM;;;;UO_0000065;;;;;0;CHEMBL2411626;Inhibition of human erythrocyte full length Cal1 using (DABCYL)TPLK-SPPSPR-(EDANS) as substrate after 20 min by FRET assay;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL2407090;1;Scientific Literature;J. Med. Chem.;2013;None;
CHEMBL2408910;;0;344.33;0;-0.07;26;O=C(Nc1ccccc1)[C@H](Cc1cnc[nH]1)NC(=O)[C@H]1O[C@@H]1C(=O)O;IC50;'=''';5000;nM;5.3;;;UO_0000065;15.4;0.29;5.37;3.88;1;CHEMBL2411626;Inhibition of human erythrocyte full length Cal1 using (DABCYL)TPLK-SPPSPR-(EDANS) as substrate after 20 min by FRET assay;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL2407090;1;Scientific Literature;J. Med. Chem.;2013;None;
CHEMBL2408922;;0;421.45;0;2.27;22a;CC(C)C[C@H](NC(=O)[C@H]1O[C@@H]1C(=O)O)C(=O)Nc1nc(-c2ccc(F)cc2)cs1;IC50;'=''';50;nM;7.3;;;UO_0000065;17.32;0.34;5.03;6.04;1;CHEMBL2411626;Inhibition of human erythrocyte full length Cal1 using (DABCYL)TPLK-SPPSPR-(EDANS) as substrate after 20 min by FRET assay;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL2407090;1;Scientific Literature;J. Med. Chem.;2013;None;
CHEMBL2408923;;0;356.33;0;1.29;21b;CC(C)C[C@H](NC(=O)[C@@H]1O[C@H]1C(=O)O)C(=O)Nc1c(F)cccc1F;IC50;'>''';1000;nM;;;;UO_0000065;;;;;0;CHEMBL2411626;Inhibition of human erythrocyte full length Cal1 using (DABCYL)TPLK-SPPSPR-(EDANS) as substrate after 20 min by FRET assay;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL2407090;1;Scientific Literature;J. Med. Chem.;2013;None;
CHEMBL374508;E-64;0;357.41;0;-1.46;E-64;CC(C)C[C@H](NC(=O)[C@H]1O[C@@H]1C(=O)O)C(=O)NCCCCN=C(N)N;IC50;'=''';100;nM;7;;;UO_0000065;19.59;0.38;8.46;4.06;0;CHEMBL2411626;Inhibition of human erythrocyte full length Cal1 using (DABCYL)TPLK-SPPSPR-(EDANS) as substrate after 20 min by FRET assay;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL2407090;1;Scientific Literature;J. Med. Chem.;2013;None;
CHEMBL455277;;0;623.74;1;1.42;5, SNJ-1957;COCCOCCOCCOCCOCCOC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)C(=O)NC1CC1;IC50;'=''';420;nM;6.38;;;UO_0000065;10.22;0.2;4.96;3.99;0;CHEMBL991566;Inhibition of human erythrocyte mu-calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1144224;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2008;None;
CHEMBL489728;;0;368.26;0;4.17;22;CC(=O)c1c(Nc2cc(F)c(F)cc2F)[nH]c2c(F)cc(F)cc2c1=O;IC50;;;;;;Not Determined;;;;;;0;CHEMBL1021957;Inhibition of human erythrocytes mu-calpain by fluorometric assay using pep2 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL489530;;0;348.74;0;4.41;15;CC(=O)c1c(Nc2ccc(Cl)cc2)[nH]c2c(F)ccc(F)c2c1=O;IC50;;;;;;Not Determined;;;;;;0;CHEMBL1021957;Inhibition of human erythrocytes mu-calpain by fluorometric assay using pep2 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL1923969;;0;372.46;0;1.86;23 (D,D);CC(C)C[C@H](C=O)NC(=O)[C@H](NS(=O)(=O)c1ccc(F)cc1)C(C)C;IC50;'=''';1000000;nM;;Outside typical range;;UO_0000065;;;;;0;CHEMBL744609;In vitro inhibition of porcine mu-calpain.;B;BAO_0000357;single protein format;Sus scrofa;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1145779;1;Scientific Literature;J. Med. Chem.;2003;None;
CHEMBL418130;;0;438.95;0;2.84;1h;CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)OCc1ccccc1Cl;IC50;'=''';2000;nM;5.7;;;UO_0000065;12.98;0.26;2.86;5.87;0;CHEMBL657758;The calpain inhibitory activity(I 50) was measured as ability to enter the platelet to inhibit calpain after cell lysis(assay 2);B;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None;
CHEMBL323656;;0;418.47;0;0.83;15c;COc1cc2c(cc1OC)S(=O)(=O)NC(C(=O)N[C@H](C=O)Cc1ccccc1)C2;IC50;'=''';700;nM;6.16;;;UO_0000065;14.71;0.29;5.32;5.55;0;CHEMBL877099;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL117694;;0;400.46;0;1.56;26d;COC1=C(C(=O)N[C@H](C=O)Cc2ccccc2)N(C)S(=O)(=O)c2ccccc21;IC50;'=''';3200;nM;5.5;;;UO_0000065;;;;;0;CHEMBL714770;Inhibitory concentration against MOLT-4 cells (human T-cell leukemia cell line);F;BAO_0000219;cell-based format;None;None;None;MOLT-4;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;CHEMBL3307557;
CHEMBL269333;;0;442.49;0;1.75;(text) (pg no 1038);CCN1C(C(=O)N[C@H](C=O)Cc2ccccc2)=Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';8;nM;8.1;;;UO_0000065;18.3;0.36;6.35;7.94;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL261953;;0;365.5;0;1.92;17;Cc1cccc(NC(=S)N[C@@H](CC(C)C)C(=O)N[C@H]2CCOC2O)c1;IC50;'=''';180;nM;6.75;;;UO_0000065;18.45;0.37;4.82;8.16;0;CHEMBL863671;Inhibition of human erythrocyte mu calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138043;1;Scientific Literature;J. Med. Chem.;2006;None;
CHEMBL207440;;0;351.47;0;1.61;8, SNJ-1715;CC(C)C[C@H](NC(=S)Nc1ccccc1)C(=O)N[C@H]1CCOC1O;IC50;'=''';86;nM;7.07;;;UO_0000065;20.1;0.4;5.46;8.55;0;CHEMBL863671;Inhibition of human erythrocyte mu calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138043;1;Scientific Literature;J. Med. Chem.;2006;None;
CHEMBL209457;;0;471.6;0;2.14;4;CCCCNC(=O)C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NS(=O)(=O)c1ccc(F)cc1)C(C)C;IC50;'=''';21;nM;7.68;;;UO_0000065;16.28;0.33;5.54;6.32;0;CHEMBL863671;Inhibition of human erythrocyte mu calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138043;1;Scientific Literature;J. Med. Chem.;2006;None;
CHEMBL340840;;0;642.69;2;6.82;1f;CC(C)C(NC(=O)OCc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)P(=O)(OCc1ccccc1)OCc1ccccc1;IC50;'=''';6000;nM;5.22;;;UO_0000065;8.12;0.16;-1.6;4.35;0;CHEMBL658527;inhibitory activity measured against recombinant human Calpain-I receptor;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1131587;1;Scientific Literature;J. Med. Chem.;1998;None;
CHEMBL8757;;0;702.78;1;1.31;11j;CCN1C(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCCCNS(=O)(=O)c2ccc(F)cc2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';2400;nM;5.62;;;UO_0000065;8;0.16;4.31;3.17;0;CHEMBL656844;In vitro inhibitory activity against human calpain 1 in Molt-4 cells (intact human T-cell leukemia cell line);B;BAO_0000219;cell-based format;None;None;None;MOLT-4;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;CHEMBL3307557;
CHEMBL286722;;0;382.46;0;2.86;Cbz-Val-Phe-H;CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@H](C=O)Cc1ccccc1;IC50;'=''';300;nM;6.52;;;UO_0000065;17.06;0.32;3.66;7.72;0;CHEMBL658526;Inhibition of intracellular Calpain-I receptor using intact cell assay system;B;BAO_0000219;cell-based format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1131026;1;Scientific Literature;J. Med. Chem.;1998;None;
CHEMBL168471;;0;372.46;0;1.86;22 (D,L);CC(C)C[C@H](C=O)NC(=O)[C@@H](NS(=O)(=O)c1ccc(F)cc1)C(C)C;IC50;'=''';42000;nM;4.38;;;UO_0000065;11.75;0.24;2.52;4.74;0;CHEMBL744609;In vitro inhibition of porcine mu-calpain.;B;BAO_0000357;single protein format;Sus scrofa;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1145779;1;Scientific Literature;J. Med. Chem.;2003;None;
CHEMBL345338;;0;546.71;1;3.09;Z-Ala-Leu-Leu-Leu-H;CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](C)NC(=O)OCc1ccccc1;IC50;'=''';6;nM;8.22;;;UO_0000065;15.04;0.29;5.13;5.76;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL276726;;0;729.79;2;1.08;11f;CCN1C(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCCCNS(=O)(=O)c2ccc([N+](=O)[O-])cc2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';50;nM;7.3;;;UO_0000065;10;0.2;6.22;3.31;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL8686;;0;642.71;1;0.05;11b;O=C(NCCNS(=O)(=O)c1ccccc1)C(=O)[C@H](Cc1ccccc1)NC(=O)C1Cc2cc3c(cc2S(=O)(=O)N1)OCCO3;IC50;'=''';76;nM;7.12;;;UO_0000065;11.08;0.22;7.07;3.83;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL1793864;;0;509.63;1;1.41;8b (Single diastereomer);CCCCNC(=O)C(=O)[C@H](CC(C)C)NC(=O)C1Cc2cc3c(cc2S(=O)(=O)N1CC)OCCO3;IC50;'=''';500;nM;6.3;;;UO_0000065;12.36;0.25;4.89;4.81;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL433563;;0;482.39;None;None;10a;CC(C)CN(CC(=O)N(CC(C)C)NC(=O)OCc1ccccc1)/N=C/c1ccccc1B(O)O;IC50;'>''';1000000;nM;;Outside typical range;;UO_0000065;;;;;0;CHEMBL826414;Inhibitory concentration against Calpain I activity;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1139495;1;Scientific Literature;J. Med. Chem.;2005;None;
CHEMBL115073;;0;441.51;0;2.36;109;Cc1ccc(S(=O)(=O)N2CC(N=[N+]=[N-])CC2C(=O)N[C@H](C=O)Cc2ccccc2)cc1;IC50;'=''';28;nM;7.55;;;UO_0000065;17.11;0.33;5.19;5.71;0;CHEMBL821730;Inhibitory activity against calpain.;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1133572;1;Scientific Literature;J. Med. Chem.;2000;None;
CHEMBL303315;;0;572.7;1;3.6;1j;CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)Oc1ccc2[nH]cc(CCNC(=O)OC(C)(C)C)c2c1;IC50;'=''';2000;nM;5.7;;;UO_0000065;9.95;0.19;2.1;3.77;0;CHEMBL659382;The ability of compound to inhibit calpain in a preparation of lysed platelets was measured with a caseinolytic assay(assay 1);B;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None;
CHEMBL354575;;0;330.38;0;0.83;11;CC(C)[C@H](NS(=O)(=O)c1ccc(F)cc1)C(=O)N[C@H](C)C=O;IC50;'=''';630;nM;6.2;;;UO_0000065;18.77;0.38;5.37;6.72;0;CHEMBL744609;In vitro inhibition of porcine mu-calpain.;B;BAO_0000357;single protein format;Sus scrofa;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1145779;1;Scientific Literature;J. Med. Chem.;2003;None;
CHEMBL473251;;0;579.69;1;1.4;4, SNJ-1953;COCCOCCOCCOCCOC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)C(=O)NC1CC1;IC50;'=''';220;nM;6.66;;;UO_0000065;11.48;0.22;5.26;4.42;0;CHEMBL991566;Inhibition of human erythrocyte mu-calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1144224;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2008;None;
CHEMBL466551;;0;352.39;0;1.43;4a-2;NC(=O)C(=O)[C@H](Cc1ccccc1)NC(=O)CCC(=O)c1ccccc1;IC50;'=''';3200;nM;5.5;;;UO_0000065;15.59;0.29;4.06;5.17;0;CHEMBL1013486;Inhibition of human erythrocytes mu-calpain;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1154513;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2009;None;
CHEMBL150620;;0;509.65;1;3.78;Z-Leu-Phe-Leu-H;CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](C=O)CC(C)C;IC50;'=''';68;nM;7.17;;;UO_0000065;14.06;0.26;3.39;6.31;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL340663;;0;357.37;0;2.86;1;NC(=O)c1cn(-c2ccc(O)cc2)c2cc(-c3ccncc3)ccc2c1=O;IC50;'=''';2000;nM;5.7;;;UO_0000065;15.95;0.29;2.84;5.8;0;CHEMBL656843;In vitro inhibitory activity against human erythrocyte Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1153663;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1995;None;
CHEMBL42716;;0;435.56;1;5.28;7c;CC(C)C[C@@H](C=O)NC(=O)[C@@H](CC(=O)C1c2ccccc2Oc2ccccc21)CC(C)C;IC50;'=''';25;nM;7.6;;;UO_0000065;17.45;0.32;2.32;10.49;1;CHEMBL654084;Inhibitory activity of compound against recombinant human Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1151519;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1996;None;
CHEMBL301598;;0;483.57;0;2.69;3b;CCONC(=O)C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1;IC50;'=''';19;nM;7.72;;;UO_0000065;15.97;0.3;5.03;6.29;0;CHEMBL657770;Inhibition of human recombinant Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1133978;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2001;None;
CHEMBL4287411;;0;376.84;0;2.24;4o;COCCN/C(=C1/N=CN(CCOC)C1=O)c1[nH]c2ccccc2c1Cl;IC50;'>''';1000;nM;;;;UO_0000065;;;;;0;CHEMBL4263564;Inhibition of calpain (unknown origin) using Suc-LY-AMC as fluorogenic substrate after 60 mins by spectrofluorometric analysis;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL4261583;1;Scientific Literature;Eur J Med Chem;2018;None;
CHEMBL100316;;0;431.6;0;4.4;3;CC(C)C[C@@H](C=O)NC(=O)[C@@H](CCS(=O)(=O)c1ccc2ccccc2c1)CC(C)C;IC50;'=''';50;nM;7.3;;;UO_0000065;16.92;0.33;2.9;9.09;0;CHEMBL656194;Inhibitory activity using recombinant human Calpain 1 with Suc-Leu-Tyr-MNA as substrate.;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1129824;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL185356;;0;451.28;0;2.74;5p (MX-1122);CC(C)[C@H](NC(=O)OCc1ccc(Cl)cc1Cl)C(=O)NC(CC(=O)O)C(=O)CF;IC50;'~''';5000;nM;;;;UO_0000065;;;;;0;CHEMBL827793;Inhibition concentration required against calpain-1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1137919;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL8535;;0;541.63;1;1.22;8h;CCN1C(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCC2CC2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';286;nM;6.54;;;UO_0000065;12.08;0.24;5.32;4.99;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL522312;;0;477.52;0;1.93;2g;COc1ccc(CNC(=O)C(=O)[C@H](Cc2ccccc2)NC(=O)c2[nH]c(=O)ccc2C)cc1OC;IC50;'=''';35260;nM;4.45;;;UO_0000065;9.32;0.17;2.52;3.52;0;CHEMBL973384;Inhibition of human erythrocytes mu-calpain by spectrofluorimeter;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138543;1;Scientific Literature;Eur. J. Med. Chem.;2009;None;
CHEMBL2408901;;0;486.47;1;-0.35;38;O=C(NCc1cn(-c2ccc3c(c2)OCO3)nn1)[C@H](Cc1cscn1)NC(=O)[C@H]1O[C@@H]1C(=O)O;IC50;'=''';400;nM;6.4;;;UO_0000065;13.15;0.26;6.75;3.76;1;CHEMBL2411626;Inhibition of human erythrocyte full length Cal1 using (DABCYL)TPLK-SPPSPR-(EDANS) as substrate after 20 min by FRET assay;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL2407090;1;Scientific Literature;J. Med. Chem.;2013;None;
CHEMBL209274;;0;376.48;0;1.48;14;CC(C)C[C@H](NC(=S)Nc1cccc(C#N)c1)C(=O)N[C@H]1CCOC1O;IC50;'=''';260;nM;6.58;;;UO_0000065;17.49;0.35;5.11;6.19;0;CHEMBL863671;Inhibition of human erythrocyte mu calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138043;1;Scientific Literature;J. Med. Chem.;2006;None;
CHEMBL2408906;;0;478.44;0;0.2;43;O=C(NCc1cn(-c2c(F)cccc2F)nn1)[C@H](Cc1cscn1)NC(=O)[C@H]1O[C@@H]1C(=O)O;IC50;'>''';1000;nM;;;;UO_0000065;;;;;1;CHEMBL2411626;Inhibition of human erythrocyte full length Cal1 using (DABCYL)TPLK-SPPSPR-(EDANS) as substrate after 20 min by FRET assay;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL2407090;1;Scientific Literature;J. Med. Chem.;2013;None;
CHEMBL179042;;0;516.41;None;None;11b;CC(C)CN(NC(=O)OCc1ccccc1)C(=O)CN(Cc1ccccc1)/N=C/c1cccc(B(O)O)c1;IC50;'>''';1000000;nM;;Outside typical range;;UO_0000065;;;;;0;CHEMBL826414;Inhibitory concentration against Calpain I activity;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1139495;1;Scientific Literature;J. Med. Chem.;2005;None;
CHEMBL150982;;0;376.5;0;3.4;Z-Leu-(N-Me)Leu-H;CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N(C)[C@H](C=O)CC(C)C;IC50;'>''';1000;nM;;;;UO_0000065;;;;;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL294046;;0;360.43;0;0.96;1a;CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)OCCF;IC50;;;nM;;;substantial inhibition by 5-44 uM;UO_0000065;;;;;0;CHEMBL659384;The calpain inhibitory activity(I 50) was measured as ability to enter the platelet and inhibit calpain in the intact cells(assay 3); (+)indicates substantial inhibition by 5-44 uM;B;BAO_0000219;cell-based format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None
CHEMBL151536;;0;306.43;0;0.68;(S)-2-Methanesulfonylamino-4-methyl-pentanoic acid ((S)-1-formyl-3-methyl-butyl)-amide;CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NS(C)(=O)=O;IC50;'=''';10;nM;8;;;UO_0000065;26.11;0.55;7.32;8.66;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL180263;;0;368.36;0;1.76;5b (MX-1153);CC(C)[C@H](OC(=O)Nc1ccccc1)C(=O)NC(CC(=O)O)C(=O)CF;IC50;'>''';100000;nM;;;;UO_0000065;;;;;0;CHEMBL827036;Inhibitory concentration against Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1142004;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2005;None;
CHEMBL341014;;0;396.49;0;3.25;Z-Leu-Phe;CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@H](C=O)Cc1ccccc1;IC50;'=''';10;nM;8;;;UO_0000065;20.18;0.38;4.75;9.47;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL8860;;0;502.55;1;0.86;7;CCN1C(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)OC)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';1000;nM;6;;;UO_0000065;11.94;0.23;5.14;4.68;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL115573;;0;458.54;0;1.71;15n;CC(C)N1C(C(=O)N[C@H](C=O)Cc2ccccc2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';30;nM;7.52;;;UO_0000065;16.41;0.32;5.81;7.37;0;CHEMBL877099;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL115572;;0;410.49;0;1.12;15o;CCN1C(C(=O)N[C@H](C=O)CC(C)C)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'>''';3000;nM;;;;UO_0000065;;;;;0;CHEMBL714770;Inhibitory concentration against MOLT-4 cells (human T-cell leukemia cell line);F;BAO_0000219;cell-based format;None;None;None;MOLT-4;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;CHEMBL3307557;
CHEMBL421043;;0;439.32;0;2.89;26a;CN1C(C(=O)N[C@H](C=O)Cc2ccccc2)=Cc2cc(Cl)c(Cl)cc2S1(=O)=O;IC50;'=''';2900;nM;5.54;;;UO_0000065;;;;;0;CHEMBL714770;Inhibitory concentration against MOLT-4 cells (human T-cell leukemia cell line);F;BAO_0000219;cell-based format;None;None;None;MOLT-4;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;CHEMBL3307557;
CHEMBL338421;;0;380.79;0;3.71;16;NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccoc3)ccc2c1=O;IC50;'=''';2000;nM;5.7;;;UO_0000065;14.97;0.29;1.99;5.79;0;CHEMBL656843;In vitro inhibitory activity against human erythrocyte Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1153663;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1995;None;
CHEMBL168909;;0;404.53;0;2.87;6;CC(C)C[C@H](C=O)NC(=O)[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)C(C)C;IC50;'=''';10;nM;8;;;UO_0000065;19.78;0.39;5.13;8.66;0;CHEMBL744609;In vitro inhibition of porcine mu-calpain.;B;BAO_0000357;single protein format;Sus scrofa;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1145779;1;Scientific Literature;J. Med. Chem.;2003;None;
CHEMBL281874;;0;253.3;0;2.23;3;O=CC(Cc1ccccc1)NC(=O)c1ccccc1;IC50;'=''';;nM;;;;UO_0000065;;;;;0;CHEMBL654080;Inhibition of degradation of tyrosine kinase pp60src by Calpain 1 in human platelets;F;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1145789;1;Scientific Literature;J. Med. Chem.;2003;None;
CHEMBL331414;;0;390.44;0;1.3;15g;CN1C(C(=O)N[C@H](C=O)Cc2ccccc2)Cc2cc(F)ccc2S1(=O)=O;IC50;'=''';2400;nM;5.62;;;UO_0000065;;;;;0;CHEMBL714770;Inhibitory concentration against MOLT-4 cells (human T-cell leukemia cell line);F;BAO_0000219;cell-based format;None;None;None;MOLT-4;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;CHEMBL3307557;
CHEMBL169598;;0;461.97;0;3.05;14;CC(C)[C@H](NS(=O)(=O)c1ccc(Cl)cc1)C(=O)N[C@@H](C=O)Cc1c[nH]c2ccccc12;IC50;'=''';13;nM;7.89;;;UO_0000065;17.07;0.35;4.84;7.29;0;CHEMBL744609;In vitro inhibition of porcine mu-calpain.;B;BAO_0000357;single protein format;Sus scrofa;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1145779;1;Scientific Literature;J. Med. Chem.;2003;None;
CHEMBL1923968;;0;372.46;0;1.86;21(L,D);CC(C)C[C@@H](C=O)NC(=O)[C@H](NS(=O)(=O)c1ccc(F)cc1)C(C)C;IC50;'=''';14000;nM;4.85;;;UO_0000065;13.03;0.27;2.99;5.26;0;CHEMBL744609;In vitro inhibition of porcine mu-calpain.;B;BAO_0000357;single protein format;Sus scrofa;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1145779;1;Scientific Literature;J. Med. Chem.;2003;None;
CHEMBL118688;;0;441.34;0;2.47;15h;CN1C(C(=O)N[C@H](C=O)Cc2ccccc2)Cc2cc(Cl)c(Cl)cc2S1(=O)=O;IC50;'=''';1300;nM;5.89;;;UO_0000065;;;;;0;CHEMBL714770;Inhibitory concentration against MOLT-4 cells (human T-cell leukemia cell line);F;BAO_0000219;cell-based format;None;None;None;MOLT-4;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;CHEMBL3307557;
CHEMBL327448;;0;492.6;0;2.96;25;O=C[C@H](Cc1ccccc1)NC(=O)[C@@H]1C[C@@H](OCc2ccccc2)CN1S(=O)(=O)c1ccccc1;IC50;'=''';125;nM;6.9;;;UO_0000065;14.01;0.27;3.94;7.44;0;CHEMBL656842;Compound was tested for inhibitory activity against recombinant human Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130591;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1998;None;
CHEMBL88359;;0;324.4;0;0.34;17;CS(=O)(=O)N1CCC[C@@H]1C(=O)N[C@H](C=O)Cc1ccccc1;IC50;'=''';53;nM;7.28;;;UO_0000065;22.43;0.45;6.94;8.71;0;CHEMBL656842;Compound was tested for inhibitory activity against recombinant human Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130591;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1998;None;
CHEMBL151538;;0;455.6;0;1.87;Ac-Leu-Leu-Glu(t-Bu)-H;CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C=O)CCC(=O)OC(C)(C)C;IC50;'=''';1100;nM;5.96;;;UO_0000065;13.08;0.25;4.09;4.56;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL150713;;0;376.45;0;2.26;Phth-Leu-Leu-H;CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)c1ccccc1C(=O)O;IC50;'>''';1000;nM;;;;UO_0000065;;;;;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL117729;;0;448.97;0;2.84;15i;CC(C)CN1C(C(=O)N[C@H](C=O)Cc2ccccc2)Cc2cc(Cl)ccc2S1(=O)=O;IC50;'=''';200;nM;6.7;;;UO_0000065;14.92;0.3;3.86;8.02;0;CHEMBL656196;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL118688;;0;441.34;0;2.47;15h;CN1C(C(=O)N[C@H](C=O)Cc2ccccc2)Cc2cc(Cl)c(Cl)cc2S1(=O)=O;IC50;'=''';21;nM;7.68;;;UO_0000065;17.4;0.37;5.21;9.19;0;CHEMBL656196;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL338195;;0;438.51;0;4.01;1i;CC(C)CC(NC(=O)OCc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)P(C)(C)=O;IC50;'>''';10000;nM;;;;UO_0000065;;;;;0;CHEMBL658527;inhibitory activity measured against recombinant human Calpain-I receptor;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1131587;1;Scientific Literature;J. Med. Chem.;1998;None;
CHEMBL151115;;0;413.56;0;1.57;Ac-Ser(O-t-Bu)-Leu-Leu-H;CC(=O)N[C@@H](COC(C)(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C=O)CC(C)C;IC50;'=''';37;nM;7.43;;;UO_0000065;17.97;0.35;5.86;6.54;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL326161;;0;428.47;0;1.36;26b;CN1C(C(=O)N[C@H](C=O)Cc2ccccc2)=Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';900;nM;6.05;;;UO_0000065;;;;;0;CHEMBL714770;Inhibitory concentration against MOLT-4 cells (human T-cell leukemia cell line);F;BAO_0000219;cell-based format;None;None;None;MOLT-4;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;CHEMBL3307557;
CHEMBL315578;;0;453.54;0;2.34;3n;CCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccccc1)C(=O)C(=O)NOCC;IC50;'=''';193;nM;6.71;;;UO_0000065;14.8;0.28;4.37;5.91;0;CHEMBL657770;Inhibition of human recombinant Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1133978;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2001;None;
CHEMBL168965;;0;368.5;0;2.03;15;Cc1ccc(S(=O)(=O)N[C@H](C(=O)N[C@@H](C=O)CC(C)C)C(C)C)cc1;IC50;'=''';28;nM;7.55;;;UO_0000065;20.5;0.41;5.52;8.18;0;CHEMBL744609;In vitro inhibition of porcine mu-calpain.;B;BAO_0000357;single protein format;Sus scrofa;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1145779;1;Scientific Literature;J. Med. Chem.;2003;None;
CHEMBL2408922;;0;421.45;0;2.27;BDBM50437951;CC(C)C[C@H](NC(=O)[C@H]1O[C@@H]1C(=O)O)C(=O)Nc1nc(-c2ccc(F)cc2)cs1;IC50;'=''';50;nM;7.3;;419132;UO_0000065;17.32;0.34;5.03;6.04;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL489723;;0;369.42;0;1.12;2d;Cc1ccc(=O)[nH]c1C(=O)N[C@@H](Cc1ccccc1)C(=O)C(=O)NC(C)C;IC50;'>''';100000;nM;;;;UO_0000065;;;;;0;CHEMBL973384;Inhibition of human erythrocytes mu-calpain by spectrofluorimeter;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138543;1;Scientific Literature;Eur. J. Med. Chem.;2009;None;
CHEMBL490564;;0;417.47;0;1.91;2e;Cc1ccc(=O)[nH]c1C(=O)N[C@@H](Cc1ccccc1)C(=O)C(=O)NCc1ccccc1;IC50;'=''';64610;nM;4.19;;;UO_0000065;10.04;0.18;2.28;3.87;0;CHEMBL973384;Inhibition of human erythrocytes mu-calpain by spectrofluorimeter;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138543;1;Scientific Literature;Eur. J. Med. Chem.;2009;None;
CHEMBL315636;;0;404.49;0;1.05;7;CS(=O)(=O)N[C@H](COCc1ccccc1)C(=O)N[C@H](C=O)Cc1ccccc1;IC50;'=''';700;nM;6.16;;;UO_0000065;15.22;0.3;5.1;6.06;0;CHEMBL658526;Inhibition of intracellular Calpain-I receptor using intact cell assay system;B;BAO_0000219;cell-based format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1131026;1;Scientific Literature;J. Med. Chem.;1998;None;
CHEMBL1793864;;0;509.63;1;1.41;8a (Single diastereomer);CCCCNC(=O)C(=O)[C@H](CC(C)C)NC(=O)C1Cc2cc3c(cc2S(=O)(=O)N1CC)OCCO3;IC50;'=''';1000;nM;6;;;UO_0000065;11.77;0.23;4.59;4.58;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL523140;;0;415.2;1;5.8;7;CC(=O)c1c(Nc2ccc(Cl)cc2Cl)[nH]c2c(C(F)(F)F)cccc2c1=O;IC50;'=''';19200;nM;4.72;;;UO_0000065;11.36;0.24;-1.08;7.61;0;CHEMBL1021956;Inhibition of human erythrocytes mu-calpain after 30 mins by fluorometric assay using pep1 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL512192;;0;371.78;0;4.34;12;CC(=O)c1c(Nc2cccc(C)c2)[nH]c2c(Cl)ccc([N+](=O)[O-])c2c1=O;IC50;'>''';30000;nM;;;;UO_0000065;;;;;0;CHEMBL1021956;Inhibition of human erythrocytes mu-calpain after 30 mins by fluorometric assay using pep1 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL169307;;0;438.55;0;3.07;7;CC(C)[C@H](NS(=O)(=O)c1ccc2ccccc2c1)C(=O)N[C@@H](C=O)Cc1ccccc1;IC50;'=''';14;nM;7.85;;;UO_0000065;17.91;0.35;4.78;8.51;0;CHEMBL744609;In vitro inhibition of porcine mu-calpain.;B;BAO_0000357;single protein format;Sus scrofa;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1145779;1;Scientific Literature;J. Med. Chem.;2003;None;
CHEMBL169121;;0;292.4;0;0.29;17;CC(C)C[C@H](C=O)NC(=O)[C@@H](NS(C)(=O)=O)C(C)C;IC50;'=''';830;nM;6.08;;;UO_0000065;20.8;0.44;5.79;6.59;0;CHEMBL744609;In vitro inhibition of porcine mu-calpain.;B;BAO_0000357;single protein format;Sus scrofa;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1145779;1;Scientific Literature;J. Med. Chem.;2003;None;
CHEMBL195992;;0;468.51;0;3.33;2a;Cc1c(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCc2ccccc2)oc2ccccc2c1=O;IC50;'=''';720;nM;6.14;;;UO_0000065;13.11;0.24;2.81;5.82;0;CHEMBL827857;Inhibitory concentration against human plasma mu-calpain;B;BAO_0000366;cell-free format;Homo sapiens;CHEMBL3559721;Plasma;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1139593;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2005;None;
CHEMBL1770879;;0;472.54;0;3.5;4b;CC/C(=C\c1ccc(O)c(O)c1)C(=O)N[C@@H](Cc1ccccc1)C(=O)C(=O)NCc1ccccc1;IC50;'=''';610;nM;6.21;;;UO_0000065;13.15;0.24;2.71;5.37;0;CHEMBL1771900;Inhibition of human erythrocytes mu-calpain using Suc-Leu-Tyr-AMC fluorogenic substrate after 30 mins by spectrofluorimetry;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1770073;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2011;None;
CHEMBL420698;;0;372.45;0;1.16;15f;CN1C(C(=O)N[C@H](C=O)Cc2ccccc2)Cc2ccccc2S1(=O)=O;IC50;'=''';28;nM;7.55;;;UO_0000065;20.28;0.4;6.39;9.04;0;CHEMBL877099;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL8486;MDL-28170;0;264.32;0;0.78;Dipeptide(Z-Val-Phe-H);CC(C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O;IC50;'=''';11;nM;7.96;;;UO_0000065;30.11;0.57;7.18;8.61;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL523822;;0;484.58;1;5.96;17;CC(=O)c1c(Nc2ccc(Br)cc2Br)[nH]c2c(Cl)ccc(C)c2c1=O;IC50;'=''';277;nM;6.56;;;UO_0000065;13.53;0.36;0.6;10.58;0;CHEMBL1021956;Inhibition of human erythrocytes mu-calpain after 30 mins by fluorometric assay using pep1 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL489721;;0;341.37;0;0.34;2b;CNC(=O)C(=O)[C@H](Cc1ccccc1)NC(=O)c1[nH]c(=O)ccc1C;IC50;'=''';91420;nM;4.04;;;UO_0000065;11.83;0.22;3.7;3.74;0;CHEMBL973384;Inhibition of human erythrocytes mu-calpain by spectrofluorimeter;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138543;1;Scientific Literature;Eur. J. Med. Chem.;2009;None;
CHEMBL491749;;0;435.46;0;2.05;2h;Cc1ccc(=O)[nH]c1C(=O)N[C@@H](Cc1ccccc1)C(=O)C(=O)NCc1ccc(F)cc1;IC50;'=''';22130;nM;4.66;;;UO_0000065;10.69;0.2;2.61;4.31;0;CHEMBL973384;Inhibition of human erythrocytes mu-calpain by spectrofluorimeter;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138543;1;Scientific Literature;Eur. J. Med. Chem.;2009;None;
CHEMBL491919;;0;461.52;0;1.96;2k;COc1ccc(CCNC(=O)C(=O)[C@H](Cc2ccccc2)NC(=O)c2[nH]c(=O)ccc2C)cc1;IC50;'=''';6190;nM;5.21;;;UO_0000065;11.29;0.21;3.25;4.44;0;CHEMBL973384;Inhibition of human erythrocytes mu-calpain by spectrofluorimeter;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138543;1;Scientific Literature;Eur. J. Med. Chem.;2009;None;
CHEMBL423112;;0;382.46;0;2.86;1, MDL-28170;CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)NC(C=O)Cc1ccccc1;IC50;'=''';70;nM;7.16;;;UO_0000065;18.71;0.35;4.29;8.47;0;CHEMBL973384;Inhibition of human erythrocytes mu-calpain by spectrofluorimeter;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138543;1;Scientific Literature;Eur. J. Med. Chem.;2009;None;
CHEMBL2408904;;0;521.35;1;0.68;41;O=C(NCc1cn(-c2ccc(Br)cc2)nn1)[C@H](Cc1cscn1)NC(=O)[C@H]1O[C@@H]1C(=O)O;IC50;'=''';40;nM;7.4;;;UO_0000065;14.19;0.32;6.72;4.88;1;CHEMBL2411626;Inhibition of human erythrocyte full length Cal1 using (DABCYL)TPLK-SPPSPR-(EDANS) as substrate after 20 min by FRET assay;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL2407090;1;Scientific Literature;J. Med. Chem.;2013;None;
CHEMBL2408921;;0;473.52;0;0.38;23;CC(C)C[C@H](NC(=O)[C@H]1O[C@@H]1C(=O)O)C(=O)NCCCCNS(=O)(=O)c1ccc(F)cc1;IC50;'=''';150;nM;6.82;;;UO_0000065;14.41;0.29;6.44;4.43;0;CHEMBL2411626;Inhibition of human erythrocyte full length Cal1 using (DABCYL)TPLK-SPPSPR-(EDANS) as substrate after 20 min by FRET assay;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL2407090;1;Scientific Literature;J. Med. Chem.;2013;None;
CHEMBL210347;;0;376.48;0;1.48;15;CC(C)C[C@H](NC(=S)Nc1ccc(C#N)cc1)C(=O)N[C@H]1CCOC1O;IC50;'=''';140;nM;6.85;;;UO_0000065;18.21;0.36;5.37;6.44;0;CHEMBL863671;Inhibition of human erythrocyte mu calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138043;1;Scientific Literature;J. Med. Chem.;2006;None;
CHEMBL288882;;0;471.6;0;1.32;3;CC(C)C[C@@H](/C=N/NC(=O)CN(C)C)NC(=O)[C@@H](NS(=O)(=O)c1ccc(F)cc1)C(C)C;IC50;'=''';370;nM;6.43;;;UO_0000065;13.64;0.27;5.11;5.36;0;CHEMBL863671;Inhibition of human erythrocyte mu calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138043;1;Scientific Literature;J. Med. Chem.;2006;None;
CHEMBL209736;;0;360.41;0;0.35;2;CC(C)[C@H](NS(=O)(=O)c1ccc(F)cc1)C(=O)N[C@H]1CCOC1O;IC50;'=''';880;nM;6.06;;;UO_0000065;16.8;0.34;5.71;5.78;0;CHEMBL863671;Inhibition of human erythrocyte mu calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138043;1;Scientific Literature;J. Med. Chem.;2006;None;
CHEMBL2367776;;0;441.51;0;2.36;11;Cc1ccc(S(=O)(=O)N2C[C@H](N=[N+]=[N-])C[C@H]2C(=O)N[C@H](C=O)Cc2ccccc2)cc1;IC50;'=''';28;nM;7.55;;;UO_0000065;17.11;0.33;5.19;5.71;0;CHEMBL656842;Compound was tested for inhibitory activity against recombinant human Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130591;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1998;None;
CHEMBL315636;;0;404.49;0;1.05;1;CS(=O)(=O)N[C@H](COCc1ccccc1)C(=O)N[C@H](C=O)Cc1ccccc1;IC50;'=''';11;nM;7.96;;;UO_0000065;19.68;0.39;6.91;7.84;0;CHEMBL656842;Compound was tested for inhibitory activity against recombinant human Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130591;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1998;None;
CHEMBL62988;;0;660.85;1;4.01;1i;CCCCC(COC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1;IC50;;;nM;;;Little inhibition;UO_0000065;;;;;0;CHEMBL656704;The calpain inhibitory activity(I 50) was measured as ability to enter the platelet and inhibit calpain in the intact cells(assay 3); (-)indicates little inhibition by 444 uM;B;BAO_0000219;cell-based format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None
CHEMBL63440;ALOXISTATIN;0;342.44;0;1.01;E64d;CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C;IC50;;;nM;;;substantial inhibition by 5-44 uM;UO_0000065;;;;;0;CHEMBL659384;The calpain inhibitory activity(I 50) was measured as ability to enter the platelet and inhibit calpain in the intact cells(assay 3); (+)indicates substantial inhibition by 5-44 uM;B;BAO_0000219;cell-based format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None
CHEMBL418661;E-64C;0;314.38;0;0.53;E64c;CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)O;IC50;;;nM;;;Little inhibition;UO_0000065;;;;;0;CHEMBL656704;The calpain inhibitory activity(I 50) was measured as ability to enter the platelet and inhibit calpain in the intact cells(assay 3); (-)indicates little inhibition by 444 uM;B;BAO_0000219;cell-based format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None
CHEMBL92708;CALPEPTIN;0;362.47;0;3.2;108 (calpeptin);CCCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1;IC50;'=''';1000;nM;6;;;UO_0000065;16.55;0.32;2.8;7.1;0;CHEMBL821730;Inhibitory activity against calpain.;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1133572;1;Scientific Literature;J. Med. Chem.;2000;None;
CHEMBL253314;;0;468.51;0;2.46;3i;Cc1c(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCc2ccccn2)[nH]c2ccccc2c1=O;IC50;'=''';7720;nM;5.11;;;UO_0000065;10.91;0.2;2.65;4.22;0;CHEMBL928702;Inhibition of human mu-calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1140783;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2008;None;
CHEMBL465172;;0;488.58;0;3.64;4i-8;COc1ccc(OC)c(CCCC(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCc2ccccc2)c1;IC50;'=''';8000;nM;5.1;;;UO_0000065;10.43;0.19;1.46;5.44;0;CHEMBL1013486;Inhibition of human erythrocytes mu-calpain;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1154513;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2009;None;
CHEMBL150076;;0;362.47;0;3.2;Z-Nle-Leu-H;CCCC[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@H](C=O)CC(C)C;IC50;'=''';33;nM;7.48;;;UO_0000065;20.64;0.39;4.28;8.85;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL92708;CALPEPTIN;0;362.47;0;3.2;108 (calpeptin);CCCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1;IC50;'=''';5;nM;8.3;;;UO_0000065;22.9;0.44;5.1;9.82;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL2368566;;0;462.52;0;3.79;Z-FF-FMK;O=C(N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)CF)OCc1ccccc1;IC50;'=''';397.1;nM;6.4;;;UO_0000065;13.84;0.26;2.61;7.58;0;CHEMBL4718381;Inhibition of human erythrocytes mu-calpain using Pep1 as substrate incubated for 30 mins under shaking condition in presence of CaCl2 by fluorescence assay;B;BAO_0000221;tissue-based format;Homo sapiens;None;Blood;Erythrocyte;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL4715741;1;Scientific Literature;Eur J Med Chem;2016;None;TIME = 0.5 hr
CHEMBL4740912;;0;306.32;0;3.85;7;O=C(/C=C/c1ccc(O)c2ccccc12)c1ccc(O)cc1O;IC50;'=''';18830;nM;4.72;;;UO_0000065;15.43;0.28;0.88;6.08;0;CHEMBL4718381;Inhibition of human erythrocytes mu-calpain using Pep1 as substrate incubated for 30 mins under shaking condition in presence of CaCl2 by fluorescence assay;B;BAO_0000221;tissue-based format;Homo sapiens;None;Blood;Erythrocyte;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL4715741;1;Scientific Literature;Eur J Med Chem;2016;None;TIME = 0.5 hr
CHEMBL421043;;0;439.32;0;2.89;26a;CN1C(C(=O)N[C@H](C=O)Cc2ccccc2)=Cc2cc(Cl)c(Cl)cc2S1(=O)=O;IC50;'=''';15;nM;7.82;;;UO_0000065;17.81;0.38;4.93;9.36;0;CHEMBL877099;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL151827;;0;306.36;0;1.64;Z-Leu-Gly-H;CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)NCC=O;IC50;'=''';300;nM;6.52;;;UO_0000065;21.29;0.4;4.88;7.72;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL345337;;0;525.65;1;3.49;Z-Tyr-Leu-Leu-H;CC(C)C[C@H](C=O)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)OCc1ccccc1;IC50;'=''';8;nM;8.1;;;UO_0000065;15.4;0.29;4.61;6.05;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL460813;;0;382.42;0;1.44;4b-2;COc1ccccc1C(=O)CCC(=O)N[C@@H](Cc1ccccc1)C(=O)C(N)=O;IC50;'=''';540;nM;6.27;;;UO_0000065;16.39;0.31;4.83;5.42;0;CHEMBL1013486;Inhibition of human erythrocytes mu-calpain;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1154513;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2009;None;
CHEMBL302443;;0;579.12;1;2.83;1g;CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)OCC(Br)(Br)Br;IC50;;;nM;;;substantial inhibition by 5-44 uM;UO_0000065;;;;;0;CHEMBL659384;The calpain inhibitory activity(I 50) was measured as ability to enter the platelet and inhibit calpain in the intact cells(assay 3); (+)indicates substantial inhibition by 5-44 uM;B;BAO_0000219;cell-based format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None
CHEMBL3920677;;0;314.39;0;1.41;BDBM240234;C#CCNC(=O)[C@H](CC(C)C)NC(=O)C1OC1c1ccccc1;IC50;'>''';1000;nM;;;419077;UO_0000065;;;;;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL3938833;;0;480.5;0;-1.09;BDBM240265;CC(C)C[C@H](NC(=O)[C@H]1O[C@@H]1C(=O)O)C(=O)NCc1cn(-c2ccc(S(N)(=O)=O)cc2)nn1;IC50;'=''';50;nM;7.3;;419119;UO_0000065;15.19;0.3;8.39;3.67;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL2367773;;0;511.52;1;1.73;16;Cc1ccc(S(=O)(=O)N2C[C@H](NC(=O)C(F)(F)F)C[C@H]2C(=O)N[C@H](C=O)Cc2ccccc2)cc1;IC50;'=''';100;nM;7;;;UO_0000065;13.68;0.27;5.27;6.21;0;CHEMBL656842;Compound was tested for inhibitory activity against recombinant human Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130591;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1998;None;
CHEMBL80605;;0;455.6;0;4.53;5d;CCN(CC)Cc1ccc(/C=C/c2ccccc2C(=O)NC(Cc2ccccc2)C(N)=O)cc1;IC50;'=''';700;nM;6.16;;;UO_0000065;;;;;0;CHEMBL654080;Inhibition of degradation of tyrosine kinase pp60src by Calpain 1 in human platelets;F;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1145789;1;Scientific Literature;J. Med. Chem.;2003;None;
CHEMBL2408902;;0;521.54;2;-1.43;39;NS(=O)(=O)c1ccc(-n2cc(CNC(=O)[C@H](Cc3cscn3)NC(=O)[C@H]3O[C@@H]3C(=O)O)nn2)cc1;IC50;'>''';1000;nM;;;;UO_0000065;;;;;1;CHEMBL2411626;Inhibition of human erythrocyte full length Cal1 using (DABCYL)TPLK-SPPSPR-(EDANS) as substrate after 20 min by FRET assay;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL2407090;1;Scientific Literature;J. Med. Chem.;2013;None;
CHEMBL2408898;;0;442.46;0;-0.08;35;O=C(NCc1cn(-c2ccccc2)nn1)[C@H](Cc1cscn1)NC(=O)[C@H]1O[C@@H]1C(=O)O;IC50;'=''';1000;nM;6;;;UO_0000065;13.56;0.26;6.08;3.96;1;CHEMBL2411626;Inhibition of human erythrocyte full length Cal1 using (DABCYL)TPLK-SPPSPR-(EDANS) as substrate after 20 min by FRET assay;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL2407090;1;Scientific Literature;J. Med. Chem.;2013;None;
CHEMBL2408896;;0;459.46;0;1.5;33;Cc1ncc(C[C@H](NC(=O)[C@H]2O[C@@H]2C(=O)O)C(=O)Nc2nc(-c3ccc(F)cc3)cs2)[nH]1;IC50;'=''';5000;nM;5.3;;;UO_0000065;11.54;0.23;3.8;3.54;0;CHEMBL2411626;Inhibition of human erythrocyte full length Cal1 using (DABCYL)TPLK-SPPSPR-(EDANS) as substrate after 20 min by FRET assay;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL2407090;1;Scientific Literature;J. Med. Chem.;2013;None;
CHEMBL314039;;0;491.57;0;0.49;3i;CCONC(=O)C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](COCc1ccccc1)NS(C)(=O)=O;IC50;'=''';56;nM;7.25;;;UO_0000065;14.75;0.29;6.76;5.18;0;CHEMBL657770;Inhibition of human recombinant Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1133978;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2001;None;
CHEMBL209286;;0;365.5;0;1.92;16;Cc1ccccc1NC(=S)N[C@@H](CC(C)C)C(=O)N[C@H]1CCOC1O;IC50;'=''';240;nM;6.62;;;UO_0000065;18.11;0.36;4.7;8.01;0;CHEMBL863671;Inhibition of human erythrocyte mu calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138043;1;Scientific Literature;J. Med. Chem.;2006;None;
CHEMBL64647;;0;468.33;0;1.43;1d;CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)OCCI;IC50;'=''';6000;nM;5.22;;;UO_0000065;11.15;0.29;3.79;5.38;0;CHEMBL657758;The calpain inhibitory activity(I 50) was measured as ability to enter the platelet to inhibit calpain after cell lysis(assay 2);B;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None;
CHEMBL2408919;;0;320.35;0;1.01;20;CC(C)C[C@H](NC(=O)[C@H]1O[C@@H]1C(=O)O)C(=O)Nc1ccccc1;IC50;'=''';100;nM;7;;;UO_0000065;21.85;0.42;5.99;6.48;1;CHEMBL2411626;Inhibition of human erythrocyte full length Cal1 using (DABCYL)TPLK-SPPSPR-(EDANS) as substrate after 20 min by FRET assay;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL2407090;1;Scientific Literature;J. Med. Chem.;2013;None;
CHEMBL401986;;0;481.55;0;3.11;3j;Cc1c(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCCc2ccccc2)[nH]c2ccccc2c1=O;IC50;'=''';3710;nM;5.43;;;UO_0000065;11.28;0.21;2.32;5.02;0;CHEMBL928702;Inhibition of human mu-calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1140783;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2008;None;
CHEMBL418130;;0;438.95;0;2.84;1h;CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)OCc1ccccc1Cl;IC50;;;nM;;;substantial inhibition by 5-44 uM;UO_0000065;;;;;0;CHEMBL659383;The ability of compound to inhibit calpain in a preparation of lysed platelets was measured with a caseinolytic assay(assay 1); (+)indicates substantial inhibition by 5-44 uM;B;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None
CHEMBL195728;;0;378.38;0;1.5;2i;Cc1c(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(N)=O)oc2ccccc2c1=O;IC50;'=''';240;nM;6.62;;;UO_0000065;17.5;0.32;5.12;5.54;0;CHEMBL827857;Inhibitory concentration against human plasma mu-calpain;B;BAO_0000366;cell-free format;Homo sapiens;CHEMBL3559721;Plasma;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1139593;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2005;None;
CHEMBL92708;CALPEPTIN;0;362.47;0;3.2;108 (calpeptin);CCCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1;IC50;'=''';40;nM;7.4;;;UO_0000065;20.41;0.39;4.2;8.75;0;CHEMBL658506;Inhibitory activity against Calpain 1 in platelets.;B;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1133572;1;Scientific Literature;J. Med. Chem.;2000;None;
CHEMBL86486;;0;509.63;1;2.16;Page 2616;CS(=O)(=O)N[C@H](COCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccccc1;IC50;'=''';28;nM;7.55;;;UO_0000065;14.82;0.29;5.39;6.65;0;CHEMBL657770;Inhibition of human recombinant Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1133978;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2001;None;
CHEMBL3913999;;0;569.73;1;0.59;BDBM240230;CCOC(=O)[C@H]1OC1C(=O)N[C@@H](CC(C)C)C(=O)NCCCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12;IC50;'>''';1000;nM;;;419073;UO_0000065;;;;;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL3970497;;0;348.4;0;1.49;BDBM240254;CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)Nc1ccccc1;IC50;'=''';2500;nM;5.6;;419107;UO_0000065;16.08;0.31;4.11;5.77;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL150774;;0;435.52;0;3.74;Z-Trp-Leu-H;CC(C)C[C@@H](C=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)OCc1ccccc1;IC50;'=''';120;nM;6.92;;;UO_0000065;15.89;0.3;3.18;6.9;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL92114;;0;420.56;0;1.76;22;CS(=O)(=O)N[C@H](CSCc1ccccc1)C(=O)N[C@H](C=O)Cc1ccccc1;IC50;'=''';800;nM;6.1;;;UO_0000065;14.5;0.3;4.34;6.6;0;CHEMBL658526;Inhibition of intracellular Calpain-I receptor using intact cell assay system;B;BAO_0000219;cell-based format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1131026;1;Scientific Literature;J. Med. Chem.;1998;None;
CHEMBL467750;;0;412.44;0;1.45;3;COc1ccc(OC)c(C(=O)CCC(=O)N[C@@H](Cc2ccccc2)C(=O)C(N)=O)c1;IC50;'=''';520;nM;6.28;;;UO_0000065;15.24;0.29;4.83;5.04;0;CHEMBL1771900;Inhibition of human erythrocytes mu-calpain using Suc-Leu-Tyr-AMC fluorogenic substrate after 30 mins by spectrofluorimetry;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1770073;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2011;None;
CHEMBL323656;;0;418.47;0;0.83;15c;COc1cc2c(cc1OC)S(=O)(=O)NC(C(=O)N[C@H](C=O)Cc1ccccc1)C2;IC50;'=''';800;nM;6.1;;;UO_0000065;14.57;0.29;5.27;5.5;0;CHEMBL656196;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL115954;;0;430.48;0;0.93;15l;CN1C(C(=O)N[C@H](C=O)Cc2ccccc2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';24;nM;7.62;;;UO_0000065;17.7;0.35;6.69;7.47;0;CHEMBL877099;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL64174;;0;396.41;0;1.55;1e;CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)OCC(F)(F)F;IC50;;;nM;;;substantial inhibition by 5-44 uM;UO_0000065;;;;;0;CHEMBL659383;The ability of compound to inhibit calpain in a preparation of lysed platelets was measured with a caseinolytic assay(assay 1); (+)indicates substantial inhibition by 5-44 uM;B;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None
CHEMBL64174;;0;396.41;0;1.55;1e;CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)OCC(F)(F)F;IC50;'=''';2000;nM;5.7;;;UO_0000065;14.38;0.29;4.15;5.87;0;CHEMBL657758;The calpain inhibitory activity(I 50) was measured as ability to enter the platelet to inhibit calpain after cell lysis(assay 2);B;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None;
CHEMBL4279497;;0;356.43;0;1.98;4n;COCCCN/C(=C1/N=CN(CCOC)C1=O)c1cc2ccccc2[nH]1;IC50;'=''';1020;nM;5.99;;;UO_0000065;16.81;0.31;4.01;7.59;0;CHEMBL4263564;Inhibition of calpain (unknown origin) using Suc-LY-AMC as fluorogenic substrate after 60 mins by spectrofluorometric analysis;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL4261583;1;Scientific Literature;Eur J Med Chem;2018;None;
CHEMBL303315;;0;572.7;1;3.6;1j;CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)Oc1ccc2[nH]cc(CCNC(=O)OC(C)(C)C)c2c1;IC50;;;nM;;;substantial inhibition by 5-44 uM;UO_0000065;;;;;0;CHEMBL659384;The calpain inhibitory activity(I 50) was measured as ability to enter the platelet and inhibit calpain in the intact cells(assay 3); (+)indicates substantial inhibition by 5-44 uM;B;BAO_0000219;cell-based format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None
CHEMBL3937799;;0;513.59;1;1.15;BDBM240244;CCOC(=O)[C@H]1O[C@@H]1C(=O)NC1(C(=O)NCCCCNS(=O)(=O)c2ccc(F)cc2)CCCCC1;IC50;'>''';1000;nM;;;419086;UO_0000065;;;;;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL3928775;;0;463.53;0;2.77;BDBM240246;CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N(C)c1nc(-c2ccc(F)cc2)cs1;IC50;'>''';1000;nM;;;419088;UO_0000065;;;;;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL382711;;0;482.54;0;3.37;2c;Cc1c(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCCc2ccccc2)oc2ccccc2c1=O;IC50;'=''';530;nM;6.28;;;UO_0000065;13.01;0.24;2.91;5.95;0;CHEMBL827857;Inhibitory concentration against human plasma mu-calpain;B;BAO_0000366;cell-free format;Homo sapiens;CHEMBL3559721;Plasma;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1139593;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2005;None;
CHEMBL64647;;0;468.33;0;1.43;1d;CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)OCCI;IC50;;;nM;;;substantial inhibition by 5-44 uM;UO_0000065;;;;;0;CHEMBL659383;The ability of compound to inhibit calpain in a preparation of lysed platelets was measured with a caseinolytic assay(assay 1); (+)indicates substantial inhibition by 5-44 uM;B;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None
CHEMBL492175;;0;392.2;0;4.69;1;CC(=O)c1c(Nc2ccc(Cl)cc2)[nH]c2c(Cl)cc([N+](=O)[O-])cc2c1=O;IC50;'=''';4560;nM;5.34;;;UO_0000065;13.62;0.28;0.65;5.08;0;CHEMBL1021956;Inhibition of human erythrocytes mu-calpain after 30 mins by fluorometric assay using pep1 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL358196;;0;249.31;0;2.53;Z-Leu-H;CC(C)C[C@H](C=O)NC(=O)OCc1ccccc1;IC50;'=''';10000;nM;5;;;UO_0000065;20.06;0.38;2.47;9.03;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL491898;;0;450.29;1;5.79;16;CC(=O)c1c(Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)[nH]c2c(F)ccc(F)c2c1=O;IC50;;;;;;Not Determined;;;;;;0;CHEMBL1021957;Inhibition of human erythrocytes mu-calpain by fluorometric assay using pep2 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL151679;;0;612.77;1;3.04;Z-His-Leu-Leu-Leu-H;CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)OCc1ccccc1;IC50;'=''';17;nM;7.77;;;UO_0000065;12.68;0.24;4.73;4.53;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL151415;;0;490.65;0;2.67;Z-Lys-Leu-Leu-H;CC(C)C[C@H](C=O)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)OCc1ccccc1;IC50;'=''';20;nM;7.7;;;UO_0000065;15.69;0.3;5.03;5.51;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL128948;;0;373.37;0;2.56;11;NC(=O)c1cn(-c2ccc(O)c(O)c2)c2cc(-c3ccncc3)ccc2c1=O;IC50;'=''';7000;nM;5.16;;;UO_0000065;13.81;0.25;2.59;4.35;0;CHEMBL656843;In vitro inhibitory activity against human erythrocyte Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1153663;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1995;None;
CHEMBL89560;;0;354.41;0;1.55;1;CN1C(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)[C@@H]1Cc1ccc(O)cc1;IC50;'=''';800;nM;6.1;;;UO_0000065;17.2;0.32;4.55;7.52;0;CHEMBL659376;Compound was tested for its inhibitory activity against calpain isolated from Streptomyces griseus (SC488);B;BAO_0000357;single protein format;Streptomyces griseus;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1133981;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2001;None;
CHEMBL419498;;0;228.29;0;2.9;2;CC(C)c1ncc(Cc2ccccc2)nc1O;IC50;'=''';1200;nM;5.92;;;UO_0000065;25.94;0.48;3.02;12.87;0;CHEMBL659377;Compound was tested for its inhibitory activity against calpain isolated from Streptomyces species;B;BAO_0000357;single protein format;Streptomyces griseus;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1133981;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2001;None;
CHEMBL89766;;0;418.52;0;1.44;17;CC(OCc1ccccc1)[C@@H](NS(C)(=O)=O)C(=O)N[C@H](C=O)Cc1ccccc1;IC50;'=''';500;nM;6.3;;;UO_0000065;15.06;0.3;4.86;6.2;0;CHEMBL658526;Inhibition of intracellular Calpain-I receptor using intact cell assay system;B;BAO_0000219;cell-based format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1131026;1;Scientific Literature;J. Med. Chem.;1998;None;
CHEMBL3923350;;0;389.5;0;1.04;BDBM240240;CC(C)C[C@H](NC(=O)C1OC1c1ccccc1)C(=O)NCCCCNC(=N)N;IC50;'>''';1000;nM;;;419082;UO_0000065;;;;;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL2408899;;0;460.45;0;0.06;BDBM50437948;O=C(NCc1cn(-c2ccc(F)cc2)nn1)[C@H](Cc1cscn1)NC(=O)[C@H]1O[C@@H]1C(=O)O;IC50;'=''';100;nM;7;;419139;UO_0000065;15.2;0.3;6.94;4.62;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL168471;;0;372.46;0;1.86;8;CC(C)C[C@H](C=O)NC(=O)[C@@H](NS(=O)(=O)c1ccc(F)cc1)C(C)C;IC50;'=''';7.5;nM;8.12;;;UO_0000065;21.81;0.44;6.26;8.8;0;CHEMBL744609;In vitro inhibition of porcine mu-calpain.;B;BAO_0000357;single protein format;Sus scrofa;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1145779;1;Scientific Literature;J. Med. Chem.;2003;None;
CHEMBL418946;;0;553.64;1;1.67;3h;CS(=O)(=O)N[C@H](COCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)C(=O)NOCc1ccccc1;IC50;'=''';28;nM;7.55;;;UO_0000065;13.64;0.26;5.88;5.4;0;CHEMBL657770;Inhibition of human recombinant Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1133978;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2001;None;
CHEMBL8673;;0;515.59;1;0.83;8e;CCNC(=O)C(=O)[C@H](Cc1ccccc1)NC(=O)C1Cc2cc3c(cc2S(=O)(=O)N1CC)OCCO3;IC50;'=''';340;nM;6.47;;;UO_0000065;12.55;0.25;5.64;4.93;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL333622;;0;551.64;1;0.84;15p;CN1C(C(=O)N[C@H](C=O)CCCCNS(=O)(=O)c2ccccc2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';36;nM;7.44;;;UO_0000065;13.49;0.27;6.6;5.02;0;CHEMBL877099;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL313995;;0;386.47;0;1.77;23;O=C[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1S(=O)(=O)c1ccccc1;IC50;'=''';41;nM;7.39;;;UO_0000065;19.11;0.37;5.62;8.84;0;CHEMBL656842;Compound was tested for inhibitory activity against recombinant human Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130591;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1998;None;
CHEMBL43057;;0;501.6;2;5.81;10b;CC(C)C[C@H](CC(=O)C1c2ccccc2Oc2ccccc21)C(=O)NC(Cc1ccccc1)C(=O)CF;IC50;;;nM;;;Not Determined;UO_0000065;;;;;0;CHEMBL654085;Inhibitory activity of compound against recombinant human Calpain 1; No data;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1151519;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1996;None
CHEMBL333622;;0;551.64;1;0.84;15p;CN1C(C(=O)N[C@H](C=O)CCCCNS(=O)(=O)c2ccccc2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';107;nM;6.97;;;UO_0000065;12.64;0.26;6.13;4.7;0;CHEMBL656196;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL269384;;0;444.51;0;1.32;15m;CCN1C(C(=O)N[C@H](C=O)Cc2ccccc2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';7;nM;8.15;;;UO_0000065;18.35;0.36;6.83;7.99;1;CHEMBL877099;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL3900802;;0;435.48;0;2.29;BDBM240247;CC(C)C[C@H](NC(=O)[C@H]1O[C@@H]1C(=O)O)C(=O)N(C)c1nc(-c2ccc(F)cc2)cs1;IC50;'=''';200;nM;6.7;;419089;UO_0000065;15.38;0.3;4.41;5.97;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL2408919;;0;320.35;0;1.01;BDBM240255;CC(C)C[C@H](NC(=O)[C@H]1O[C@@H]1C(=O)O)C(=O)Nc1ccccc1;IC50;'=''';100;nM;7;;419108;UO_0000065;21.85;0.42;5.99;6.48;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL3975602;;0;372.38;0;0.41;BDBM240256;CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)Nc1ccccc1;IC50;'>''';10000;nM;;;419109;UO_0000065;;;;;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL340133;;0;358.35;0;3.46;2;O=C(O)c1cn(-c2ccc(O)cc2)c2cc(-c3ccncc3)ccc2c1=O;IC50;'=''';20000;nM;4.7;;;UO_0000065;13.11;0.24;1.24;5.08;0;CHEMBL656843;In vitro inhibitory activity against human erythrocyte Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1153663;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1995;None;
CHEMBL340921;;0;371.4;0;3.17;SID103905356;Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21;IC50;'=''';500;nM;6.3;;;UO_0000065;16.97;0.31;3.13;6.42;0;CHEMBL656843;In vitro inhibitory activity against human erythrocyte Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1153663;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1995;None;
CHEMBL193345;;0;364.36;0;1.19;2l;NC(=O)C(=O)[C@H](Cc1ccccc1)NC(=O)c1cc(=O)c2ccccc2o1;IC50;'=''';8730;nM;5.06;;;UO_0000065;13.88;0.26;3.87;4.23;0;CHEMBL827857;Inhibitory concentration against human plasma mu-calpain;B;BAO_0000366;cell-free format;Homo sapiens;CHEMBL3559721;Plasma;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1139593;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2005;None;
CHEMBL379402;;0;365.5;0;1.29;11;CC(C)C[C@H](NC(=S)NCc1ccccc1)C(=O)N[C@H]1CCOC1O;IC50;'=''';150;nM;6.82;;;UO_0000065;18.67;0.37;5.53;8.26;0;CHEMBL863671;Inhibition of human erythrocyte mu calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138043;1;Scientific Literature;J. Med. Chem.;2006;None;
CHEMBL326758;;0;336.39;0;1.61;36b;CN1C(=O)c2ccccc2CC1C(=O)N[C@H](C=O)Cc1ccccc1;IC50;'=''';85;nM;7.07;;;UO_0000065;21.02;0.39;5.46;10.64;0;CHEMBL657768;Compound was evaluated for inhibitory activity towards human calpain I isomer 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL117006;;0;457.55;0;0.99;15k;CN1C(C(=O)N[C@H](C=O)Cc2ccccc2)Cc2cc(N3CCOCC3)ccc2S1(=O)=O;IC50;'=''';4100;nM;5.39;;;UO_0000065;;;;;0;CHEMBL714770;Inhibitory concentration against MOLT-4 cells (human T-cell leukemia cell line);F;BAO_0000219;cell-based format;None;None;None;MOLT-4;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;CHEMBL3307557;
CHEMBL117553;;0;406.89;0;1.81;15j;CN1C(C(=O)N[C@H](C=O)Cc2ccccc2)Cc2cc(Cl)ccc2S1(=O)=O;IC50;'=''';2200;nM;5.66;;;UO_0000065;;;;;0;CHEMBL714770;Inhibitory concentration against MOLT-4 cells (human T-cell leukemia cell line);F;BAO_0000219;cell-based format;None;None;None;MOLT-4;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;CHEMBL3307557;
CHEMBL340384;;0;391.81;0;3.51;8;NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O;IC50;'=''';600;nM;6.22;;;UO_0000065;15.88;0.3;2.71;6.34;0;CHEMBL656843;In vitro inhibitory activity against human erythrocyte Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1153663;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1995;None;
CHEMBL117639;;0;404.49;0;1.05;1;CS(=O)(=O)NC(COCc1ccccc1)C(=O)N[C@H](C=O)Cc1ccccc1;IC50;'=''';11;nM;7.96;;;UO_0000065;19.68;0.39;6.91;7.84;0;CHEMBL654081;Inhibitory activity against calpain-I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL115573;;0;458.54;0;1.71;15n;CC(C)N1C(C(=O)N[C@H](C=O)Cc2ccccc2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';2600;nM;5.58;;;UO_0000065;;;;;0;CHEMBL714770;Inhibitory concentration against MOLT-4 cells (human T-cell leukemia cell line);F;BAO_0000219;cell-based format;None;None;None;MOLT-4;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;CHEMBL3307557;
CHEMBL151829;;0;402.54;0;3.98;Z-Leu-Cha-H;CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@H](C=O)CC1CCCCC1;IC50;'=''';11;nM;7.96;;;UO_0000065;19.77;0.37;3.98;9.42;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL269333;;0;442.49;0;1.75;26c;CCN1C(C(=O)N[C@H](C=O)Cc2ccccc2)=Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';2100;nM;5.68;;;UO_0000065;;;;;0;CHEMBL714770;Inhibitory concentration against MOLT-4 cells (human T-cell leukemia cell line);F;BAO_0000219;cell-based format;None;None;None;MOLT-4;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;CHEMBL3307557;
CHEMBL118806;;0;322.36;0;1.27;36a;O=C[C@H](Cc1ccccc1)NC(=O)C1Cc2ccccc2C(=O)N1;IC50;'~''';5000;nM;;;;UO_0000065;;;;;0;CHEMBL657768;Compound was evaluated for inhibitory activity towards human calpain I isomer 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL333622;;0;551.64;1;0.84;15p;CN1C(C(=O)N[C@H](C=O)CCCCNS(=O)(=O)c2ccccc2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';1800;nM;5.75;;;UO_0000065;;;;;0;CHEMBL714770;Inhibitory concentration against MOLT-4 cells (human T-cell leukemia cell line);F;BAO_0000219;cell-based format;None;None;None;MOLT-4;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;CHEMBL3307557;
CHEMBL169230;;0;388.92;0;2.37;12;CC(C)C[C@H](C=O)NC(=O)[C@@H](NS(=O)(=O)c1ccc(Cl)cc1)C(C)C;IC50;'=''';31;nM;7.51;;;UO_0000065;19.31;0.41;5.14;8.13;0;CHEMBL744609;In vitro inhibition of porcine mu-calpain.;B;BAO_0000357;single protein format;Sus scrofa;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1145779;1;Scientific Literature;J. Med. Chem.;2003;None;
CHEMBL332638;;0;508.6;1;2.75;15e;COc1cc2c(cc1OC)S(=O)(=O)N(Cc1ccccc1)C(C(=O)N[C@H](C=O)Cc1ccccc1)C2;IC50;'=''';150;nM;6.82;;;UO_0000065;13.42;0.26;4.07;6.69;0;CHEMBL877099;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL491899;;0;379.22;1;5.23;18;CC(=O)c1c(Nc2ccc(Cl)cc2F)[nH]c2c(Cl)ccc(C)c2c1=O;IC50;'>''';30000;nM;;;;UO_0000065;;;;;0;CHEMBL1021956;Inhibition of human erythrocytes mu-calpain after 30 mins by fluorometric assay using pep1 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL492175;;0;392.2;0;4.69;1;CC(=O)c1c(Nc2ccc(Cl)cc2)[nH]c2c(Cl)cc([N+](=O)[O-])cc2c1=O;IC50;'=''';8080;nM;5.09;;;UO_0000065;12.98;0.27;0.4;4.85;0;CHEMBL1021957;Inhibition of human erythrocytes mu-calpain by fluorometric assay using pep2 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL523140;;0;415.2;1;5.8;7;CC(=O)c1c(Nc2ccc(Cl)cc2Cl)[nH]c2c(C(F)(F)F)cccc2c1=O;IC50;;;;;;Not Determined;;;;;;0;CHEMBL1021957;Inhibition of human erythrocytes mu-calpain by fluorometric assay using pep2 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL127716;;0;470.5;0;3.87;1b;COP(=O)(OC)C(=O)[C@@H](CC(C)C)NC(=O)C(CC(C)C)NC(=O)OCc1ccccc1;IC50;'=''';430;nM;6.37;;;UO_0000065;13.53;0.27;2.5;5.3;0;CHEMBL658527;inhibitory activity measured against recombinant human Calpain-I receptor;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1131587;1;Scientific Literature;J. Med. Chem.;1998;None;
CHEMBL304784;;0;383.53;0;1.94;ALLN;CCCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(C)=O;IC50;'>''';1000;nM;;;;UO_0000065;;;;;0;CHEMBL833501;Inhibitory concentration against Calpain I activity;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1139495;1;Scientific Literature;J. Med. Chem.;2005;None;
CHEMBL434278;;0;348.44;0;2.67;Z-Val-Leu-H;CC(C)C[C@@H](C=O)NC(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)C;IC50;'=''';29;nM;7.54;;;UO_0000065;21.63;0.41;4.87;8.92;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL331733;;0;385.44;0;1.06;15a;COc1cc2c(cc1OC)S(=O)(=O)OC(C(=O)N[C@H](C=O)CC(C)C)C2;IC50;'=''';130;nM;6.89;;;UO_0000065;17.87;0.36;5.83;6.38;0;CHEMBL877099;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL331649;;0;419.46;0;1.26;15b;COc1cc2c(cc1OC)S(=O)(=O)OC(C(=O)N[C@H](C=O)Cc1ccccc1)C2;IC50;'=''';51;nM;7.29;;;UO_0000065;17.39;0.34;6.03;6.75;0;CHEMBL877099;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL269384;;0;444.51;0;1.32;15m;CCN1C(C(=O)N[C@H](C=O)Cc2ccccc2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';500;nM;6.3;;;UO_0000065;;;;;0;CHEMBL714770;Inhibitory concentration against MOLT-4 cells (human T-cell leukemia cell line);F;BAO_0000219;cell-based format;None;None;None;MOLT-4;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;CHEMBL3307557;
CHEMBL382964;;0;436.42;0;1.27;2j;Cc1c(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(N)=O)oc2cc3c(cc2c1=O)OCCO3;IC50;'=''';810;nM;6.09;;;UO_0000065;13.96;0.26;4.82;4.42;0;CHEMBL827857;Inhibitory concentration against human plasma mu-calpain;B;BAO_0000366;cell-free format;Homo sapiens;CHEMBL3559721;Plasma;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1139593;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2005;None;
CHEMBL333995;;0;451.57;0;2.62;6d;CC(C)C[C@H](NC(=O)c1ccc2c(c1)CCN2Cc1ccccc1)C(=O)N[C@H]1CCOC1O;IC50;'=''';20;nM;7.7;;;UO_0000065;17.05;0.32;5.08;8.47;0;CHEMBL654082;Inhibitory activity against on human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146815;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL470707;;0;515;2;5.76;9;CC(=O)c1c(Nc2ccc(Br)cc2)[nH]c2c(Br)ccc(Br)c2c1=O;IC50;'=''';3590;nM;5.45;;;UO_0000065;10.57;0.31;-0.32;8.79;0;CHEMBL1021956;Inhibition of human erythrocytes mu-calpain after 30 mins by fluorometric assay using pep1 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL491348;;0;426.64;1;5.34;6;CC(=O)c1c(Nc2ccc(Cl)cc2Cl)[nH]c2c([N+](=O)[O-])cc(Cl)cc2c1=O;IC50;'=''';3160;nM;5.5;;;UO_0000065;12.89;0.28;0.16;5.23;0;CHEMBL1021957;Inhibition of human erythrocytes mu-calpain by fluorometric assay using pep2 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL3920009;;0;485.53;0;0.67;BDBM240241;O=C(O)[C@H]1O[C@@H]1C(=O)NC1(C(=O)NCCCCNS(=O)(=O)c2ccc(F)cc2)CCCCC1;IC50;'=''';1000;nM;6;;419083;UO_0000065;12.36;0.25;5.33;3.89;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL3929814;;0;419.39;0;0.68;BDBM240263;O=C(Nc1nc2ccc(F)cc2s1)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1O[C@@H]1C(=O)O;IC50;'=''';535;nM;6.27;;419116;UO_0000065;14.95;0.3;5.59;4.19;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL2408899;;0;460.45;0;0.06;BDBM50437948;O=C(NCc1cn(-c2ccc(F)cc2)nn1)[C@H](Cc1cscn1)NC(=O)[C@H]1O[C@@H]1C(=O)O;IC50;'=''';125;nM;6.9;;419121;UO_0000065;14.99;0.29;6.84;4.55;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL195728;;0;378.38;0;1.5;2;Cc1c(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(N)=O)oc2ccccc2c1=O;IC50;'=''';40;nM;7.4;;;UO_0000065;19.55;0.36;5.9;6.19;0;CHEMBL1013486;Inhibition of human erythrocytes mu-calpain;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1154513;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2009;None;
CHEMBL464965;;0;532.59;1;3.29;4i-3;COc1ccc(CNC(=O)C(=O)[C@H](Cc2ccccc2)NC(=O)CCC(=O)c2cc(OC)ccc2OC)cc1;IC50;'=''';2350;nM;5.63;;;UO_0000065;10.57;0.2;2.34;4.69;0;CHEMBL1013486;Inhibition of human erythrocytes mu-calpain;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1154513;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2009;None;
CHEMBL23453;;0;396.42;0;1.52;5;COC(=O)CC(NC(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)C)C(=O)CF;IC50;'=''';120;nM;6.92;;;UO_0000065;17.46;0.34;5.4;6.25;0;CHEMBL884254;Compound was evaluated for its inhibitory activity against the Calpain-1 enzyme;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1147604;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL402385;;0;419.48;0;2.27;3d;Cc1c(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NC(C)C)[nH]c2ccccc2c1=O;IC50;'>''';50000;nM;;;;UO_0000065;;;;;0;CHEMBL928702;Inhibition of human mu-calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1140783;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2008;None;
CHEMBL253112;;0;527.58;1;3.08;3g;COc1ccc(CNC(=O)C(=O)[C@H](Cc2ccccc2)NC(=O)c2[nH]c3ccccc3c(=O)c2C)cc1OC;IC50;'=''';1780;nM;5.75;;;UO_0000065;10.9;0.2;2.67;4.54;0;CHEMBL928702;Inhibition of human mu-calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1140783;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2008;None;
CHEMBL8757;;0;702.78;1;1.31;11j;CCN1C(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCCCNS(=O)(=O)c2ccc(F)cc2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';50;nM;7.3;;;UO_0000065;10.39;0.21;5.99;4.12;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL276726;;0;729.79;2;1.08;11f;CCN1C(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCCCNS(=O)(=O)c2ccc([N+](=O)[O-])cc2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';3600;nM;5.44;;;UO_0000065;7.46;0.15;4.36;2.47;0;CHEMBL656844;In vitro inhibitory activity against human calpain 1 in Molt-4 cells (intact human T-cell leukemia cell line);B;BAO_0000219;cell-based format;None;None;None;MOLT-4;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;CHEMBL3307557;
CHEMBL151333;;0;362.47;0;3.06;Z-Leu-t-BuGly-H;CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@H](C=O)C(C)(C)C;IC50;'=''';35;nM;7.46;;;UO_0000065;20.57;0.39;4.4;8.82;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL88895;;0;380.49;0;1.13;24;CS(=O)(=O)N[C@H](Cc1cccs1)C(=O)N[C@H](C=O)Cc1ccccc1;IC50;'=''';300;nM;6.52;;;UO_0000065;17.14;0.36;5.39;7.06;0;CHEMBL658526;Inhibition of intracellular Calpain-I receptor using intact cell assay system;B;BAO_0000219;cell-based format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1131026;1;Scientific Literature;J. Med. Chem.;1998;None;
CHEMBL63494;;0;421.33;0;1.39;1c;CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)OCCBr;IC50;'=''';1000;nM;6;;;UO_0000065;14.24;0.33;4.61;6.18;0;CHEMBL659382;The ability of compound to inhibit calpain in a preparation of lysed platelets was measured with a caseinolytic assay(assay 1);B;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None;
CHEMBL418150;;0;608.7;1;-0.64;11a;CCN1C(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCCNS(C)(=O)=O)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';89;nM;7.05;;;UO_0000065;11.58;0.23;7.69;3.98;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL8104;;0;715.76;2;0.69;11e;CCN1C(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCCNS(=O)(=O)c2ccc([N+](=O)[O-])cc2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';4200;nM;5.38;;;UO_0000065;7.51;0.15;4.69;2.44;0;CHEMBL656844;In vitro inhibitory activity against human calpain 1 in Molt-4 cells (intact human T-cell leukemia cell line);B;BAO_0000219;cell-based format;None;None;None;MOLT-4;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;CHEMBL3307557;
CHEMBL167224;;0;422.93;0;2.57;13;CC(C)[C@H](NS(=O)(=O)c1ccc(Cl)cc1)C(=O)N[C@@H](C=O)Cc1ccccc1;IC50;'=''';14;nM;7.85;;;UO_0000065;18.57;0.38;5.28;8.51;0;CHEMBL744609;In vitro inhibition of porcine mu-calpain.;B;BAO_0000357;single protein format;Sus scrofa;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1145779;1;Scientific Literature;J. Med. Chem.;2003;None;
CHEMBL262694;;0;578.65;1;1.4;8q;CCN1C(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCc2ccncc2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';240;nM;6.62;;;UO_0000065;11.44;0.22;5.22;4.6;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL146;BUTYLATED HYDROXYTOLUENE;2;220.36;0;4.3;BHT;Cc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1;IC50;;;nM;;;Not Active;UO_0000065;;;;;0;CHEMBL659381;Inhibitory activity against on calpain in C6 glial cells; Not active;F;BAO_0000219;cell-based format;Rattus norvegicus;None;None;C6;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146815;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;CHEMBL3308345
CHEMBL441262;;0;511.62;1;3.47;3e;CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)C(=O)NOC(C)(C)C;IC50;'=''';26;nM;7.58;;;UO_0000065;14.83;0.28;4.12;6.18;0;CHEMBL657770;Inhibition of human recombinant Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1133978;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2001;None;
CHEMBL378215;;0;365.5;0;1.92;18;Cc1ccc(NC(=S)N[C@@H](CC(C)C)C(=O)N[C@H]2CCOC2O)cc1;IC50;'=''';910;nM;6.04;;;UO_0000065;16.53;0.33;4.12;7.31;0;CHEMBL863671;Inhibition of human erythrocyte mu calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138043;1;Scientific Literature;J. Med. Chem.;2006;None;
CHEMBL513042;;0;426.1;1;5.54;10;CC(=O)c1c(Nc2ccc(Cl)cc2)[nH]c2c(Br)ccc(Cl)c2c1=O;IC50;'=''';9940;nM;5;;;UO_0000065;11.74;0.28;-0.54;8.07;0;CHEMBL1021957;Inhibition of human erythrocytes mu-calpain by fluorometric assay using pep2 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL459288;;0;442.47;0;1.42;4f-2;COCOc1cc(OC)ccc1C(=O)CCC(=O)N[C@@H](Cc1ccccc1)C(=O)C(N)=O;IC50;'=''';700;nM;6.16;;;UO_0000065;13.91;0.26;4.73;4.59;0;CHEMBL1013486;Inhibition of human erythrocytes mu-calpain;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1154513;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2009;None;
CHEMBL457776;;0;474.51;0;2.67;4h-1;O=C(CCC(=O)c1ccc(O)cc1O)N[C@@H](Cc1ccccc1)C(=O)C(=O)NCc1ccccc1;IC50;'=''';5730;nM;5.24;;;UO_0000065;11.05;0.2;2.57;3.95;0;CHEMBL1013486;Inhibition of human erythrocytes mu-calpain;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1154513;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2009;None;
CHEMBL489535;;0;380.75;0;4.85;19;CC(=O)c1c(Nc2cc(F)c(F)cc2F)[nH]c2c(Cl)ccc(C)c2c1=O;IC50;;;;;;Not Determined;;;;;;0;CHEMBL1021957;Inhibition of human erythrocytes mu-calpain by fluorometric assay using pep2 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL3960800;;0;462.48;0;1.92;BDBM240262;O=C(Nc1nc(-c2ccc(F)cc2)cs1)[C@H](Cc1cscn1)NC(=O)[C@@H]1O[C@H]1C(=O)O;IC50;'=''';100;nM;7;;419115;UO_0000065;15.14;0.31;5.08;5.23;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL340210;;0;380.79;0;2.63;15;NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-n3cccn3)ccc2c1=O;IC50;'=''';600;nM;6.22;;;UO_0000065;16.34;0.31;3.59;6.03;0;CHEMBL656843;In vitro inhibitory activity against human erythrocyte Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1153663;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1995;None;
CHEMBL42617;;0;421.58;1;5.17;7b;CC(C)C[C@@H](C=O)NC(=O)[C@@H](CC(=O)C(c1ccccc1)c1ccccc1)CC(C)C;IC50;'=''';50;nM;7.3;;;UO_0000065;17.32;0.32;2.13;11.54;0;CHEMBL654084;Inhibitory activity of compound against recombinant human Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1151519;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1996;None;
CHEMBL115954;;0;430.48;0;0.93;15l;CN1C(C(=O)N[C@H](C=O)Cc2ccccc2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';2000;nM;5.7;;;UO_0000065;;;;;0;CHEMBL714770;Inhibitory concentration against MOLT-4 cells (human T-cell leukemia cell line);F;BAO_0000219;cell-based format;None;None;None;MOLT-4;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;CHEMBL3307557;
CHEMBL117729;;0;448.97;0;2.84;15i;CC(C)CN1C(C(=O)N[C@H](C=O)Cc2ccccc2)Cc2cc(Cl)ccc2S1(=O)=O;IC50;'=''';200;nM;6.7;;;UO_0000065;14.92;0.3;3.86;8.02;0;CHEMBL877099;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL332683;;0;432.5;0;1.18;15d;COc1cc2c(cc1OC)S(=O)(=O)N(C)C(C(=O)N[C@H](C=O)Cc1ccccc1)C2;IC50;'=''';38;nM;7.42;;;UO_0000065;17.16;0.34;6.24;7.27;0;CHEMBL877099;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL253113;;0;485.52;0;3.2;3h;Cc1c(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCc2ccc(F)cc2)[nH]c2ccccc2c1=O;IC50;'=''';5630;nM;5.25;;;UO_0000065;10.81;0.2;2.05;4.85;0;CHEMBL928702;Inhibition of human mu-calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1140783;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2008;None;
CHEMBL253111;;0;467.53;0;3.06;3e;Cc1c(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCc2ccccc2)[nH]c2ccccc2c1=O;IC50;'=''';5010;nM;5.3;;;UO_0000065;11.34;0.21;2.24;4.9;0;CHEMBL928702;Inhibition of human mu-calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1140783;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2008;None;
CHEMBL254948;;0;391.43;0;1.49;3b;CNC(=O)C(=O)[C@H](Cc1ccccc1)NC(=O)c1[nH]c2ccccc2c(=O)c1C;IC50;'=''';8620;nM;5.06;;;UO_0000065;12.94;0.24;3.57;4.68;0;CHEMBL928702;Inhibition of human mu-calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1140783;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2008;None;
CHEMBL2408910;;0;344.33;0;-0.07;BDBM240257;O=C(Nc1ccccc1)[C@H](Cc1cnc[nH]1)NC(=O)[C@H]1O[C@@H]1C(=O)O;IC50;'=''';5000;nM;5.3;;419110;UO_0000065;15.4;0.29;5.37;3.88;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL2408898;;0;442.46;0;-0.08;BDBM240267;O=C(NCc1cn(-c2ccccc2)nn1)[C@H](Cc1cscn1)NC(=O)[C@H]1O[C@@H]1C(=O)O;IC50;'=''';1000;nM;6;;419122;UO_0000065;13.56;0.26;6.08;3.96;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL3938487;;0;503.69;1;2.1;BDBM240231;CC(C)C[C@H](NC(=O)C1O[C@@H]1C(=O)O)C(=O)NCCCCNC(=O)CCCCC1CCSS1;IC50;'=''';100;nM;7;;419135;UO_0000065;13.9;0.29;4.9;5.1;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL423112;;0;382.46;0;2.86;15;CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)NC(C=O)Cc1ccccc1;IC50;'=''';11;nM;7.96;;;UO_0000065;20.81;0.39;5.1;9.42;0;CHEMBL656194;Inhibitory activity using recombinant human Calpain 1 with Suc-Leu-Tyr-MNA as substrate.;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1129824;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL2371036;;0;334.42;0;2.42;Z-Leu-Abu-H;CC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1;IC50;'=''';10;nM;8;;;UO_0000065;23.92;0.46;5.58;9.47;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL348197;;0;270.37;0;1.27;Ac-Leu-Leu-H;CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CC(C)C;IC50;'=''';130;nM;6.89;;;UO_0000065;25.47;0.49;5.62;9.15;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL64174;;0;396.41;0;1.55;1e;CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)OCC(F)(F)F;IC50;;;nM;;;substantial inhibition by 5-44 uM;UO_0000065;;;;;0;CHEMBL659384;The calpain inhibitory activity(I 50) was measured as ability to enter the platelet and inhibit calpain in the intact cells(assay 3); (+)indicates substantial inhibition by 5-44 uM;B;BAO_0000219;cell-based format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None
CHEMBL63494;;0;421.33;0;1.39;1c;CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)OCCBr;IC50;;;nM;;;substantial inhibition by 5-44 uM;UO_0000065;;;;;0;CHEMBL659384;The calpain inhibitory activity(I 50) was measured as ability to enter the platelet and inhibit calpain in the intact cells(assay 3); (+)indicates substantial inhibition by 5-44 uM;B;BAO_0000219;cell-based format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None
CHEMBL378465;;0;381.5;0;1.62;13;COc1ccc(NC(=S)N[C@@H](CC(C)C)C(=O)N[C@H]2CCOC2O)cc1;IC50;'=''';220;nM;6.66;;;UO_0000065;17.45;0.35;5.04;7.25;0;CHEMBL863671;Inhibition of human erythrocyte mu calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138043;1;Scientific Literature;J. Med. Chem.;2006;None;
CHEMBL492180;;0;415.2;1;5.8;3;CC(=O)c1c(Nc2cccc(C(F)(F)F)c2)[nH]c2c(Cl)c(Cl)ccc2c1=O;IC50;'>''';30000;nM;;;;UO_0000065;;;;;0;CHEMBL1021956;Inhibition of human erythrocytes mu-calpain after 30 mins by fluorometric assay using pep1 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL489727;;0;412.77;1;5.59;21;CC(=O)c1c(Nc2cc(C)ccc2F)[nH]c2c(Cl)ccc(C(F)(F)F)c2c1=O;IC50;;;;;;Not Determined;;;;;;0;CHEMBL1021957;Inhibition of human erythrocytes mu-calpain by fluorometric assay using pep2 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL423112;;0;382.46;0;2.86;MDL-28170;CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)NC(C=O)Cc1ccccc1;IC50;'=''';199;nM;6.7;;;UO_0000065;17.52;0.33;3.84;7.93;0;CHEMBL1021957;Inhibition of human erythrocytes mu-calpain by fluorometric assay using pep2 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL471916;;0;330.75;0;4.27;13;CC(=O)c1c(Nc2ccccc2)[nH]c2c(Cl)ccc(F)c2c1=O;IC50;;;;;;Not Determined;;;;;;0;CHEMBL1021957;Inhibition of human erythrocytes mu-calpain by fluorometric assay using pep2 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL492082;;0;432.48;0;1.35;2l;Cc1ccc(=O)[nH]c1C(=O)N[C@@H](Cc1ccccc1)C(=O)C(=O)NCCc1ccccn1;IC50;'=''';34010;nM;4.47;;;UO_0000065;10.33;0.19;3.12;3.69;0;CHEMBL973384;Inhibition of human erythrocytes mu-calpain by spectrofluorimeter;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138543;1;Scientific Literature;Eur. J. Med. Chem.;2009;None;
CHEMBL492089;;0;380.75;0;4.85;20;CC(=O)c1c(Nc2ccc(F)c(F)c2F)[nH]c2c(Cl)ccc(C)c2c1=O;IC50;'>''';30000;nM;;;;UO_0000065;;;;;0;CHEMBL1021956;Inhibition of human erythrocytes mu-calpain after 30 mins by fluorometric assay using pep1 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL492180;;0;415.2;1;5.8;3;CC(=O)c1c(Nc2cccc(C(F)(F)F)c2)[nH]c2c(Cl)c(Cl)ccc2c1=O;IC50;;;;;;Not Determined;;;;;;0;CHEMBL1021957;Inhibition of human erythrocytes mu-calpain by fluorometric assay using pep2 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL490503;;0;448.75;1;6.17;4;CC(=O)c1c(Nc2ccc(C(F)(F)F)cc2)[nH]c2c(C(F)(F)F)cc(Cl)cc2c1=O;IC50;;;;;;Not Determined;;;;;;0;CHEMBL1021957;Inhibition of human erythrocytes mu-calpain by fluorometric assay using pep2 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL467750;;0;412.44;0;1.45;4i-2;COc1ccc(OC)c(C(=O)CCC(=O)N[C@@H](Cc2ccccc2)C(=O)C(N)=O)c1;IC50;'=''';520;nM;6.28;;;UO_0000065;15.24;0.29;4.83;5.04;1;CHEMBL1013486;Inhibition of human erythrocytes mu-calpain;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1154513;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2009;None;
CHEMBL195728;;0;378.38;0;1.5;2, KYS 4516;Cc1c(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(N)=O)oc2ccccc2c1=O;IC50;'=''';70;nM;7.16;;;UO_0000065;18.91;0.35;5.65;5.99;0;CHEMBL1771900;Inhibition of human erythrocytes mu-calpain using Suc-Leu-Tyr-AMC fluorogenic substrate after 30 mins by spectrofluorimetry;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1770073;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2011;None;
CHEMBL150134;;0;495.66;0;4.25;Naphthyl-2-CO-Leu-Leu-Leu-H;CC(C)C[C@H](NC(=O)c1ccc2ccccc2c1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C=O)CC(C)C;IC50;'=''';10;nM;8;;;UO_0000065;16.14;0.3;3.75;7.67;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL125908;;0;426.26;0;4.16;17;NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3Cl)ccc2c1=O;IC50;'=''';2000;nM;5.7;;;UO_0000065;13.37;0.27;1.54;5.8;0;CHEMBL656843;In vitro inhibitory activity against human erythrocyte Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1153663;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1995;None;
CHEMBL128946;;0;391.81;0;3.51;20;NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccccn3)ccc2c1=O;IC50;'=''';30000;nM;4.52;;;UO_0000065;11.54;0.22;1.01;4.61;0;CHEMBL656843;In vitro inhibitory activity against human erythrocyte Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1153663;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1995;None;
CHEMBL492081;;0;447.49;0;1.92;2f;COc1ccc(CNC(=O)C(=O)[C@H](Cc2ccccc2)NC(=O)c2[nH]c(=O)ccc2C)cc1;IC50;'=''';6190;nM;5.21;;;UO_0000065;11.64;0.22;3.29;4.44;0;CHEMBL973384;Inhibition of human erythrocytes mu-calpain by spectrofluorimeter;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138543;1;Scientific Literature;Eur. J. Med. Chem.;2009;None;
CHEMBL254949;;0;405.45;0;1.88;3c;CCNC(=O)C(=O)[C@H](Cc1ccccc1)NC(=O)c1[nH]c2ccccc2c(=O)c1C;IC50;'=''';40170;nM;4.4;;;UO_0000065;10.84;0.2;2.52;4.07;0;CHEMBL928702;Inhibition of human mu-calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1140783;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2008;None;
CHEMBL2408902;;0;521.54;2;-1.43;BDBM240270;NS(=O)(=O)c1ccc(-n2cc(CNC(=O)[C@H](Cc3cscn3)NC(=O)[C@H]3O[C@@H]3C(=O)O)nn2)cc1;IC50;'>''';1000;nM;;;419125;UO_0000065;;;;;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL115572;;0;410.49;0;1.12;15o;CCN1C(C(=O)N[C@H](C=O)CC(C)C)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';37;nM;7.43;;;UO_0000065;18.1;0.36;6.31;7.29;0;CHEMBL877099;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL420698;;0;372.45;0;1.16;15f;CN1C(C(=O)N[C@H](C=O)Cc2ccccc2)Cc2ccccc2S1(=O)=O;IC50;'=''';110;nM;6.96;;;UO_0000065;18.68;0.37;5.8;8.33;0;CHEMBL656196;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL302443;;0;579.12;1;2.83;1g;CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)OCC(Br)(Br)Br;IC50;;;nM;;;substantial inhibition by 5-44 uM;UO_0000065;;;;;0;CHEMBL659383;The ability of compound to inhibit calpain in a preparation of lysed platelets was measured with a caseinolytic assay(assay 1); (+)indicates substantial inhibition by 5-44 uM;B;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None
CHEMBL439590;;0;399.6;1;5.71;12;CC(C)C[C@@H](C=O)NC(=O)[C@@H](CCSc1ccc2ccccc2c1)CC(C)C;IC50;'=''';75;nM;7.12;;;UO_0000065;17.83;0.35;1.41;15.43;0;CHEMBL656194;Inhibitory activity using recombinant human Calpain 1 with Suc-Leu-Tyr-MNA as substrate.;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1129824;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL302897;;0;376.88;0;1.23;1b;CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)OCCCl;IC50;'=''';2000;nM;5.7;;;UO_0000065;15.12;0.31;4.47;5.87;0;CHEMBL659382;The ability of compound to inhibit calpain in a preparation of lysed platelets was measured with a caseinolytic assay(assay 1);B;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None;
CHEMBL151206;;0;383.53;0;1.8;Ac-Leu-Leu-Leu-H;CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C=O)CC(C)C;IC50;'=''';15;nM;7.82;;;UO_0000065;20.4;0.4;6.02;7.5;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL521636;;0;413.86;1;5.33;2;CC(=O)c1c(Nc2ccc(C(C)(C)C)cc2)[nH]c2c(Cl)cc([N+](=O)[O-])cc2c1=O;IC50;'=''';3690;nM;5.43;;;UO_0000065;13.13;0.26;0.1;5.17;0;CHEMBL1021956;Inhibition of human erythrocytes mu-calpain after 30 mins by fluorometric assay using pep1 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL491348;;0;426.64;1;5.34;6;CC(=O)c1c(Nc2ccc(Cl)cc2Cl)[nH]c2c([N+](=O)[O-])cc(Cl)cc2c1=O;IC50;'=''';4640;nM;5.33;;;UO_0000065;12.5;0.27;-0.01;5.07;0;CHEMBL1021956;Inhibition of human erythrocytes mu-calpain after 30 mins by fluorometric assay using pep1 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL268950;;0;753.88;2;1.91;11k;CCN1C(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCCNS(=O)(=O)c2ccc(-c3ccccn3)s2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';1300;nM;5.89;;;UO_0000065;7.81;0.16;3.98;3.1;0;CHEMBL656844;In vitro inhibitory activity against human calpain 1 in Molt-4 cells (intact human T-cell leukemia cell line);B;BAO_0000219;cell-based format;None;None;None;MOLT-4;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;CHEMBL3307557;
CHEMBL169103;;0;386.49;0;2.25;18;CC(C)C[C@H](NS(=O)(=O)c1ccc(F)cc1)C(=O)N[C@@H](C=O)CC(C)C;IC50;'=''';130;nM;6.89;;;UO_0000065;17.82;0.36;4.64;7.46;0;CHEMBL744609;In vitro inhibition of porcine mu-calpain.;B;BAO_0000357;single protein format;Sus scrofa;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1145779;1;Scientific Literature;J. Med. Chem.;2003;None;
CHEMBL117553;;0;406.89;0;1.81;15j;CN1C(C(=O)N[C@H](C=O)Cc2ccccc2)Cc2cc(Cl)ccc2S1(=O)=O;IC50;'=''';5;nM;8.3;;;UO_0000065;20.4;0.42;6.49;9.94;0;CHEMBL877099;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL332683;;0;432.5;0;1.18;15d;COc1cc2c(cc1OC)S(=O)(=O)N(C)C(C(=O)N[C@H](C=O)Cc1ccccc1)C2;IC50;'=''';200;nM;6.7;;;UO_0000065;15.49;0.3;5.52;6.57;0;CHEMBL656196;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL499571;;0;576.65;1;3.34;4i-7;COc1ccc(OC)c(C(=O)CCC(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCCc2ccc(OC)c(OC)c2)c1;IC50;'=''';2130;nM;5.67;;;UO_0000065;9.84;0.18;2.33;4.39;0;CHEMBL1013486;Inhibition of human erythrocytes mu-calpain;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1154513;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2009;None;
CHEMBL512192;;0;371.78;0;4.34;12;CC(=O)c1c(Nc2cccc(C)c2)[nH]c2c(Cl)ccc([N+](=O)[O-])c2c1=O;IC50;;;;;;Not Determined;;;;;;0;CHEMBL1021957;Inhibition of human erythrocytes mu-calpain by fluorometric assay using pep2 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL4285250;;0;342.4;0;1.59;4b;COCCN/C(=C1/N=CN(CCOC)C1=O)c1cc2ccccc2[nH]1;IC50;'=''';460;nM;6.34;;;UO_0000065;18.51;0.35;4.75;8.03;0;CHEMBL4263564;Inhibition of calpain (unknown origin) using Suc-LY-AMC as fluorogenic substrate after 60 mins by spectrofluorometric analysis;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL4261583;1;Scientific Literature;Eur J Med Chem;2018;None;
CHEMBL3901496;;0;357.41;1;-1.25;BDBM240232;CC(C)C[C@H](NC(=O)C1O[C@@H]1C(=O)O)C(=O)NCCCCNC(=N)N;IC50;'=''';100;nM;7;;419075;UO_0000065;19.59;0.38;8.25;4.12;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL3915178;;0;535.78;1;4.38;BDBM240236;CC(C)C[C@H](NC(=O)C1OC1c1ccccc1)C(=O)NCCCCNC(=O)CCCCC1CCSS1;IC50;'>''';1000;nM;;;419079;UO_0000065;;;;;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL2408924;;0;356.32;0;1.29;21a;CC(C)C[C@H](NC(=O)[C@H]1O[C@@H]1C(=O)O)C(=O)Nc1c(F)cccc1F;IC50;'=''';100;nM;7;;;UO_0000065;19.65;0.38;5.71;6.48;1;CHEMBL2411626;Inhibition of human erythrocyte full length Cal1 using (DABCYL)TPLK-SPPSPR-(EDANS) as substrate after 20 min by FRET assay;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL2407090;1;Scientific Literature;J. Med. Chem.;2013;None;
CHEMBL2408908;;0;503.69;1;2.1;24;CC(C)C[C@H](NC(=O)[C@H]1O[C@@H]1C(=O)O)C(=O)NCCCCNC(=O)CCCCC1CCSS1;IC50;'=''';100;nM;7;;;UO_0000065;13.9;0.29;4.9;5.1;0;CHEMBL2411626;Inhibition of human erythrocyte full length Cal1 using (DABCYL)TPLK-SPPSPR-(EDANS) as substrate after 20 min by FRET assay;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL2407090;1;Scientific Literature;J. Med. Chem.;2013;None;
CHEMBL8486;MDL-28170;0;264.32;0;0.78;Z-Val-Phe-H;CC(C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O;IC50;'=''';11;nM;7.96;;;UO_0000065;30.11;0.57;7.18;8.61;1;CHEMBL884249;Inhibitory activity was evaluated against recombinant human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL151468;;0;341.45;0;0.77;Ac-Ala-Leu-Leu-H;CC(=O)N[C@@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C=O)CC(C)C;IC50;'=''';18;nM;7.75;;;UO_0000065;22.68;0.44;6.97;7.42;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL423112;;0;382.46;0;2.86;1, MDL-28170;CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)NC(C=O)Cc1ccccc1;IC50;'=''';70;nM;7.16;;;UO_0000065;18.71;0.35;4.29;8.47;1;CHEMBL928702;Inhibition of human mu-calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1140783;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2008;None;
CHEMBL331414;;0;390.44;0;1.3;15g;CN1C(C(=O)N[C@H](C=O)Cc2ccccc2)Cc2cc(F)ccc2S1(=O)=O;IC50;'=''';28;nM;7.55;;;UO_0000065;19.34;0.38;6.25;9.04;0;CHEMBL877099;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL60482;;0;472.59;0;1.99;2d;CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)NCCc1c[nH]c2ccc(O)cc12;IC50;'=''';6000;nM;5.22;;;UO_0000065;11.05;0.21;3.23;3.84;0;CHEMBL659382;The ability of compound to inhibit calpain in a preparation of lysed platelets was measured with a caseinolytic assay(assay 1);B;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None;
CHEMBL3706727;;0;441.55;0;3.26;6c;CC(C)C[C@H](NC(=O)c1cccc2c1Nc1ccccc1S2)C(=O)N[C@H]1CCOC1O;IC50;'=''';82;nM;7.09;;;UO_0000065;16.05;0.31;3.83;7.11;0;CHEMBL654082;Inhibitory activity against on human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146815;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL268737;;0;591.69;1;2.05;8k;CCN1C(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCCc2ccccc2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';63;nM;7.2;;;UO_0000065;12.17;0.23;5.15;5.49;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL151937;;0;383.53;0;1.94;Ac-Leu-Leu-Nle-H;CCCC[C@H](C=O)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(C)=O;IC50;'=''';12;nM;7.92;;;UO_0000065;20.65;0.4;5.98;7.59;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL326161;;0;428.47;0;1.36;26b;CN1C(C(=O)N[C@H](C=O)Cc2ccccc2)=Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';6;nM;8.22;;;UO_0000065;19.19;0.37;6.86;8.06;0;CHEMBL877099;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL294046;;0;360.43;0;0.96;1a;CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)OCCF;IC50;'=''';500;nM;6.3;;;UO_0000065;17.48;0.34;5.34;6.49;0;CHEMBL659382;The ability of compound to inhibit calpain in a preparation of lysed platelets was measured with a caseinolytic assay(assay 1);B;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None;
CHEMBL87146;;0;542.64;1;2.15;24;O=C[C@H](Cc1ccccc1)NC(=O)[C@@H]1C[C@@H](OS(=O)(=O)c2ccccc2)CN1S(=O)(=O)c1ccccc1;IC50;'=''';13;nM;7.89;;;UO_0000065;14.53;0.29;5.74;6.21;0;CHEMBL656842;Compound was tested for inhibitory activity against recombinant human Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130591;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1998;None;
CHEMBL60482;;0;472.59;0;1.99;2d;CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)NCCc1c[nH]c2ccc(O)cc12;IC50;;;nM;;;Little inhibition;UO_0000065;;;;;0;CHEMBL656704;The calpain inhibitory activity(I 50) was measured as ability to enter the platelet and inhibit calpain in the intact cells(assay 3); (-)indicates little inhibition by 444 uM;B;BAO_0000219;cell-based format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None
CHEMBL63440;ALOXISTATIN;0;342.44;0;1.01;E64d;CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C;IC50;'=''';4000;nM;5.4;;;UO_0000065;15.76;0.31;4.39;5.56;0;CHEMBL659382;The ability of compound to inhibit calpain in a preparation of lysed platelets was measured with a caseinolytic assay(assay 1);B;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None;
CHEMBL418150;;0;608.7;1;-0.64;11a;CCN1C(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCCNS(C)(=O)=O)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;;;nM;;;Not Determined;UO_0000065;;;;;0;CHEMBL656845;In vitro inhibitory activity against human calpain I in Molt-4 cells (intact human T-cell leukemia cell line); Not determined;B;BAO_0000219;cell-based format;None;None;None;MOLT-4;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;CHEMBL3307557
CHEMBL196184;;0;549.58;1;1.23;2f;Cc1c(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCCN2CCOCC2)oc2cc3c(cc2c1=O)OCCO3;IC50;'>''';20000;nM;;;;UO_0000065;;;;;0;CHEMBL827857;Inhibitory concentration against human plasma mu-calpain;B;BAO_0000366;cell-free format;Homo sapiens;CHEMBL3559721;Plasma;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1139593;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2005;None;
CHEMBL333995;;0;451.57;0;2.62;6d;CC(C)C[C@H](NC(=O)c1ccc2c(c1)CCN2Cc1ccccc1)C(=O)N[C@H]1CCOC1O;IC50;'>''';100000;nM;;;;UO_0000065;;;;;0;CHEMBL659380;Inhibitory activity against on calpain in C6 glial cells;F;BAO_0000219;cell-based format;Rattus norvegicus;None;None;C6;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146815;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;CHEMBL3308345;
CHEMBL169551;;0;402.52;0;2.22;16;Cc1ccc(S(=O)(=O)N[C@H](C(=O)N[C@@H](C=O)Cc2ccccc2)C(C)C)cc1;IC50;'=''';18;nM;7.75;;;UO_0000065;19.24;0.38;5.52;8.39;0;CHEMBL744609;In vitro inhibition of porcine mu-calpain.;B;BAO_0000357;single protein format;Sus scrofa;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1145779;1;Scientific Literature;J. Med. Chem.;2003;None;
CHEMBL326758;;0;336.39;0;1.61;36b;CN1C(=O)c2ccccc2CC1C(=O)N[C@H](C=O)Cc1ccccc1;IC50;'~''';1000;nM;;;;UO_0000065;;;;;0;CHEMBL656196;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL466550;;0;442.52;0;3.26;4a-1;O=C(CCC(=O)c1ccccc1)N[C@@H](Cc1ccccc1)C(=O)C(=O)NCc1ccccc1;IC50;'=''';6250;nM;5.2;;;UO_0000065;11.76;0.22;1.94;5.64;0;CHEMBL1013486;Inhibition of human erythrocytes mu-calpain;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1154513;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2009;None;
CHEMBL464136;;0;532.59;1;3.25;4f-1;COCOc1cc(OC)ccc1C(=O)CCC(=O)N[C@@H](Cc1ccccc1)C(=O)C(=O)NCc1ccccc1;IC50;'=''';4250;nM;5.37;;;UO_0000065;10.09;0.19;2.12;4.48;0;CHEMBL1013486;Inhibition of human erythrocytes mu-calpain;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1154513;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2009;None;
CHEMBL489535;;0;380.75;0;4.85;19;CC(=O)c1c(Nc2cc(F)c(F)cc2F)[nH]c2c(Cl)ccc(C)c2c1=O;IC50;'>''';30000;nM;;;;UO_0000065;;;;;0;CHEMBL1021956;Inhibition of human erythrocytes mu-calpain after 30 mins by fluorometric assay using pep1 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL489728;;0;368.26;0;4.17;22;CC(=O)c1c(Nc2cc(F)c(F)cc2F)[nH]c2c(F)cc(F)cc2c1=O;IC50;'>''';30000;nM;;;;UO_0000065;;;;;0;CHEMBL1021956;Inhibition of human erythrocytes mu-calpain after 30 mins by fluorometric assay using pep1 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL521636;;0;413.86;1;5.33;2;CC(=O)c1c(Nc2ccc(C(C)(C)C)cc2)[nH]c2c(Cl)cc([N+](=O)[O-])cc2c1=O;IC50;'=''';7430;nM;5.13;;;UO_0000065;12.39;0.24;-0.2;4.88;0;CHEMBL1021957;Inhibition of human erythrocytes mu-calpain by fluorometric assay using pep2 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL470707;;0;515;2;5.76;9;CC(=O)c1c(Nc2ccc(Br)cc2)[nH]c2c(Br)ccc(Br)c2c1=O;IC50;'=''';1690;nM;5.77;;;UO_0000065;11.21;0.33;0.01;9.32;0;CHEMBL1021957;Inhibition of human erythrocytes mu-calpain by fluorometric assay using pep2 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL491899;;0;379.22;1;5.23;18;CC(=O)c1c(Nc2ccc(Cl)cc2F)[nH]c2c(Cl)ccc(C)c2c1=O;IC50;;;;;;Not Determined;;;;;;0;CHEMBL1021957;Inhibition of human erythrocytes mu-calpain by fluorometric assay using pep2 as substrate;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138527;1;Scientific Literature;J. Med. Chem.;2009;None;
CHEMBL492083;;0;327.34;0;0.08;2a;Cc1ccc(=O)[nH]c1C(=O)N[C@@H](Cc1ccccc1)C(=O)C(N)=O;IC50;'=''';2810;nM;5.55;;;UO_0000065;16.96;0.32;5.47;4.55;0;CHEMBL973384;Inhibition of human erythrocytes mu-calpain by spectrofluorimeter;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138543;1;Scientific Literature;Eur. J. Med. Chem.;2009;None;
CHEMBL150565;;0;326.39;0;0.89;Maleyl-Leu-Leu-H;CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)/C=C\C(=O)O;IC50;'~''';10000;nM;;;;UO_0000065;;;;;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL422142;;0;362.47;0;3.06;Z-Ile-Leu-H;CC[C@H](C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@H](C=O)CC(C)C;IC50;'=''';41;nM;7.39;;;UO_0000065;20.38;0.39;4.33;8.74;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL60482;;0;472.59;0;1.99;2d;CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)NCCc1c[nH]c2ccc(O)cc12;IC50;'=''';4000;nM;5.4;;;UO_0000065;11.42;0.22;3.41;3.97;0;CHEMBL657758;The calpain inhibitory activity(I 50) was measured as ability to enter the platelet to inhibit calpain after cell lysis(assay 2);B;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None;
CHEMBL318779;;0;401.57;0;1.5;Ac-Leu-Leu-Met-H;CSCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(C)=O;IC50;'=''';23;nM;7.64;;;UO_0000065;19.02;0.39;6.14;7.32;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL423223;;0;410.51;0;3.64;Z-Leu-b-benzyl-b-Ala-H;CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@H](CC=O)Cc1ccccc1;IC50;'>''';1000;nM;;;;UO_0000065;;;;;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL169573;;0;445.52;0;2.54;10;CC(C)[C@H](NS(=O)(=O)c1ccc(F)cc1)C(=O)N[C@@H](C=O)Cc1c[nH]c2ccccc12;IC50;'=''';23;nM;7.64;;;UO_0000065;17.14;0.34;5.1;7.06;0;CHEMBL744609;In vitro inhibition of porcine mu-calpain.;B;BAO_0000357;single protein format;Sus scrofa;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1145779;1;Scientific Literature;J. Med. Chem.;2003;None;
CHEMBL2408900;;0;589.66;2;0.09;37;O=C(NCc1cn(-c2ccc(S(=O)(=O)N3CCCCC3)cc2)nn1)[C@H](Cc1cscn1)NC(=O)[C@H]1O[C@@H]1C(=O)O;IC50;'=''';1500;nM;5.82;;;UO_0000065;9.88;0.2;5.73;3.08;1;CHEMBL2411626;Inhibition of human erythrocyte full length Cal1 using (DABCYL)TPLK-SPPSPR-(EDANS) as substrate after 20 min by FRET assay;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL2407090;1;Scientific Literature;J. Med. Chem.;2013;None;
CHEMBL4290527;;0;310.4;0;3.11;4d;CC(C)N/C(=C1/N=CN(C(C)C)C1=O)c1cc2ccccc2[nH]1;IC50;'>''';1000;nM;;;;UO_0000065;;;;;0;CHEMBL4263564;Inhibition of calpain (unknown origin) using Suc-LY-AMC as fluorogenic substrate after 60 mins by spectrofluorometric analysis;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL4261583;1;Scientific Literature;Eur J Med Chem;2018;None;
CHEMBL117694;;0;400.46;0;1.56;26d;COC1=C(C(=O)N[C@H](C=O)Cc2ccccc2)N(C)S(=O)(=O)c2ccccc21;IC50;'=''';37;nM;7.43;;;UO_0000065;18.56;0.36;5.87;8.01;0;CHEMBL877099;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL146;BUTYLATED HYDROXYTOLUENE;2;220.36;0;4.3;BHT;Cc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1;IC50;;;nM;;;Not Active;UO_0000065;;;;;0;CHEMBL654083;Inhibitory activity against on human calpain 1; Not active;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146815;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None
CHEMBL169690;;0;406.48;0;2.06;9;CC(C)[C@H](NS(=O)(=O)c1ccc(F)cc1)C(=O)N[C@@H](C=O)Cc1ccccc1;IC50;'=''';27;nM;7.57;;;UO_0000065;18.62;0.37;5.51;8.2;0;CHEMBL744609;In vitro inhibition of porcine mu-calpain.;B;BAO_0000357;single protein format;Sus scrofa;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1145779;1;Scientific Literature;J. Med. Chem.;2003;None;
CHEMBL26631;;0;355.44;0;4.4;4a;O=CC(Cc1ccccc1)NC(=O)c1ccccc1/C=C/c1ccccc1;IC50;'=''';;nM;;;;UO_0000065;;;;;0;CHEMBL654080;Inhibition of degradation of tyrosine kinase pp60src by Calpain 1 in human platelets;F;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1145789;1;Scientific Literature;J. Med. Chem.;2003;None;
CHEMBL8605;;0;358.42;0;0.82;(text) (pg no 1035);O=C[C@H](Cc1ccccc1)NC(=O)C1Cc2ccccc2S(=O)(=O)N1;IC50;'=''';7;nM;8.15;;;UO_0000065;22.75;0.45;7.33;8.83;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL316418;;0;531.61;1;3.48;3j;CC(C)[C@@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)C(=O)NOCc1ccccc1;IC50;'=''';12;nM;7.92;;;UO_0000065;14.9;0.28;4.44;6.45;0;CHEMBL657770;Inhibition of human recombinant Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1133978;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2001;None;
CHEMBL266807;;0;529.62;1;1.21;8g;CCN1C(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NC(C)C)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';205;nM;6.69;;;UO_0000065;12.63;0.25;5.48;5.1;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL8858;;0;670.77;1;0.78;11c;CCN1C(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCCNS(=O)(=O)c2ccccc2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';40;nM;7.4;;;UO_0000065;11.03;0.22;6.62;4.17;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL418661;E-64C;0;314.38;0;0.53;E64c;CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)O;IC50;;;nM;;;Little inhibition;UO_0000065;;;;;0;CHEMBL657759;The calpain inhibitory activity(I 50) was measured as ability to enter the platelet to inhibit calpain after cell lysis(assay 2); (-)indicates little inhibition by 444 uM;B;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None
CHEMBL2408914;;0;419.39;0;0.68;BDBM240285;O=C(Nc1nc2ccc(F)cc2s1)[C@H](Cc1c[nH]cn1)NC(=O)[C@H]1O[C@@H]1C(=O)O;IC50;'>''';1000;nM;;;419117;UO_0000065;;;;;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL303315;;0;572.7;1;3.6;1j;CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)Oc1ccc2[nH]cc(CCNC(=O)OC(C)(C)C)c2c1;IC50;'=''';2000;nM;5.7;;;UO_0000065;9.95;0.19;2.1;3.77;0;CHEMBL657758;The calpain inhibitory activity(I 50) was measured as ability to enter the platelet to inhibit calpain after cell lysis(assay 2);B;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None;
CHEMBL3913213;;0;449.5;0;2.75;BDBM240245;CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)Nc1nc(-c2ccc(F)cc2)cs1;IC50;'>''';1000;nM;;;419093;UO_0000065;;;;;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL3898233;;0;279.29;0;0.13;BDBM240252;CCOC(=O)[C@H]1O[C@@H]1C(=O)NCc1ccc(CO)cc1;IC50;'>''';1000;nM;;;419100;UO_0000065;;;;;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL2408924;;0;356.32;0;1.29;BDBM240251;CC(C)C[C@H](NC(=O)[C@H]1O[C@@H]1C(=O)O)C(=O)Nc1c(F)cccc1F;IC50;'>''';1000;nM;;;419102;UO_0000065;;;;;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL3922764;;0;251.24;0;-0.35;BDBM240253;O=C(O)[C@H]1O[C@@H]1C(=O)NCc1ccc(CO)cc1;IC50;'>''';1000;nM;;;419106;UO_0000065;;;;;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL3962819;;0;419.41;0;0.41;BDBM240264;CC(C)C[C@H](NC(=O)[C@H]1O[C@@H]1C(=O)O)C(=O)NCc1cn(-c2ccc(F)cc2)nn1;IC50;'=''';30;nM;7.52;;419118;UO_0000065;17.94;0.34;7.11;5.42;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL2408901;;0;486.47;1;-0.35;BDBM240269;O=C(NCc1cn(-c2ccc3c(c2)OCO3)nn1)[C@H](Cc1cscn1)NC(=O)[C@H]1O[C@@H]1C(=O)O;IC50;'=''';400;nM;6.4;;419124;UO_0000065;13.15;0.26;6.75;3.76;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL419311;;0;551.68;1;4.25;3f;CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)C(=O)NOC1CCC(C)CC1;IC50;'=''';21;nM;7.68;;;UO_0000065;13.92;0.26;3.43;6.25;0;CHEMBL657770;Inhibition of human recombinant Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1133978;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2001;None;
CHEMBL150976;;0;505.66;1;3.36;Z-Ser(O-t-Bu)-Leu-Leu-H;CC(C)C[C@H](C=O)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](COC(C)(C)C)NC(=O)OCc1ccccc1;IC50;'=''';12;nM;7.92;;;UO_0000065;15.66;0.3;4.56;6.45;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL61010;;0;445.77;0;2.36;1f;CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)OCC(Cl)(Cl)Cl;IC50;'=''';700;nM;6.16;;;UO_0000065;13.81;0.31;3.79;6.34;0;CHEMBL659382;The ability of compound to inhibit calpain in a preparation of lysed platelets was measured with a caseinolytic assay(assay 1);B;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None;
CHEMBL478222;;0;447.53;0;1.35;1, SNJ-1919;COCCOC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)C(=O)NC1CC1;IC50;'=''';110;nM;6.96;;;UO_0000065;15.55;0.3;5.61;5.67;0;CHEMBL991566;Inhibition of human erythrocyte mu-calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1144224;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2008;None;
CHEMBL2408908;;0;503.69;1;2.1;BDBM240242;CC(C)C[C@H](NC(=O)[C@H]1O[C@@H]1C(=O)O)C(=O)NCCCCNC(=O)CCCCC1CCSS1;IC50;'=''';150;nM;6.82;;419084;UO_0000065;13.55;0.28;4.72;4.98;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL2408922;;0;421.45;0;2.27;BDBM50437951;CC(C)C[C@H](NC(=O)[C@H]1O[C@@H]1C(=O)O)C(=O)Nc1nc(-c2ccc(F)cc2)cs1;IC50;'=''';30;nM;7.52;;419090;UO_0000065;17.85;0.35;5.25;6.22;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL3931539;;0;201.22;0;-0.16;BDBM240276;CCOC(=O)[C@H]1O[C@@H]1C(=O)NC(C)C;IC50;'>''';1000;nM;;;419091;UO_0000065;;;;;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL2408924;;0;356.32;0;1.29;BDBM240251;CC(C)C[C@H](NC(=O)[C@H]1O[C@@H]1C(=O)O)C(=O)Nc1c(F)cccc1F;IC50;'=''';50;nM;7.3;;419104;UO_0000065;20.49;0.4;6.01;6.76;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL61010;;0;445.77;0;2.36;1f;CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)OCC(Cl)(Cl)Cl;IC50;'=''';1000;nM;6;;;UO_0000065;13.46;0.3;3.64;6.18;0;CHEMBL657758;The calpain inhibitory activity(I 50) was measured as ability to enter the platelet to inhibit calpain after cell lysis(assay 2);B;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None;
CHEMBL516123;;0;535.64;1;1.38;3, SNJ-1955;COCCOCCOCCOC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)C(=O)NC1CC1;IC50;'=''';190;nM;6.72;;;UO_0000065;12.55;0.24;5.34;4.76;0;CHEMBL991566;Inhibition of human erythrocyte mu-calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1144224;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2008;None;
CHEMBL475920;;0;491.59;0;1.37;2, SNJ-1945;COCCOCCOC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)C(=O)NC1CC1;IC50;'=''';170;nM;6.77;;;UO_0000065;13.77;0.26;5.4;5.13;0;CHEMBL991566;Inhibition of human erythrocyte mu-calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1144224;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2008;None;
CHEMBL89008;;0;418.52;0;1.44;12;CCS(=O)(=O)N[C@H](COCc1ccccc1)C(=O)N[C@H](C=O)Cc1ccccc1;IC50;'=''';400;nM;6.4;;;UO_0000065;15.29;0.3;4.96;6.3;0;CHEMBL658526;Inhibition of intracellular Calpain-I receptor using intact cell assay system;B;BAO_0000219;cell-based format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1131026;1;Scientific Literature;J. Med. Chem.;1998;None;
CHEMBL433914;;0;400.52;0;2.64;19;CC(C)CC[C@H](NS(=O)(=O)c1ccc(F)cc1)C(=O)N[C@@H](C=O)CC(C)C;IC50;'=''';260;nM;6.58;;;UO_0000065;16.44;0.33;3.95;7.13;0;CHEMBL744609;In vitro inhibition of porcine mu-calpain.;B;BAO_0000357;single protein format;Sus scrofa;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1145779;1;Scientific Literature;J. Med. Chem.;2003;None;
CHEMBL423112;;0;382.46;0;2.86;MDL-28170, (1);CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)NC(C=O)Cc1ccccc1;IC50;'=''';700;nM;6.16;;;UO_0000065;;;;;0;CHEMBL654080;Inhibition of degradation of tyrosine kinase pp60src by Calpain 1 in human platelets;F;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1145789;1;Scientific Literature;J. Med. Chem.;2003;None;
CHEMBL423112;;0;382.46;0;2.86;11 (Cbz-Val-Phe-H, MDL-28170);CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)NC(C=O)Cc1ccccc1;IC50;'=''';17;nM;7.77;;;UO_0000065;20.31;0.38;4.91;9.19;0;CHEMBL654084;Inhibitory activity of compound against recombinant human Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1151519;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1996;None;
CHEMBL518334;;0;472.54;0;3.27;4b-1;COc1ccccc1C(=O)CCC(=O)N[C@@H](Cc1ccccc1)C(=O)C(=O)NCc1ccccc1;IC50;'=''';3330;nM;5.48;;;UO_0000065;11.59;0.21;2.21;5.39;0;CHEMBL1013486;Inhibition of human erythrocytes mu-calpain;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1154513;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2009;None;
CHEMBL458859;;0;412.44;0;1.41;4c-2;COCOc1ccccc1C(=O)CCC(=O)N[C@@H](Cc1ccccc1)C(=O)C(N)=O;IC50;'=''';340;nM;6.47;;;UO_0000065;15.68;0.29;5.06;5.18;0;CHEMBL1013486;Inhibition of human erythrocytes mu-calpain;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1154513;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2009;None;
CHEMBL457993;;0;502.57;1;3.28;4i-1;COc1ccc(OC)c(C(=O)CCC(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCc2ccccc2)c1;IC50;'=''';3770;nM;5.42;;;UO_0000065;10.79;0.2;2.14;4.89;0;CHEMBL1013486;Inhibition of human erythrocytes mu-calpain;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1154513;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2009;None;
CHEMBL423112;;0;382.46;0;2.86;1, MDL-28170;CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)NC(C=O)Cc1ccccc1;IC50;'=''';70;nM;7.16;;;UO_0000065;18.71;0.35;4.29;8.47;1;CHEMBL1013486;Inhibition of human erythrocytes mu-calpain;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1154513;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2009;None;
CHEMBL461666;;0;516.59;1;3.32;4i-5;COc1ccc(OC)c(C(=O)CCC(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCCc2ccccc2)c1;IC50;'=''';2090;nM;5.68;;;UO_0000065;10.99;0.2;2.36;5.13;0;CHEMBL1013486;Inhibition of human erythrocytes mu-calpain;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1154513;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2009;None;
CHEMBL127630;;0;490.49;0;3.68;1d;COP(=O)(OC)C(=O)[C@@H](Cc1ccccc1)NC(=O)C(NC(=O)OCc1ccccc1)C(C)C;IC50;'=''';7400;nM;5.13;;;UO_0000065;10.46;0.21;1.45;4.27;0;CHEMBL658527;inhibitory activity measured against recombinant human Calpain-I receptor;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1131587;1;Scientific Literature;J. Med. Chem.;1998;None;
CHEMBL41337;;0;478.63;1;5.21;10a;CCNC(=O)C(CC(C)C)NC(=O)[C@@H](CC(=O)C1c2ccccc2Oc2ccccc21)CC(C)C;IC50;'=''';130;nM;6.89;;;UO_0000065;14.39;0.27;1.68;8.15;0;CHEMBL654084;Inhibitory activity of compound against recombinant human Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1151519;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1996;None;
CHEMBL196671;;0;392.41;0;1.75;2k;CCc1c(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(N)=O)oc2ccccc2c1=O;IC50;'=''';450;nM;6.35;;;UO_0000065;16.17;0.3;4.6;5.31;0;CHEMBL827857;Inhibitory concentration against human plasma mu-calpain;B;BAO_0000366;cell-free format;Homo sapiens;CHEMBL3559721;Plasma;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1139593;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2005;None;
CHEMBL296285;;0;405.5;0;1.93;12 (Cbz-Leu-Abu-CONHEt);CCNC(=O)C(=O)C(CC)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1;IC50;'=''';240;nM;6.62;;;UO_0000065;16.33;0.31;4.69;5.83;0;CHEMBL654084;Inhibitory activity of compound against recombinant human Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1151519;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1996;None;
CHEMBL1770881;;0;486.57;0;3.89;4d;CCC/C(=C\c1ccc(O)c(O)c1)C(=O)N[C@@H](Cc1ccccc1)C(=O)C(=O)NCc1ccccc1;IC50;'=''';360;nM;6.44;;;UO_0000065;13.24;0.24;2.55;5.57;0;CHEMBL1771900;Inhibition of human erythrocytes mu-calpain using Suc-Leu-Tyr-AMC fluorogenic substrate after 30 mins by spectrofluorimetry;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1770073;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2011;None;
CHEMBL1771026;;0;558.68;1;4.64;4i;CCCC/C(=C\c1ccc(O)c(OC)c1)C(=O)N[C@@H](Cc1ccccc1)C(=O)C(=O)NCCc1ccc(OC)cc1;IC50;'=''';630;nM;6.2;;;UO_0000065;11.1;0.21;1.56;5.44;0;CHEMBL1771900;Inhibition of human erythrocytes mu-calpain using Suc-Leu-Tyr-AMC fluorogenic substrate after 30 mins by spectrofluorimetry;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1770073;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2011;None;
CHEMBL80903;;0;405.5;1;5.55;4b;O=CC(Cc1ccccc1)NC(=O)c1ccccc1/C=C/c1cccc2ccccc12;IC50;'=''';;nM;;;;UO_0000065;;;;;0;CHEMBL654080;Inhibition of degradation of tyrosine kinase pp60src by Calpain 1 in human platelets;F;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1145789;1;Scientific Literature;J. Med. Chem.;2003;None;
CHEMBL127231;;0;378.47;0;2.94;Cbz-Leu-Leu-COOH;CC(C)CC(NC(=O)OCc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)O;IC50;'=''';7;nM;8.15;;;UO_0000065;21.55;0.41;5.21;7.79;0;CHEMBL658527;inhibitory activity measured against recombinant human Calpain-I receptor;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1131587;1;Scientific Literature;J. Med. Chem.;1998;None;
CHEMBL150256;;0;521.66;1;4.01;Z-Tic-Leu-Leu-H;CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)C1Cc2ccccc2CN1C(=O)OCc1ccccc1;IC50;'=''';15;nM;7.82;;;UO_0000065;15;0.28;3.81;7.46;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL433692;;0;426.56;0;-0.19;Ac-Leu-Leu-Arg-H;CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C=O)CCCN=C(N)N;IC50;'=''';72;nM;7.14;;;UO_0000065;16.74;0.33;7.33;4.23;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL357595;;0;433.55;0;2.56;Z-Ala-Leu-Leu-H;CC(C)C[C@H](C=O)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](C)NC(=O)OCc1ccccc1;IC50;'=''';5;nM;8.3;;;UO_0000065;19.15;0.37;5.74;7.31;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL150572;;0;320.39;0;2.03;[2-((S)-1-Formyl-3-methyl-butylcarbamoyl)-ethyl]-carbamic acid benzyl ester;CC(C)C[C@@H](C=O)NC(=O)CCNC(=O)OCc1ccccc1;IC50;'>>''';10000;nM;;;;UO_0000065;;;;;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL1770878;;0;444.49;0;2.72;4a;O=C(/C=C/c1ccc(O)c(O)c1)N[C@@H](Cc1ccccc1)C(=O)C(=O)NCc1ccccc1;IC50;'=''';6070;nM;5.22;;;UO_0000065;11.74;0.22;2.5;4.51;0;CHEMBL1771900;Inhibition of human erythrocytes mu-calpain using Suc-Leu-Tyr-AMC fluorogenic substrate after 30 mins by spectrofluorimetry;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1770073;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2011;None;
CHEMBL1771023;;0;500.6;1;4.28;4f;CCCC/C(=C\c1ccc(O)c(O)c1)C(=O)N[C@@H](Cc1ccccc1)C(=O)C(=O)NCc1ccccc1;IC50;'=''';670;nM;6.17;;;UO_0000065;12.33;0.23;1.89;5.33;0;CHEMBL1771900;Inhibition of human erythrocytes mu-calpain using Suc-Leu-Tyr-AMC fluorogenic substrate after 30 mins by spectrofluorimetry;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1770073;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2011;None;
CHEMBL310648;;0;324.4;0;0.34;22;CS(=O)(=O)N1CCC[C@H]1C(=O)N[C@H](C=O)Cc1ccccc1;IC50;'=''';45;nM;7.35;;;UO_0000065;22.65;0.46;7.01;8.79;0;CHEMBL656842;Compound was tested for inhibitory activity against recombinant human Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130591;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1998;None;
CHEMBL77784;;0;393.53;0;3.69;5b;CCCCC(NC(=O)c1ccccc1/C=C/c1ccc(CN(C)C)cc1)C(N)=O;IC50;'=''';800;nM;6.1;;;UO_0000065;;;;;0;CHEMBL654080;Inhibition of degradation of tyrosine kinase pp60src by Calpain 1 in human platelets;F;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1145789;1;Scientific Literature;J. Med. Chem.;2003;None;
CHEMBL288365;;0;372.46;0;1.86;1, SJA6017;CC(C)C[C@@H](C=O)NC(=O)[C@@H](NS(=O)(=O)c1ccc(F)cc1)C(C)C;IC50;'=''';22;nM;7.66;;;UO_0000065;20.56;0.42;5.8;8.29;0;CHEMBL863671;Inhibition of human erythrocyte mu calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138043;1;Scientific Literature;J. Med. Chem.;2006;None;
CHEMBL151913;;0;402.54;0;3.98;Z-Cha-Leu-H;CC(C)C[C@@H](C=O)NC(=O)[C@H](CC1CCCCC1)NC(=O)OCc1ccccc1;IC50;'=''';580;nM;6.24;;;UO_0000065;15.49;0.29;2.26;7.38;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL151979;;0;490.65;0;2.67;Z-Leu-Lys-Leu-H;CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](C=O)CC(C)C;IC50;'~''';10000;nM;;;;UO_0000065;;;;;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL151595;;0;495.62;0;3.39;Z-Val-Phe-Leu-H;CC(C)C[C@H](C=O)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)C;IC50;'=''';31;nM;7.51;;;UO_0000065;15.15;0.28;4.12;6.61;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL423112;;0;382.46;0;2.86;MDL-28170;CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)NC(C=O)Cc1ccccc1;IC50;'=''';200;nM;6.7;;;UO_0000065;17.52;0.33;3.84;7.93;1;CHEMBL827857;Inhibitory concentration against human plasma mu-calpain;B;BAO_0000366;cell-free format;Homo sapiens;CHEMBL3559721;Plasma;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1139593;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2005;None;
CHEMBL2408907;;0;484.54;0;0.84;44;Cc1cc(C)c(-n2cc(CNC(=O)[C@H](Cc3cscn3)NC(=O)[C@H]3O[C@@H]3C(=O)O)nn2)c(C)c1;IC50;'>''';1000;nM;;;;UO_0000065;;;;;1;CHEMBL2411626;Inhibition of human erythrocyte full length Cal1 using (DABCYL)TPLK-SPPSPR-(EDANS) as substrate after 20 min by FRET assay;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL2407090;1;Scientific Literature;J. Med. Chem.;2013;None;
CHEMBL2408909;;0;541.67;2;0.11;25;CC(C)C[C@H](NC(=O)[C@H]1O[C@@H]1C(=O)O)C(=O)NCCCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12;IC50;'=''';100;nM;7;;;UO_0000065;12.92;0.26;6.89;3.93;0;CHEMBL2411626;Inhibition of human erythrocyte full length Cal1 using (DABCYL)TPLK-SPPSPR-(EDANS) as substrate after 20 min by FRET assay;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL2407090;1;Scientific Literature;J. Med. Chem.;2013;None;
CHEMBL2408920;;0;421.45;0;2.27;22b;CC(C)C[C@H](NC(=O)[C@@H]1O[C@H]1C(=O)O)C(=O)Nc1nc(-c2ccc(F)cc2)cs1;IC50;'=''';250;nM;6.6;;;UO_0000065;15.67;0.31;4.33;5.46;0;CHEMBL2411626;Inhibition of human erythrocyte full length Cal1 using (DABCYL)TPLK-SPPSPR-(EDANS) as substrate after 20 min by FRET assay;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL2407090;1;Scientific Literature;J. Med. Chem.;2013;None;
CHEMBL356841;;0;362.47;0;3.06;Z-Leu-Leu;CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1;IC50;'=''';8;nM;8.1;;;UO_0000065;22.34;0.43;5.04;9.58;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL316010;;0;400.5;0;2.07;20;Cc1ccc(S(=O)(=O)N2CCC[C@@H]2C(=O)N[C@H](C=O)Cc2ccccc2)cc1;IC50;'=''';14;nM;7.85;;;UO_0000065;19.61;0.38;5.78;9.4;0;CHEMBL656842;Compound was tested for inhibitory activity against recombinant human Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130591;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1998;None;
CHEMBL302443;;0;579.12;1;2.83;1g;CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)OCC(Br)(Br)Br;IC50;'=''';5000;nM;5.3;;;UO_0000065;9.15;0.27;2.47;5.46;0;CHEMBL657758;The calpain inhibitory activity(I 50) was measured as ability to enter the platelet to inhibit calpain after cell lysis(assay 2);B;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None;
CHEMBL61010;;0;445.77;0;2.36;1f;CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)OCC(Cl)(Cl)Cl;IC50;;;nM;;;substantial inhibition by 5-44 uM;UO_0000065;;;;;0;CHEMBL659384;The calpain inhibitory activity(I 50) was measured as ability to enter the platelet and inhibit calpain in the intact cells(assay 3); (+)indicates substantial inhibition by 5-44 uM;B;BAO_0000219;cell-based format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None
CHEMBL3963225;;0;384.38;0;1.76;BDBM240250;CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)Nc1c(F)cccc1F;IC50;'>''';1000;nM;;;419101;UO_0000065;;;;;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL2408911;;0;386.41;0;0.85;BDBM240260;Cc1cc(C)c(NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H]2O[C@@H]2C(=O)O)c(C)c1;IC50;'=''';5000;nM;5.3;;419113;UO_0000065;13.72;0.26;4.45;3.88;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL3919703;;0;282.3;0;-0.88;BDBM240266;C#CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)O;IC50;'=''';275;nM;6.56;;419120;UO_0000065;23.24;0.45;7.44;6.07;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL2408907;;0;484.54;0;0.84;BDBM240275;Cc1cc(C)c(-n2cc(CNC(=O)[C@H](Cc3cscn3)NC(=O)[C@H]3O[C@@H]3C(=O)O)nn2)c(C)c1;IC50;'>''';1000;nM;;;419130;UO_0000065;;;;;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL418661;E-64C;0;314.38;0;0.53;E64c;CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(=O)O;IC50;'=''';40;nM;7.4;;;UO_0000065;23.53;0.46;6.87;6.85;0;CHEMBL659382;The ability of compound to inhibit calpain in a preparation of lysed platelets was measured with a caseinolytic assay(assay 1);B;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1126246;1;Scientific Literature;J. Med. Chem.;1992;None;
CHEMBL358404;;0;286.37;0;1.49;[(S)-1-((S)-1-Formyl-3-methyl-butylcarbamoyl)-3-methyl-butyl]-carbamic acid methyl ester;COC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CC(C)C;IC50;'=''';12;nM;7.92;;;UO_0000065;27.66;0.54;6.43;9.37;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL150136;;0;403.52;0;1.6;Ac-Val-Phe-Leu-H;CC(=O)N[C@H](C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](C=O)CC(C)C)C(C)C;IC50;'=''';110;nM;6.96;;;UO_0000065;17.24;0.33;5.36;6.67;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL87454;;0;507.57;1;0.07;3g;COC[C@H](NC(=O)[C@@H](COCc1ccccc1)NS(C)(=O)=O)C(=O)C(=O)NOCc1ccccc1;IC50;'=''';152;nM;6.82;;;UO_0000065;13.43;0.27;6.75;4.57;0;CHEMBL657770;Inhibition of human recombinant Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1133978;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2001;None;
CHEMBL151970;;0;548.68;1;4.27;Z-Leu-Trp-Leu-H;CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C=O)CC(C)C;IC50;'=''';45;nM;7.35;;;UO_0000065;13.39;0.25;3.08;5.68;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL269383;;0;541.63;1;2.04;(text) (pg no 1038);CCCCNC(=O)C(=O)[C@H](Cc1ccccc1)NC(=O)C1=Cc2cc3c(cc2S(=O)(=O)N1CC)OCCO3;IC50;'=''';155;nM;6.81;;;UO_0000065;12.57;0.24;4.77;5.19;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL127408;;0;456.48;0;3.22;1a;COP(=O)(O)C(=O)[C@@H](CC(C)C)NC(=O)C(CC(C)C)NC(=O)OCc1ccccc1;IC50;'=''';5200;nM;5.28;;;UO_0000065;11.58;0.23;2.06;4.03;0;CHEMBL658527;inhibitory activity measured against recombinant human Calpain-I receptor;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1131587;1;Scientific Literature;J. Med. Chem.;1998;None;
CHEMBL1771025;;0;500.6;1;4.14;4h;CC(C)C/C(=C\c1ccc(O)c(O)c1)C(=O)N[C@@H](Cc1ccccc1)C(=O)C(=O)NCc1ccccc1;IC50;'=''';320;nM;6.5;;;UO_0000065;12.97;0.24;2.35;5.61;0;CHEMBL1771900;Inhibition of human erythrocytes mu-calpain using Suc-Leu-Tyr-AMC fluorogenic substrate after 30 mins by spectrofluorimetry;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1770073;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2011;None;
CHEMBL338041;;0;631.54;2;6.71;1h;CC(C)CC(NC(=O)OCc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)P(=O)(c1ccc(Cl)cc1)c1ccc(Cl)cc1;IC50;'=''';350;nM;6.46;;;UO_0000065;10.22;0.21;-0.25;6.36;0;CHEMBL658527;inhibitory activity measured against recombinant human Calpain-I receptor;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1131587;1;Scientific Literature;J. Med. Chem.;1998;None;
CHEMBL338647;;0;406.52;0;3.42;Cbz-Leu-Leu-CO2Et;CCOC(=O)[C@@H](CC(C)C)NC(=O)C(CC(C)C)NC(=O)OCc1ccccc1;IC50;'=''';600;nM;6.22;;;UO_0000065;15.31;0.29;2.8;6.64;0;CHEMBL658527;inhibitory activity measured against recombinant human Calpain-I receptor;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1131587;1;Scientific Literature;J. Med. Chem.;1998;None;
CHEMBL8378;;0;420.92;0;2.2;(text) (pg no 1038);CCN1C(C(=O)N[C@H](C=O)Cc2ccccc2)Cc2cc(Cl)ccc2S1(=O)=O;IC50;'=''';5;nM;8.3;;;UO_0000065;19.72;0.4;6.1;9.94;0;CHEMBL654078;In vitro inhibitory activity against human calpain I; Not determined;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None
CHEMBL8741;;0;557.67;1;2;8i;CCCCCNC(=O)C(=O)[C@H](Cc1ccccc1)NC(=O)C1Cc2cc3c(cc2S(=O)(=O)N1CC)OCCO3;IC50;'=''';150;nM;6.82;;;UO_0000065;12.24;0.24;4.82;5.2;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL3706728;;0;483.59;0;3.83;7;CC(=O)OC1OCC[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)c1ccc2c(c1)Nc1ccccc1S2;IC50;'=''';13340;nM;4.88;;;UO_0000065;;;;;0;CHEMBL653672;Inhibitory activity against on calpain 1 in C6 glial cells;F;BAO_0000219;cell-based format;Rattus norvegicus;None;None;C6;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146815;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;CHEMBL3308345;
CHEMBL8858;;0;670.77;1;0.78;11c;CCN1C(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCCNS(=O)(=O)c2ccccc2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';5000;nM;5.3;;;UO_0000065;7.9;0.16;4.52;2.99;0;CHEMBL656844;In vitro inhibitory activity against human calpain 1 in Molt-4 cells (intact human T-cell leukemia cell line);B;BAO_0000219;cell-based format;None;None;None;MOLT-4;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;CHEMBL3307557;
CHEMBL8703;;0;436.53;0;2.5;(text) (pg no 1035);O=C[C@H](Cc1ccccc1)NC(=O)C(Cc1ccccc1)NS(=O)(=O)c1ccccc1;IC50;'=''';20;nM;7.7;;;UO_0000065;17.64;0.34;5.2;8.34;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL151370;;0;509.65;1;3.78;Z-Phe-Leu-Leu-H;CC(C)C[C@H](C=O)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1;IC50;'=''';11;nM;7.96;;;UO_0000065;15.62;0.29;4.18;7.01;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL98832;;0;415.6;0;4.73;14;CC(C)C[C@@H](C=O)NC(=O)[C@@H](CC[S+]([O-])c1ccc2ccccc2c1)CC(C)C;IC50;'=''';30;nM;7.52;;;UO_0000065;18.1;0.35;2.79;11.9;0;CHEMBL656194;Inhibitory activity using recombinant human Calpain 1 with Suc-Leu-Tyr-MNA as substrate.;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1129824;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL150600;;0;348.44;0;2.67;Z-Leu-Val-H;CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@H](C=O)C(C)C;IC50;'=''';4;nM;8.4;;;UO_0000065;24.1;0.46;5.73;9.94;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL149754;;0;450.58;0;4.67;FMOC-Leu-Leu-H;CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)OCC1c2ccccc2-c2ccccc21;IC50;'=''';11;nM;7.96;;;UO_0000065;17.66;0.33;3.29;9.42;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL1770882;;0;530.62;1;3.95;4e;CCC/C(=C\c1ccc(O)c(O)c1)C(=O)N[C@@H](Cc1ccccc1)C(=O)C(=O)NCCc1ccc(OC)cc1;IC50;'=''';130;nM;6.89;;;UO_0000065;12.98;0.24;2.94;5.51;0;CHEMBL1771900;Inhibition of human erythrocytes mu-calpain using Suc-Leu-Tyr-AMC fluorogenic substrate after 30 mins by spectrofluorimetry;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1770073;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2011;None;
CHEMBL117006;;0;457.55;0;0.99;15k;CN1C(C(=O)N[C@H](C=O)Cc2ccccc2)Cc2cc(N3CCOCC3)ccc2S1(=O)=O;IC50;'=''';30;nM;7.52;;;UO_0000065;16.44;0.32;6.53;7.83;0;CHEMBL877099;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL150090;;0;419.52;0;2.17;Z-Leu-Gly-Leu-H;CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)NCC(=O)N[C@@H](C=O)CC(C)C;IC50;'~''';10000;nM;;;;UO_0000065;;;;;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL149404;;0;376.5;0;3.4;Z-(N-Me)Leu-Leu-H;CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)N(C)C(=O)OCc1ccccc1;IC50;'>''';10000;nM;;;;UO_0000065;;;;;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL151176;;0;475.63;0;3.59;Z-Leu-Leu-Leu-H;CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C=O)CC(C)C;IC50;'=''';19;nM;7.72;;;UO_0000065;16.23;0.31;4.13;6.8;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL358158;;0;547.69;1;3.66;Z-Glu(t-Bu)-Leu-Leu-H;CC(C)C[C@H](C=O)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)OCc1ccccc1;IC50;'=''';25;nM;7.6;;;UO_0000065;13.88;0.27;3.94;5.43;0;CHEMBL656195;Inhibitory activity evaluated against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1130294;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1997;None;
CHEMBL2408899;;0;460.45;0;0.06;36;O=C(NCc1cn(-c2ccc(F)cc2)nn1)[C@H](Cc1cscn1)NC(=O)[C@H]1O[C@@H]1C(=O)O;IC50;'=''';100;nM;7;;;UO_0000065;15.2;0.3;6.94;4.62;1;CHEMBL2411626;Inhibition of human erythrocyte full length Cal1 using (DABCYL)TPLK-SPPSPR-(EDANS) as substrate after 20 min by FRET assay;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL2407090;1;Scientific Literature;J. Med. Chem.;2013;None;
CHEMBL2408918;;0;468.52;0;1.77;32;C#Cc1ccc(-c2csc(NC(=O)[C@H](Cc3cscn3)NC(=O)[C@H]3O[C@@H]3C(=O)O)n2)cc1;IC50;'=''';100;nM;7;;;UO_0000065;14.94;0.3;5.23;5.23;1;CHEMBL2411626;Inhibition of human erythrocyte full length Cal1 using (DABCYL)TPLK-SPPSPR-(EDANS) as substrate after 20 min by FRET assay;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL2407090;1;Scientific Literature;J. Med. Chem.;2013;None;
CHEMBL310855;;0;420.51;0;4.84;5a;NC(=O)C(Cc1ccccc1)NC(=O)c1ccccc1/C=C/c1cccc2ccccc12;IC50;'=''';1400;nM;5.85;;;UO_0000065;;;;;0;CHEMBL654080;Inhibition of degradation of tyrosine kinase pp60src by Calpain 1 in human platelets;F;BAO_0000019;assay format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1145789;1;Scientific Literature;J. Med. Chem.;2003;None;
CHEMBL115572;;0;410.49;0;1.12;15o;CCN1C(C(=O)N[C@H](C=O)CC(C)C)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';300;nM;6.52;;;UO_0000065;15.89;0.32;5.4;6.39;0;CHEMBL656196;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL337944;;0;392.8;0;2.91;18;NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3cccnn3)ccc2c1=O;IC50;'=''';2000;nM;5.7;;;UO_0000065;14.51;0.28;2.79;5.13;0;CHEMBL656843;In vitro inhibitory activity against human erythrocyte Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1153663;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1995;None;
CHEMBL299750;;0;545.64;1;3.87;3c;CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)C(=O)NOCc1ccccc1;IC50;'=''';6;nM;8.22;;;UO_0000065;15.07;0.28;4.35;6.69;0;CHEMBL657770;Inhibition of human recombinant Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1133978;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2001;None;
CHEMBL313895;;0;658.8;1;4.4;3m;CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)C(=O)NOCc1ccccc1;IC50;'=''';17;nM;7.77;;;UO_0000065;11.79;0.22;3.37;5.11;0;CHEMBL657770;Inhibition of human recombinant Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1133978;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2001;None;
CHEMBL4281019;;0;340.43;0;2.74;4l;CCCCN/C(=C1/N=CN(CCOC)C1=O)c1cc2ccccc2[nH]1;IC50;'=''';350;nM;6.46;;;UO_0000065;18.96;0.35;3.72;9.26;0;CHEMBL4263564;Inhibition of calpain (unknown origin) using Suc-LY-AMC as fluorogenic substrate after 60 mins by spectrofluorometric analysis;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL4261583;1;Scientific Literature;Eur J Med Chem;2018;None;
CHEMBL85296;;0;497.59;0;3.43;3k;CCCC[C@H](NC(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)C)C(=O)C(=O)NOCc1ccccc1;IC50;'=''';21;nM;7.68;;;UO_0000065;15.43;0.29;4.25;6.25;0;CHEMBL657770;Inhibition of human recombinant Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1133978;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2001;None;
CHEMBL4285540;;0;418.5;0;3.01;4k;COCCN/C(=C1/N=C(c2ccccc2)N(CCOC)C1=O)c1cc2ccccc2[nH]1;IC50;'>''';1000;nM;;;;UO_0000065;;;;;0;CHEMBL4263564;Inhibition of calpain (unknown origin) using Suc-LY-AMC as fluorogenic substrate after 60 mins by spectrofluorometric analysis;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL4261583;1;Scientific Literature;Eur J Med Chem;2018;None;
CHEMBL4293865;;0;468.3;0;2.19;4q;COCCN/C(=C1/N=CN(CCOC)C1=O)c1[nH]c2ccccc2c1I;IC50;'=''';1080;nM;5.97;;;UO_0000065;12.74;0.31;3.78;7.56;0;CHEMBL4263564;Inhibition of calpain (unknown origin) using Suc-LY-AMC as fluorogenic substrate after 60 mins by spectrofluorometric analysis;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL4261583;1;Scientific Literature;Eur J Med Chem;2018;None;
CHEMBL1770880;;0;516.59;1;3.56;4c;CC/C(=C\c1ccc(O)c(O)c1)C(=O)N[C@@H](Cc1ccccc1)C(=O)C(=O)NCCc1ccc(OC)cc1;IC50;'=''';460;nM;6.34;;;UO_0000065;12.27;0.23;2.78;5.07;0;CHEMBL1771900;Inhibition of human erythrocytes mu-calpain using Suc-Leu-Tyr-AMC fluorogenic substrate after 30 mins by spectrofluorimetry;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1770073;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2011;None;
CHEMBL331649;;0;419.46;0;1.26;15b;COc1cc2c(cc1OC)S(=O)(=O)OC(C(=O)N[C@H](C=O)Cc1ccccc1)C2;IC50;'=''';2200;nM;5.66;;;UO_0000065;;;;;0;CHEMBL714770;Inhibitory concentration against MOLT-4 cells (human T-cell leukemia cell line);F;BAO_0000219;cell-based format;None;None;None;MOLT-4;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;CHEMBL3307557;
CHEMBL4277940;;0;343.39;0;0.98;4a;COCCN/C(=C1/N=CN(CCOC)C1=O)c1cc2cccnc2[nH]1;IC50;'=''';380;nM;6.42;;;UO_0000065;18.7;0.35;5.44;6.99;0;CHEMBL4263564;Inhibition of calpain (unknown origin) using Suc-LY-AMC as fluorogenic substrate after 60 mins by spectrofluorometric analysis;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL4261583;1;Scientific Literature;Eur J Med Chem;2018;None;
CHEMBL129694;;0;375.36;0;3;10;NC(=O)c1cn(-c2ccc(O)c(F)c2)c2cc(-c3ccncc3)ccc2c1=O;IC50;'=''';5000;nM;5.3;;;UO_0000065;14.12;0.26;2.3;5.4;0;CHEMBL656843;In vitro inhibitory activity against human erythrocyte Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1153663;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1995;None;
CHEMBL277776;;0;138.17;0;0.43;1a (Cystamidin A);NC(=O)CCc1cc[nH]c1;IC50;'=''';1400;nM;5.85;;;UO_0000065;42.37;0.8;5.42;9.94;0;CHEMBL659379;Inhibitory activity against calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1129109;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1996;None;
CHEMBL269333;;0;442.49;0;1.75;26c;CCN1C(C(=O)N[C@H](C=O)Cc2ccccc2)=Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';8;nM;8.1;;;UO_0000065;18.3;0.36;6.35;7.94;1;CHEMBL877099;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL340238;;0;375.36;0;3;12;NC(=O)c1cn(-c2ccc(O)cc2F)c2cc(-c3ccncc3)ccc2c1=O;IC50;'=''';7000;nM;5.16;;;UO_0000065;13.73;0.25;2.15;5.25;0;CHEMBL656843;In vitro inhibitory activity against human erythrocyte Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1153663;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1995;None;
CHEMBL8651;;0;543.64;1;1.61;8c (Single diastereomer);CCCCNC(=O)C(=O)[C@H](Cc1ccccc1)NC(=O)C1Cc2cc3c(cc2S(=O)(=O)N1CC)OCCO3;IC50;'=''';300;nM;6.52;;;UO_0000065;12;0.23;4.91;4.98;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL8651;;0;543.64;1;1.61;8c (Single diastereomer);CCCCNC(=O)C(=O)[C@H](Cc1ccccc1)NC(=O)C1Cc2cc3c(cc2S(=O)(=O)N1CC)OCCO3;IC50;'=''';2.1;nM;8.68;;;UO_0000065;15.96;0.31;7.07;6.62;0;CHEMBL654086;Inhibitory activity tested against human calpain 1 in Molt-4 cells (intact human T-cell leukemia cell line);B;BAO_0000219;cell-based format;None;None;None;MOLT-4;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;CHEMBL3307557;
CHEMBL8459;;0;577.66;1;2.01;8j;CCN1C(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCc2ccccc2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';81;nM;7.09;;;UO_0000065;12.28;0.24;5.08;5.41;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL8294;;0;688.76;1;0.92;11i;CCN1C(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCCNS(=O)(=O)c2ccc(F)cc2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';29;nM;7.54;;;UO_0000065;10.94;0.22;6.62;4.25;0;CHEMBL654079;In vitro inhibitory activity against recombinant human calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1146668;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2004;None;
CHEMBL269384;;0;444.51;0;1.32;15m;CCN1C(C(=O)N[C@H](C=O)Cc2ccccc2)Cc2cc3c(cc2S1(=O)=O)OCCO3;IC50;'=''';33;nM;7.48;;;UO_0000065;16.83;0.33;6.16;7.33;0;CHEMBL656196;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL211200;;0;369.46;0;1.75;12;CC(C)C[C@H](NC(=S)Nc1ccc(F)cc1)C(=O)N[C@H]1CCOC1O;IC50;'=''';150;nM;6.82;;;UO_0000065;18.47;0.37;5.07;8.26;0;CHEMBL863671;Inhibition of human erythrocyte mu calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138043;1;Scientific Literature;J. Med. Chem.;2006;None;
CHEMBL377197;;0;337.44;0;1.22;9;CC(C)[C@H](NC(=S)Nc1ccccc1)C(=O)N[C@H]1CCOC1O;IC50;'=''';630;nM;6.2;;;UO_0000065;18.38;0.37;4.98;7.51;0;CHEMBL863671;Inhibition of human erythrocyte mu calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138043;1;Scientific Literature;J. Med. Chem.;2006;None;
CHEMBL2408920;;0;421.45;0;2.27;BDBM62323;CC(C)C[C@H](NC(=O)[C@@H]1O[C@H]1C(=O)O)C(=O)Nc1nc(-c2ccc(F)cc2)cs1;IC50;'=''';175;nM;6.76;;419094;UO_0000065;16.03;0.32;4.49;5.59;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL253316;;0;482.54;0;2.5;3l;Cc1c(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NCCc2ccccn2)[nH]c2ccccc2c1=O;IC50;'=''';6280;nM;5.2;;;UO_0000065;10.78;0.2;2.7;4.3;0;CHEMBL928702;Inhibition of human mu-calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1140783;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2008;None;
CHEMBL254142;;0;377.4;0;1.23;3a;Cc1c(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(N)=O)[nH]c2ccccc2c1=O;IC50;'=''';710;nM;6.15;;;UO_0000065;16.29;0.3;4.92;5.03;1;CHEMBL928702;Inhibition of human mu-calpain;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1140783;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2008;None;
CHEMBL3893566;;0;459.46;0;1.2;BDBM240258;Cn1cncc1C[C@H](NC(=O)[C@H]1O[C@@H]1C(=O)O)C(=O)Nc1nc(-c2ccc(F)cc2)cs1;IC50;'=''';5000;nM;5.3;;419111;UO_0000065;11.54;0.23;4.1;3.82;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL489722;;0;355.39;0;0.73;2c;CCNC(=O)C(=O)[C@H](Cc1ccccc1)NC(=O)c1[nH]c(=O)ccc1C;IC50;'=''';40170;nM;4.4;;;UO_0000065;12.37;0.23;3.67;4.07;0;CHEMBL973384;Inhibition of human erythrocytes mu-calpain by spectrofluorimeter;B;BAO_0000019;assay format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1138543;1;Scientific Literature;Eur. J. Med. Chem.;2009;None;
CHEMBL423112;;0;382.46;0;2.86;MDL-28170;CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)NC(C=O)Cc1ccccc1;IC50;'=''';56;nM;7.25;;;UO_0000065;18.96;0.35;4.39;8.58;0;CHEMBL1012293;Inhibition of human CAPN1;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1155054;1;Scientific Literature;Bioorg. Med. Chem.;2008;None;
CHEMBL332683;;0;432.5;0;1.18;15d;COc1cc2c(cc1OC)S(=O)(=O)N(C)C(C(=O)N[C@H](C=O)Cc1ccccc1)C2;IC50;'=''';1900;nM;5.72;;;UO_0000065;;;;;0;CHEMBL714770;Inhibitory concentration against MOLT-4 cells (human T-cell leukemia cell line);F;BAO_0000219;cell-based format;None;None;None;MOLT-4;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;CHEMBL3307557;
CHEMBL197415;;0;420.47;0;2.54;2g;Cc1c(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NC(C)C)oc2ccccc2c1=O;IC50;'=''';5690;nM;5.25;;;UO_0000065;12.47;0.23;2.7;4.97;0;CHEMBL827857;Inhibitory concentration against human plasma mu-calpain;B;BAO_0000366;cell-free format;Homo sapiens;CHEMBL3559721;Plasma;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1139593;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2005;None;
CHEMBL274229;;0;478.5;0;2.31;2h;Cc1c(C(=O)N[C@@H](Cc2ccccc2)C(=O)C(=O)NC(C)C)oc2cc3c(cc2c1=O)OCCO3;IC50;'>''';20000;nM;;;;UO_0000065;;;;;0;CHEMBL827857;Inhibitory concentration against human plasma mu-calpain;B;BAO_0000366;cell-free format;Homo sapiens;CHEMBL3559721;Plasma;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1139593;1;Scientific Literature;Bioorg. Med. Chem. Lett.;2005;None;
CHEMBL3917979;;0;473.49;0;1.67;BDBM240248;CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)Nc1nc(-c2ccc(F)cc2)cs1;IC50;'>''';1000;nM;;;419096;UO_0000065;;;;;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL4756611;;0;296.32;0;3.56;11;COc1cc(/C=C/C=C/C(=O)c2ccc(O)cc2)ccc1O;IC50;'=''';16810;nM;4.77;;;UO_0000065;16.11;0.3;1.21;7.15;0;CHEMBL4718381;Inhibition of human erythrocytes mu-calpain using Pep1 as substrate incubated for 30 mins under shaking condition in presence of CaCl2 by fluorescence assay;B;BAO_0000221;tissue-based format;Homo sapiens;None;Blood;Erythrocyte;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL4715741;1;Scientific Literature;Eur J Med Chem;2016;None;TIME = 0.5 hr
CHEMBL4277595;;0;356.43;0;1.98;4j;COCCN/C(=C1/N=C(C)N(CCOC)C1=O)c1cc2ccccc2[nH]1;IC50;'=''';20;nM;7.7;;;UO_0000065;21.6;0.4;5.72;9.75;0;CHEMBL4263564;Inhibition of calpain (unknown origin) using Suc-LY-AMC as fluorogenic substrate after 60 mins by spectrofluorometric analysis;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL4261583;1;Scientific Literature;Eur J Med Chem;2018;None;
CHEMBL4288918;;0;355.44;0;1.5;4m;COCCN1C=N/C(=C(/NCCN(C)C)c2cc3ccccc3[nH]2)C1=O;IC50;'>''';1000;nM;;;;UO_0000065;;;;;0;CHEMBL4263564;Inhibition of calpain (unknown origin) using Suc-LY-AMC as fluorogenic substrate after 60 mins by spectrofluorometric analysis;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL4261583;1;Scientific Literature;Eur J Med Chem;2018;None;
CHEMBL118817;;0;357.39;0;1.13;32a;O=C[C@H](Cc1ccccc1)NC(=O)C1=NS(=O)(=O)c2ccccc2N1;IC50;'=''';83;nM;7.08;;;UO_0000065;19.81;0.39;5.95;6.76;0;CHEMBL877099;Inhibitory activity towards human calpain I;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1134781;1;Scientific Literature;J. Med. Chem.;2001;None;
CHEMBL3906209;;0;473.52;0;0.38;BDBM240238;CC(C)C[C@H](NC(=O)C1O[C@@H]1C(=O)O)C(=O)NCCCCNS(=O)(=O)c1ccc(F)cc1;IC50;'=''';150;nM;6.82;;419134;UO_0000065;14.41;0.29;6.44;4.43;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL3934516;;0;541.67;2;0.11;BDBM240233;CC(C)C[C@H](NC(=O)C1O[C@@H]1C(=O)O)C(=O)NCCCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12;IC50;'=''';100;nM;7;;419136;UO_0000065;12.92;0.26;6.89;3.93;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL4743183;;0;290.32;0;4.15;5;O=C(/C=C/c1ccc(O)c2ccccc12)c1ccc(O)cc1;IC50;'=''';69590;nM;4.16;;;UO_0000065;14.32;0.26;0.01;7.23;0;CHEMBL4718381;Inhibition of human erythrocytes mu-calpain using Pep1 as substrate incubated for 30 mins under shaking condition in presence of CaCl2 by fluorescence assay;B;BAO_0000221;tissue-based format;Homo sapiens;None;Blood;Erythrocyte;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL4715741;1;Scientific Literature;Eur J Med Chem;2016;None;TIME = 0.5 hr
CHEMBL4746320;;0;320.34;0;4.16;8;COc1cc(O)ccc1C(=O)/C=C/c1ccc(O)c2ccccc12;IC50;'=''';23820;nM;4.62;;;UO_0000065;14.43;0.26;0.46;6.92;0;CHEMBL4718381;Inhibition of human erythrocytes mu-calpain using Pep1 as substrate incubated for 30 mins under shaking condition in presence of CaCl2 by fluorescence assay;B;BAO_0000221;tissue-based format;Homo sapiens;None;Blood;Erythrocyte;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL4715741;1;Scientific Literature;Eur J Med Chem;2016;None;TIME = 0.5 hr
CHEMBL423112;;0;382.46;0;2.86;MDL28170;CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)NC(C=O)Cc1ccccc1;IC50;'=''';99;nM;7;;;UO_0000065;18.31;0.34;4.14;8.29;0;CHEMBL4718381;Inhibition of human erythrocytes mu-calpain using Pep1 as substrate incubated for 30 mins under shaking condition in presence of CaCl2 by fluorescence assay;B;BAO_0000221;tissue-based format;Homo sapiens;None;Blood;Erythrocyte;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL4715741;1;Scientific Literature;Eur J Med Chem;2016;None;TIME = 0.5 hr
CHEMBL92708;CALPEPTIN;0;362.47;0;3.2;Calpeptin;CCCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1;IC50;'=''';52;nM;7.28;;;UO_0000065;20.1;0.38;4.08;8.62;0;CHEMBL4263564;Inhibition of calpain (unknown origin) using Suc-LY-AMC as fluorogenic substrate after 60 mins by spectrofluorometric analysis;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL4261583;1;Scientific Literature;Eur J Med Chem;2018;None;
CHEMBL4764053;;0;265.31;0;3.54;14;COc1ccccc1/C=C/C=C/C(=O)c1cccnc1;IC50;'=''';19060;nM;4.72;;;UO_0000065;17.79;0.32;1.18;12.04;0;CHEMBL4718381;Inhibition of human erythrocytes mu-calpain using Pep1 as substrate incubated for 30 mins under shaking condition in presence of CaCl2 by fluorescence assay;B;BAO_0000221;tissue-based format;Homo sapiens;None;Blood;Erythrocyte;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL4715741;1;Scientific Literature;Eur J Med Chem;2016;None;TIME = 0.5 hr
CHEMBL191881;LEUPEPTIN;0;426.56;1;0.02;25 (Leupeptin);CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCNC(=N)N;IC50;'=''';300;nM;6.52;;;UO_0000065;15.29;0.3;6.5;3.92;0;CHEMBL656843;In vitro inhibitory activity against human erythrocyte Calpain 1;B;BAO_0000357;single protein format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1153663;1;Scientific Literature;Bioorg. Med. Chem. Lett.;1995;None;
CHEMBL88646;;0;374.46;0;1.07;19;CS(=O)(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C=O)Cc1ccccc1;IC50;'=''';600;nM;6.22;;;UO_0000065;16.62;0.33;5.15;6.74;0;CHEMBL658526;Inhibition of intracellular Calpain-I receptor using intact cell assay system;B;BAO_0000219;cell-based format;None;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL1131026;1;Scientific Literature;J. Med. Chem.;1998;None;
CHEMBL3938487;;0;503.69;1;2.1;BDBM240231;CC(C)C[C@H](NC(=O)C1O[C@@H]1C(=O)O)C(=O)NCCCCNC(=O)CCCCC1CCSS1;IC50;'=''';150;nM;6.82;;419074;UO_0000065;13.55;0.28;4.72;4.98;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL3974202;;0;389.5;0;1.69;BDBM240235;CC(=O)NCCCCNC(=O)[C@H](CC(C)C)NC(=O)C1OC1c1ccccc1;IC50;'=''';1000;nM;6;;419078;UO_0000065;15.4;0.29;4.31;6.01;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL2408912;;0;445.43;0;1.19;28a;O=C(Nc1nc(-c2ccc(F)cc2)cs1)C(Cc1cnc[nH]1)NC(=O)[C@H]1O[C@@H]1C(=O)O;IC50;'=''';100;nM;7;;;UO_0000065;15.72;0.31;5.81;4.68;1;CHEMBL2411626;Inhibition of human erythrocyte full length Cal1 using (DABCYL)TPLK-SPPSPR-(EDANS) as substrate after 20 min by FRET assay;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL2407090;1;Scientific Literature;J. Med. Chem.;2013;None;
CHEMBL4765091;;0;304.35;0;4.45;6;COc1ccc(/C=C/C(=O)c2ccc(O)cc2)c2ccccc12;IC50;'=''';10230;nM;4.99;;;UO_0000065;16.4;0.3;0.54;10.72;0;CHEMBL4718381;Inhibition of human erythrocytes mu-calpain using Pep1 as substrate incubated for 30 mins under shaking condition in presence of CaCl2 by fluorescence assay;B;BAO_0000221;tissue-based format;Homo sapiens;None;Blood;Erythrocyte;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL4715741;1;Scientific Literature;Eur J Med Chem;2016;None;TIME = 0.5 hr
CHEMBL4799634;;0;324.38;0;4.25;12;CCOc1cc(O)ccc1C(=O)/C=C/C=C/c1ccccc1OC;IC50;'=''';12980;nM;4.89;;;UO_0000065;15.06;0.28;0.64;8.76;0;CHEMBL4718381;Inhibition of human erythrocytes mu-calpain using Pep1 as substrate incubated for 30 mins under shaking condition in presence of CaCl2 by fluorescence assay;B;BAO_0000221;tissue-based format;Homo sapiens;None;Blood;Erythrocyte;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL4715741;1;Scientific Literature;Eur J Med Chem;2016;None;TIME = 0.5 hr
CHEMBL4283272;;0;421.3;0;2.35;4p;COCCN/C(=C1/N=CN(CCOC)C1=O)c1[nH]c2ccccc2c1Br;IC50;'>''';1000;nM;;;;UO_0000065;;;;;0;CHEMBL4263564;Inhibition of calpain (unknown origin) using Suc-LY-AMC as fluorogenic substrate after 60 mins by spectrofluorometric analysis;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL4261583;1;Scientific Literature;Eur J Med Chem;2018;None;
CHEMBL3906209;;0;473.52;0;0.38;BDBM240238;CC(C)C[C@H](NC(=O)C1O[C@@H]1C(=O)O)C(=O)NCCCCNS(=O)(=O)c1ccc(F)cc1;IC50;'=''';100;nM;7;;419081;UO_0000065;14.78;0.3;6.62;4.54;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL2408904;;0;521.35;1;0.68;BDBM240272;O=C(NCc1cn(-c2ccc(Br)cc2)nn1)[C@H](Cc1cscn1)NC(=O)[C@H]1O[C@@H]1C(=O)O;IC50;'=''';40;nM;7.4;;419127;UO_0000065;14.19;0.32;6.72;4.88;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL3929814;;0;419.39;0;0.68;BDBM240263;O=C(Nc1nc2ccc(F)cc2s1)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1O[C@@H]1C(=O)O;IC50;'=''';530;nM;6.28;;419137;UO_0000065;14.96;0.3;5.6;4.2;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL3961304;;0;159.14;0;-1.2;BDBM240279;CCOC(=O)[C@H]1O[C@@H]1C(N)=O;IC50;'>''';1000;nM;;;419095;UO_0000065;;;;;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL2408912;;0;445.43;0;1.19;BDBM240249;O=C(Nc1nc(-c2ccc(F)cc2)cs1)C(Cc1cnc[nH]1)NC(=O)[C@H]1O[C@@H]1C(=O)O;IC50;'=''';100;nM;7;;419099;UO_0000065;15.72;0.31;5.81;4.68;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL3963225;;0;384.38;0;1.76;BDBM240250;CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)Nc1c(F)cccc1F;IC50;'>''';1000;nM;;;419103;UO_0000065;;;;;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL4784996;;0;270.28;0;3;2;COc1ccc(O)cc1/C=C/C(=O)c1ccc(O)cc1;IC50;'=''';16670;nM;4.78;;;UO_0000065;17.68;0.33;1.78;7.16;0;CHEMBL4718384;Inhibition of human erythrocytes mu-calpain using Pep2 as substrate incubated for 30 mins under shaking condition in presence of CaCl2 by fluorescence assay;B;BAO_0000221;tissue-based format;Homo sapiens;None;Blood;Erythrocyte;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL4715741;1;Scientific Literature;Eur J Med Chem;2016;None;TIME = 0.5 hr
CHEMBL3917979;;0;473.49;0;1.67;BDBM240248;CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)Nc1nc(-c2ccc(F)cc2)cs1;IC50;'>''';1000;nM;;;419098;UO_0000065;;;;;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL3898233;;0;279.29;0;0.13;BDBM240252;CCOC(=O)[C@H]1O[C@@H]1C(=O)NCc1ccc(CO)cc1;IC50;'>''';1000;nM;;;419105;UO_0000065;;;;;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL2408916;;0;361.38;0;0.66;BDBM240261;O=C(Nc1ccccc1)[C@H](Cc1cscn1)NC(=O)[C@H]1O[C@@H]1C(=O)O;IC50;'=''';2500;nM;5.6;;419114;UO_0000065;15.5;0.31;4.94;4.63;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL3943150;;0;501.58;1;0.86;BDBM240237;CCOC(=O)[C@H]1OC1C(=O)N[C@@H](CC(C)C)C(=O)NCCCCNS(=O)(=O)c1ccc(F)cc1;IC50;'>''';1000;nM;;;419080;UO_0000065;;;;;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL2408900;;0;589.66;2;0.09;BDBM240268;O=C(NCc1cn(-c2ccc(S(=O)(=O)N3CCCCC3)cc2)nn1)[C@H](Cc1cscn1)NC(=O)[C@H]1O[C@@H]1C(=O)O;IC50;'=''';1500;nM;5.82;;419123;UO_0000065;9.88;0.2;5.73;3.08;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL2408906;;0;478.44;0;0.2;BDBM240274;O=C(NCc1cn(-c2c(F)cccc2F)nn1)[C@H](Cc1cscn1)NC(=O)[C@H]1O[C@@H]1C(=O)O;IC50;'>''';1000;nM;;;419129;UO_0000065;;;;;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL4786246;;0;280.32;0;3.85;13;COc1ccccc1/C=C/C=C/C(=O)c1ccc(O)cc1;IC50;'=''';13700;nM;4.86;;;UO_0000065;17.35;0.32;1.01;10.45;0;CHEMBL4718381;Inhibition of human erythrocytes mu-calpain using Pep1 as substrate incubated for 30 mins under shaking condition in presence of CaCl2 by fluorescence assay;B;BAO_0000221;tissue-based format;Homo sapiens;None;Blood;Erythrocyte;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL4715741;1;Scientific Literature;Eur J Med Chem;2016;None;TIME = 0.5 hr
CHEMBL3913213;;0;449.5;0;2.75;BDBM240245;CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)Nc1nc(-c2ccc(F)cc2)cs1;IC50;'>''';1000;nM;;;419087;UO_0000065;;;;;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL3959031;;0;173.17;0;-0.64;BDBM240277;CC(C)NC(=O)[C@H]1O[C@@H]1C(=O)O;IC50;'>''';1000;nM;;;419092;UO_0000065;;;;;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL4740843;;0;264.28;0;4.03;10;O=C(/C=C/c1ccc(O)c2ccccc12)c1ccco1;IC50;'=''';40870;nM;4.39;;;UO_0000065;16.61;0.3;0.36;8.7;0;CHEMBL4718381;Inhibition of human erythrocytes mu-calpain using Pep1 as substrate incubated for 30 mins under shaking condition in presence of CaCl2 by fluorescence assay;B;BAO_0000221;tissue-based format;Homo sapiens;None;Blood;Erythrocyte;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL4715741;1;Scientific Literature;Eur J Med Chem;2016;None;TIME = 0.5 hr
CHEMBL4780290;;0;310.35;0;3.71;15;COc1ccc(/C=C/C(=O)/C=C/c2ccc(O)cc2OC)cc1;IC50;'=''';46570;nM;4.33;;;UO_0000065;13.96;0.26;0.62;7.77;0;CHEMBL4718381;Inhibition of human erythrocytes mu-calpain using Pep1 as substrate incubated for 30 mins under shaking condition in presence of CaCl2 by fluorescence assay;B;BAO_0000221;tissue-based format;Homo sapiens;None;Blood;Erythrocyte;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL4715741;1;Scientific Literature;Eur J Med Chem;2016;None;TIME = 0.5 hr
CHEMBL3934516;;0;541.67;2;0.11;BDBM240233;CC(C)C[C@H](NC(=O)C1O[C@@H]1C(=O)O)C(=O)NCCCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12;IC50;'=''';150;nM;6.82;;419076;UO_0000065;12.6;0.25;6.71;3.83;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL2408921;;0;473.52;0;0.38;BDBM240243;CC(C)C[C@H](NC(=O)[C@H]1O[C@@H]1C(=O)O)C(=O)NCCCCNS(=O)(=O)c1ccc(F)cc1;IC50;'=''';100;nM;7;;419085;UO_0000065;14.78;0.3;6.62;4.54;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL3946507;;0;445.43;0;1.19;BDBM240281;O=C(Nc1nc(-c2ccc(F)cc2)cs1)[C@H](Cc1cnc[nH]1)NC(=O)[C@H]1O[C@@H]1C(=O)O;IC50;'>''';1000;nM;;;419097;UO_0000065;;;;;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL3921574;;0;459.46;0;1.2;BDBM240259;Cn1cnc(C[C@H](NC(=O)[C@H]2O[C@@H]2C(=O)O)C(=O)Nc2nc(-c3ccc(F)cc3)cs2)c1;IC50;'=''';225;nM;6.65;;419112;UO_0000065;14.47;0.28;5.45;4.79;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL92708;CALPEPTIN;0;362.47;0;3.2;Calpeptin;CCCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1;IC50;'=''';297;nM;6.53;;;UO_0000065;18.01;0.34;3.33;7.72;0;CHEMBL4718381;Inhibition of human erythrocytes mu-calpain using Pep1 as substrate incubated for 30 mins under shaking condition in presence of CaCl2 by fluorescence assay;B;BAO_0000221;tissue-based format;Homo sapiens;None;Blood;Erythrocyte;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL4715741;1;Scientific Literature;Eur J Med Chem;2016;None;TIME = 0.5 hr
CHEMBL490920;;0;383.45;0;-0.11;CA074;CCCNC(=O)[C@H]1O[C@@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)CC;IC50;'>''';100000;nM;;;;UO_0000065;;;;;0;CHEMBL4718381;Inhibition of human erythrocytes mu-calpain using Pep1 as substrate incubated for 30 mins under shaking condition in presence of CaCl2 by fluorescence assay;B;BAO_0000221;tissue-based format;Homo sapiens;None;Blood;Erythrocyte;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL4715741;1;Scientific Literature;Eur J Med Chem;2016;None;TIME = 0.5 hr
CHEMBL4741582;;0;244.25;0;2.89;4;COc1cc(/C=C/C(=O)c2ccco2)ccc1O;IC50;'=''';15390;nM;4.81;;;UO_0000065;19.7;0.37;1.92;8.07;0;CHEMBL4718384;Inhibition of human erythrocytes mu-calpain using Pep2 as substrate incubated for 30 mins under shaking condition in presence of CaCl2 by fluorescence assay;B;BAO_0000221;tissue-based format;Homo sapiens;None;Blood;Erythrocyte;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL4715741;1;Scientific Literature;Eur J Med Chem;2016;None;TIME = 0.5 hr
CHEMBL63440;ALOXISTATIN;0;342.44;0;1.01;E64D;CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C;IC50;'=''';62260;nM;4.21;;;UO_0000065;12.28;0.24;3.2;4.33;0;CHEMBL4718381;Inhibition of human erythrocytes mu-calpain using Pep1 as substrate incubated for 30 mins under shaking condition in presence of CaCl2 by fluorescence assay;B;BAO_0000221;tissue-based format;Homo sapiens;None;Blood;Erythrocyte;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL4715741;1;Scientific Literature;Eur J Med Chem;2016;None;TIME = 0.5 hr
CHEMBL4789024;;0;280.35;0;4.5;9;O=C(/C=C/c1ccc(O)c2ccccc12)c1cccs1;IC50;'>''';50000;nM;;;;UO_0000065;;;;;0;CHEMBL4718381;Inhibition of human erythrocytes mu-calpain using Pep1 as substrate incubated for 30 mins under shaking condition in presence of CaCl2 by fluorescence assay;B;BAO_0000221;tissue-based format;Homo sapiens;None;Blood;Erythrocyte;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL4715741;1;Scientific Literature;Eur J Med Chem;2016;None;TIME = 0.5 hr
CHEMBL253777;;0;270.28;0;3;3;COc1cc(O)ccc1C(=O)/C=C/c1ccc(O)cc1;IC50;'=''';16920;nM;4.77;;;UO_0000065;17.65;0.33;1.77;7.15;0;CHEMBL4718384;Inhibition of human erythrocytes mu-calpain using Pep2 as substrate incubated for 30 mins under shaking condition in presence of CaCl2 by fluorescence assay;B;BAO_0000221;tissue-based format;Homo sapiens;None;Blood;Erythrocyte;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL4715741;1;Scientific Literature;Eur J Med Chem;2016;None;TIME = 0.5 hr
CHEMBL2408922;;0;421.45;0;2.27;BDBM50437951;CC(C)C[C@H](NC(=O)[C@H]1O[C@@H]1C(=O)O)C(=O)Nc1nc(-c2ccc(F)cc2)cs1;IC50;'=''';250;nM;6.6;;419133;UO_0000065;15.67;0.31;4.33;5.46;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL2408918;;0;468.52;0;1.77;BDBM50437949;C#Cc1ccc(-c2csc(NC(=O)[C@H](Cc3cscn3)NC(=O)[C@H]3O[C@@H]3C(=O)O)n2)cc1;IC50;'=''';100;nM;7;;419138;UO_0000065;14.94;0.3;5.23;5.23;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL2408903;;0;578.45;1;1.96;BDBM240271;O=C(NCc1cn(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)nn1)[C@H](Cc1cscn1)NC(=O)[C@H]1O[C@@H]1C(=O)O;IC50;'>''';1000;nM;;;419126;UO_0000065;;;;;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL2408924;;0;356.32;0;1.29;BDBM240251;CC(C)C[C@H](NC(=O)[C@H]1O[C@@H]1C(=O)O)C(=O)Nc1c(F)cccc1F;IC50;'=''';100;nM;7;;419131;UO_0000065;19.65;0.38;5.71;6.48;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
CHEMBL2408905;;0;487.45;1;-0.17;BDBM240273;O=C(NCc1cn(-c2ccc([N+](=O)[O-])cc2)nn1)[C@H](Cc1cscn1)NC(=O)[C@H]1O[C@@H]1C(=O)O;IC50;'=''';300;nM;6.52;;419128;UO_0000065;13.38;0.26;6.69;3.35;0;CHEMBL3888843;Inhibition FRET Assay: The Calbiochem InnoZyme activity kit was used for measuring the inhibition effect inhibitors on human erythrocyte calpain 1 activity. A calpain FRET substrate, (DABCYL)-TPLKSPPPSPR-(EDANS) (SEQ ID NO: 9), was used to detect the activity of Cal1. 20 μM of the FRET substrate, 10 nM of native Cal1, and 20 μM TCEP (reducing agent) were added to the reaction mixture containing assay buffer (Tris [10 mM], NaCl [100 mM], pH 7.4). Cal1 was activated by the addition of 10 μM calcium. Cleavage of the scissile bond amide bond, K-S, releases the fluorophore (EDANS) from the internal quenching molecule (DABCYL), resulting in an increase in fluorescence measured at 320 nm excitation and 480 nm emission wave lengths for 30 min. Each inhibitor was added to the reaction mixture at varying concentrations (10 nM, 100 nM, 1 μM, and 10 μM) to detect inhibition of Cal1 and reduction in fluorescence was measured by 96 well-plate reader.;B;BAO_0000357;single protein format;Homo sapiens;None;None;None;None;;;;CHEMBL3891;Calpain 1;Homo sapiens;SINGLE PROTEIN;CHEMBL3886857;37;BindingDB Database;;2016;None;
